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Ubiquitin is a highly conserved 76 amino acid protein which is a unique and versatile 
signalling molecule. Ubiquitin can be attached by an isopeptide bond between its C-
terminal diglycine to a lysine residue of a target substrate. However, it can also bind to 
itself though one of its own seven lysine residues allowing the formation of different 
chain types. These chains act as signals for different pathways, such as DNA damage 
repair, and in particular lysine-48 chains signal for proteins to be degraded via the 
proteasome by the ubiquitin proteasome system (UPS). This allows cells to control the 
concentration of proteins which is important in triggering cellular events, such as cyclin 
levels in cell division. Whilst old and incorrect proteins need to be removed so they do 
not interfere with normal processes. 
In order to recognise and ubiquitinate substrates an enzyme cascade has evolved. 
Ubiquitin is transferred from an ubiquitin activation enzyme (E1) to an ubiquitin 
conjugating enzyme (E2). The E2 which along with a ubiquitin ligase (E3) ubiquitinates 
a specific substrate. Research has focused on the E3 ligases since they are responsible 
for identifying substrates. One important ligase is the anaphase promoting 
complex/cyclosome (APC/C) which is responsible for faithful segregation of 
chromosome during mitosis. Failure to regulate this process can lead to aneuploidy, one 
of the main causes of cancer. It is therefore important to understand the function and 
regulation of APC/C and the UPS.  
This work firstly shows that four S. pombe kinases, Ssp2, Ppk9, Kin1 and Chk1 all 
contain a kinase associated 1 (KA1) or KA2 domain which they use to interact 
specifically with APC/C when it contained an unphosphorylated form of a subunit called 
Cut9. Yeast two hybrid and native far Westerns demonstrated that the KA domains 
interact with the APC/C co activator Slp1. Phosphorylation assays showed that three of 
these kinases phosphorylated a ~30kDa band of the APC/C complex which was shown 
to be Mad2, an important subunit of the APC/C inhibitor complex the mitotic checkpoint 
complex (MCC). These finding suggest a new role for KA contain kinases as regulators 
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of APC/C activity. Future studies to identify the residues of Mad2 which are 
phosphorylated by these kinases, as well as the binding site of Slp1 that the KA domains 
recognise, would provide a more detailed understanding of the molecular mechanisms 
involved in regulating APC/C activity. 
Secondly, this study investigated the role of the ubiquitin associated (UBA) domains in 
the S. pombe shuttle factor Rhp23. This protein can recognise the proteasome via an 
ubiquitin like (UBL) domain and ubiquitin chains via one of two UBA domains: an 
internal UBA1 and a C-terminal UBA2. To dissect the different functions of these two 
UBA domains point mutations were made that abolished the domains ability to 
recognise ubiquitin without altering the protein structure. The minimal domains and full 
length domains were tested in vitro and in vivo. These surprising results showed that the 
domains act differently in isolation when compared to the full length protein. They also 
demonstrate that the UBA1 domain is responsible for ubiquitin recognition in Rhp23, 
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1.1 S. pombe 
Schizosaccharomyces pombe, commonly called fission yeast, is a single celled free 
living organism that is a member of the Schizosaccharomycetaceae family of fungi. It 
shares some similarities to another yeast, Saccharomyces cerevisiae, both of which are 
commonly used as a model organisms for research. Both these yeasts have been 
extensively used as genetic models as their genomes, which are fully sequenced, are 
easy to manipulate. As they exist as haploids, they usually have one copy of each gene. 
Another advantage that arises with these well studied organisms is that there are now 
many reagents and protocols available (Forsburg & Rhind 2006). S. pombe has a 
genome of 13.8Mb which consists of three chromosomes as well as a 20kb 
mitochondrial genome. Together the genome encodes up to 4940 Open Reading Frames 
(ORF). Many of these genes have homologues in higher organisms (Wood et al. 2002). 
However despite those similarities there are many differences between the two yeasts 
which were estimated to have separated around 1000 million years ago. Under normal 
conditions S. pombe exist as haploid whilst S. cerevisiae are diploid, although lab strains 
can be manipulated to produce diploids or haploids respectively. Sequencing of their 
genomes revealed that S. cerevisiae has undergone a large scale duplication, something 
S. pombe has not done. S. pombe cells are 12–15µm in length and therefore larger than 
S. cerevisiae 5–10µm which makes them easier to observe. Also S. pombe undergoes 
medial fission division similar to mammalian cells whilst S. cerevisiae divides by 
forming a bud, giving rise to its common name of budding yeast (Wood et al. 2002; 
Forsburg & Rhind 2006). 
S. pombe was the model organism used by Paul Nurse and colleagues to dissect the 
components of the cell cycle. One of the features of fission yeast that allowed them to do 
this is that during the cell cycle fission yeast increases in length. By simply measuring 
the cell you can determine what stage it is in. This work lead to Sir Paul Nurse, Leland 
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Hartwell and Richard “Tim” Hunt being awarded the Nobel Prize in Physiology or 
Medicine in 2001 "for their discoveries of key regulators of the cell cycle" 
(Nobelprize.org 2011). 
 
1.2 Cell Cycle 
In order to grow, repair, develop and reproduce all cells must replicate. Cells undergo a 
tightly controlled cell cycle which allows them to divide and pass on their DNA and 
cellular components to a new sister cell. The cell cycle is divided into two stages, 
interphase and mitosis. Interphase is the longest stage which consists of G1, S and G2. G1 
is a gap phase in which cells can either commit to divide and prepare to synthesize DNA 
or enter G0, a state in which cells are no longer in the cell cycle. DNA is synthesis in S 
phase causing the cell to temporarily become polyploid. The final stage of interphase is 
G2 in which cells prepare to enter mitosis. Mitosis is sub divided into prophase, 
metaphase, anaphase and telophase. Prophase is defined by the condensing of 
chromosomes, which attach to spindle microtubules via the kinetochore before 
metaphase, when bound chromosomes align at the metaphase plate. The next stage is 
anaphase, in which attached chromosomes separate into sister chromatids via the 
degradation of the cohesion complex which holds them together. The microtubules then 
pull the sister chromatids to opposite poles of the cells to form two sister nuclei. Finally 
during telophase the two new nuclei are formed and the cell undergoes cytokinesis to 
form two cells (Lodish et al. 2004).  
1.2.1 Cdks & Cyclins 
The whole cell cycle is controlled by Cyclin Dependent Kinases (Cdk) and cyclins. Cdks 
are serine threonine kinases which bind to certain cyclins. Cyclins recognise specific 
target proteins and allows the Cdk to phosphorylate them. The levels of Cdks in the cell 
remains constant throughout the cell cycle but their activity is regulated by binding 
cyclins, Cyclin dependent Kinase Inhibitor (CKI), phosphorylation and controlling their 
location within the cell. However, in mammals the concentration of cyclins varies since 
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they contain Destruction-boxes (D- boxes) or PEST sequences (rich in proline (P), 
glutamic acid (E), serine (S) and threonine (T) residues) which marks them as targets for 
ubiquitination and degradation when they are no longer required. In mammalian systems 
Cdk6 and Cdk4 bind to D type Cyclin during G1. At the junction between G1 and S 
phase Cdk2 binds to CyclinE, then during S phase Cdk2 binds CyclinA. The transition 
between G2 to mitosis is regulated by Cdk1 and CyclinA whilst Cdk1-CyclinB is active 
during mitosis (reviewed in Schafer 1998; Vermeulen et al. 2003).   
S. pombe differs from mammals in that it only possesses one essential Cdk called Cell 
Division Cycle 2 (Cdc2). It also expressed one essential mitotic cyclin, called Cell 
Division Cycle 13 (Cdc13) and three non essential cyclins called Cig1, Cig2, Puc1. 
Instead of using different combinations of Cdks and cyclins, fission yeast uses the 
concentration of Cdc2-Cdc13, also known as the M Phase Factor (MPF), to control cell 
division. At G1 the concentration of Cdc2-Cdc13 is very low, then at S phase the 
concentration rises to an intermediate level. Mitosis is signalled by a high concentration 
of Cdc2-Cdc13. When Cdc2-Cdc13 is formed it moves into the nucleus but is 
inactivated by the Wee1 protein kinase which phosphorylates Cdc2. This 
phosphorylation is removed by the phosphatase Cdc25 at G2 activating the MPF. 
Positive feedback loops are set up since Wee1 is inactivated by MPF whilst Cdc25 is 
activated by it. This system causes a sharp peak of Cdc2-Cdc13 activation at the 
transition of G2-M phase. In order to exit mitosis, the MPF needs to be inactivated by 




 which recognises 
and ubiquitinates Cdc13 causing it to be degraded. Cdc13 is continuously translated and 
as a result Cdc2-Cdc13 starts to reform at G1. To repress its activity until it is needed, 
the CKI Rum1 binds to the Cdc2-Cdc13 dimer. However, when the cell increases in size 
Cdc2 has enough activity to phosphorylate Ste9 causing it to dissociate from APC/C and 
also phosphorylate Rum1 removing it from the MPF complex. This allows the cell to 




In order to ensure that the correct amount of good quality undamaged DNA is passed on 
to each cell, the cycle contains several checkpoints, which serve to detect any problems 
that may occur at different phases and halt the cell cycle. This gives the cell time to 
repair the problem before continuing to the next stage of the cycle, or if the problem 
cannot be rectified the cell can undergo apoptosis. The term “checkpoint” was first 
defined by Hartwell and Weinert when they discovery that irradiation of WT budding 
yeast caused the cells to undergo a cell cycle delay after G2, whilst rad9 mutants could 
carry on dividing normally, even though their DNA was damaged, which eventually led 
to lethality (Weinert & Hartwell 1988; Hartwell & Weinert, 1989).  
Since this important finding several checkpoints have been found in the cell cycle 
including: four DNA damage checkpoints at i) G1 phase ii) G1-S phase boundary iii) S 
phase iv) G2-M phase boundary as well as v) an unreplicated DNA checkpoint at G2-M 
phase boundary  vi) a spindle assembly checkpoint at metaphase to anaphase boundary 
(see section 1.6) and vii) a chromosome segregation checkpoint at telophase known as 
the NoCut pathway in yeast (Forbes & Enoch, 2000; Vermeulen et al. 2003; Lodish et 
al. 2004; Norden et al. 2006). 
In mammalian cells the DNA damage and unreplicated DNA checkpoints are controlled 
by Ataxia-Telangiectasia-Mutated (ATM) and ATaxia and Rad3 related (ATR). These 
kinases recognise DNA damage and as a result, phosphorylate p53, causing the 
transcription of many genes including p21 which is a CKI. p21 inhibits Cdk-cyclin 
activity causing the cell cycle to be blocked until the damage can be rectified. 
Alternatively ATM and ATR can block the cell cycle in a p53 independent manner by 
activating Chk1 and Chk2 (the function of Chk1 will be explained fully in section 1.9.3). 
These kinases phosphorylate Cdc25 causing it to be sequestered by binding to a 14-3-3 
protein so it cannot enter the nucleus, and, therefore, will not remove inhibitory 
phosphate groups from Cdks. ATR also activates Chk1 before mitosis, as part of the 
unreplicated DNA checkpoint which stops cells dividing if they have not fully replicated 
their DNA (Schauber et al. 1998; Vermeulen et al. 2003; Lodish et al. 2004).  
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The remaining spindle assembly and chromosome segregation checkpoints are 
controlled through regulating the activity of the enzyme APC/C. These checkpoints 
ensure that all the chromosomes have attached to spindles before entering anaphase and 
also monitor chromosomal segregation is completed before exiting mitosis respectively 
(Vermeulen et al. 2003; Lodish et al. 2004). The role and regulation of APC/C as well 
the spindle assembly checkpoint will be discussed in sections 1.5 and 1.6.                              
1.3 Protein Degradation 
For a long time the timing of transcription and translation of proteins by cells has been 
of great interest. The main focus has been put on the importance of proteins being 
expressed at the right time, but little research has concentrated on the removal of 
proteins from the cell.  
How cells orchestrate the degradation of proteins is vital for the proper function and 
survival of the cell. Degradation of mis-folded proteins is essential in order that the 
native proteins may follow their natural function without interference. Order is also 
maintained by timing the removal of old or surplus protein (Hershko et al. 1982). One of 
the best examples of this is the controlled progression through the cell cycle by 
degradation of cyclins; for example cyclinB (Evans et al. 1983; Peters 2006). Where 
there is inefficient removal of proteins, medical conditions such as neurodegenerative 
diseases (for example Alzheimer’s), can arise due to the formation of protein aggregates 
(Matsumoto et al. 2004). There are several methods that cells employ to remove 
unwanted proteins such as autophagy, the Endoplasmic Reticulum Associated Protein 
Degradation (ERAD) pathway or being directed to the proteasome where they are 





1.4.1 Structure & Enzymatic Cascade 
Ubiquitin is a small 8 kDa protein made up of 76 amino acids which form a distinct 
tertiary structure known as the β-grasp fold (Figure 1) (Winget & Mayor 2010). 
Ubiquitin is highly conserved across eukaryotic organisms and is utilised as a signalling 
molecule as it is able to covalently tag substrate proteins via an enzymatic cascade 
(Figure 2). A ubiquitin-activating enzyme (E1) uses ATP to adenylate ubiquitin, which 
causes it to become activated (Hershko et al. 1981). This active form of ubiquitin can 
bind to the E1 via the sulfhydryl group of one of its cysteine residues forming a thiol 
ester. The E1 then passes ubiquitin to an ubiquitin-conjugating enzyme (E2). This uses 
one of its cysteine residues in the catalytic site form a thiol ester with ubiquitin (Hershko 
et al. 1983). The E2s can then either transfer the ubiquitin to an ubiquitin ligase enzyme 
(E3), which recognises specific substrates, and then ubiquitinates them or the E2s can 
work together with an E3 to directly ubiquitinate a substrate without transferring the 
ubiquitin to the E3. The E3 ligases forms a covalent isopeptide bond between the C-
terminal glycine carboxyl group of ubiquitin and the ε-amino group of a lysine from the 
target protein (Ciechanover et al. 1981; Hershko et al. 1983; Hershko et al. 1986; Nandi 
et al. 2006). Single or multiple mono ubiquitination can be used to signal processes such 
as DNA damage repair, histone regulation and endocytosis (Hicke 2001; Hoeller et al. 
2006). In all organisms the ubiquitin enzyme cascade forms a hierarchy, usually with a 
few E1s at the top. In S. pombe there is one E1: Poly(A)+ RNA TRansport 3 (Ptr3) 
(Azad et al. 1997) and several E2s including: UBiquitin-Conjugating enzyme 1 (Ubc1), 
Ubc4, Ubc6, Ubc7, Ubc8, Ubc11, Ubc13, Ubc14, Ubc15, Ubc16, Rad Homolog Pombe 
6 (Rhp6) and Mms2 (C. M. Pickart 2001). As in other organisms, fission yeast encodes 




Figure 1: Tertiary Structure of Ubiquitin.  
A cartoon of the structure of S. cerevisiae ubiquitin. Lysines represented as “ball and stick” cartoon. 
Percentages shown in red next to lysine residues relate to the relative amount of linkage formed by the 





Figure 2: Enzymatic Ubiqutin Cascade.  
Ubiquitin is activated by an E1 that utilises ATP to form an adenylate ubiquitin. This form of ubiquitin 
can then bind to the E1 which passes the ubiquitin moiety onto the E2. The E2 can then either pass the 
ubiqutin onto an E3 to form a chemical intermediate which can ubiquitinate a substrate at a lysine residue 
(e.g HECT), or it can work with the E3 as a co-factor to ubiquitinate a substrate (e.g. RING). 
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1.4.2 Chain Formation 
What makes ubiquitin such a diverse signalling molecule is its ability to bind to itself 
through one of its own 7 lysine residues: K6, K11, K27, K29, K33, K48 and K63 to 
form chains (Figure 1). These different chains are used as signals for different pathways 
(Pickart & Fushman 2004). For example, K63 chains can signal for DNA repair and 
activation of kinases, but K48 chains usually mark proteins for degradation via the 
proteasome, a process which is known as the Ubiquitin Proteasome System (UPS) 
(Pickart & Hofmann 1999; Thrower et al. 2000). A fourth enzyme (E4) has been 
described which specifically recognises mono-ubiquitinated targets and facilitates poly-
ubiquitin chain formation (Koegl et al. 1999). 
1.4.3 Removing Ubiquitin 
Ubiquitination is a dynamic signal as the modification can also be removed from 
proteins by proteases called DeUBiquitin enzymes (DUB), in fission yeast known as 
Pad1, Uch2 and Ubp6 (O'Donoghue & Gordon 2008). In S. pombe, there are four genes 
which encode ubiquitin bound to a ribosomal protein. There is also a fifth gene that 
encodes a chain of four ubiquitin moieties fused together, which is expressed in times of 
cellular stress, when protein degradation is up-regulated. Ubiquitin needs to processed 
by DUBs from these proteins or cleaved into single moieties before it can modify 
substrates (Verma et al. 2002; O’Donoghue & Gordon 2008). Substrates also need to be 
deubiquitinated to turn off a signalling pathway or to allow them to to enter the 
proteasome, which is carried out by the proteasome subunit Pad1(O'Donoghue & 
Gordon 2008).  
1.4.4 Ubiquitin Like Proteins 
After the discovery of ubiquitin other similar proteins were found and classed as 
UBiquitin Like proteins (UBL). Many were discovered through sequence homology and 
all share ubiquitin’s β-grasp fold tertiary structure. These modifiers are attached to target 
proteins via a similar cascade and signal for different pathways or regulate proteins. 
Although several UBLs have been identified, two of the most well studied are Neural 
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precursor cell Expressed and Developmentally Down-regulated 8 (Nedd8) and Small 
Ubiquitin-like MOdifier (SUMO).  
Nedd8 share ~55% homology to ubiquitin and has its own dedicated E1 and E2’s but as 
yet no specific E3 has be identified for Nedd8 (Kerscher et al. 2006). Nedd8 is attached 
to conserved lysine residue of E3 cullins subunits. This neddylation appears to control 
the interaction between E3s and E2s and, therefore, neddylation of cullins activates E3 
ligases (Hori et al. 1999; Chew & Hagen 2007). It is believed that Nedd8 has other 
substrates, obesides cullins, and therefore performs other functions which have yet to be 
identified (Kerscher et al. 2006). 
SUMO shares ~18% homology to ubiquitin and has its own E1, E2s and E3s (Kerscher 
et al. 2006). As with Nedd8, a similar situation exists for SUMO, since some E2s are 
SUMOlated and SUMOlation is also needed for APC/C to degrade securin and cyclinB, 
but its precise function remains elusive (Dieckhoff et al. 2004).  
1.4.5 Ubiquitin Binding Domains 
Ubiquitin, and its different chain types, need to be recognised and distinguished in order 
to perform their function. This is carried out by several Ubiquitin Binding Domains 
(UBD) including Ubiquitin Interacting Motif (UIM) (Deveraux et al. 1994; Beal et al. 
1996), UBiquitin Associated (UBA) domain (Wilkinson et al. 2001), Pleckstrin-like 
Receptor for Ubiquitin (Pru) domain (Husnjak et al. 2008), Coupling of Ubiquitin 
conjugation of Endoplasmic reticulum degradation (CUE) domain, Npl4 Zinc Finger 
(NZF) domain, GRAM-Like Ubiquitin binding in Eap45 (GLUE) domain, GGA and 
Tom1 (GAT) domain, Polyubiquitin-Associated Zinc binding (PAZ) domain, Vps-27, 
HRS and STAM (VHS) domain and the Ubiquitin E2 Variant (UEV) domain (Hicke et 
al. 2005; Haglund & Dikic 2005). These UBDs are found in proteins responsible for 
transporting ubiquitinated substrates or in proteins that need to bind to ubiquitin to carry 
out their function such as DUBs and proteasome subunits (Hicke et al. 2005). 
These domains take on a variety of different structures (Figure 3). The UIM domains 
consists of a single α helix whereas the CUE domain and the UBA domain consists of 
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three consecutive α helices. The Pru domain takes on a Pleckstrin-Homology Domain 
(PHD) β-sandwich fold of four anti parallel β-sheets that pack against another strand of 
three β-sheets. The GLUE domain takes on a part PHD fold with a C-terminal helix 
(Schreiner et al. 2008).  
Studies investigating how these UBDs recognise ubiquitin revealed that, despite their 
different structures, nearly all of these domains bind to ubiquitin through the same area 
around its isoleucine 44 hydrophobic patch (Figure 3) (Haglund & Dikic 2005).  
Binding studies of isolated domains show that the same subtypes of UBD display 
preferences for different chain types. This has lead to the definition of four classes for 
UBA domains. Class 1: are UBA domains that selectively bind K48 linked chains. Class 
2: contains UBAs that show a preference for K63 linked ubiquitin chains. Class 3: do 
not bind to ubiquitin chains. Class 4: bind ubiquitin chains regardless of the linkage 
(Raasi et al. 2005).  
Ohno et al. (2005) demonstrated that the UBA domain of Dsk2 interact with ubiquitins 
Ile-44 patch through a hydrophobic pocket. This pocket was formed by the loop1 
between the α1 and α2 helices and the C-terminal of the α3 helix. In particular, Met-342 
of loop1 formed a hydrogen bond with Gly-47 of ubiquitin causing it to fit tightly 
inbetween ubiquitins β3 and β4 strands. Further work by Jean-François Trempe et al. 
(2005) on S. pombe Mud1 UBA domain went on to show that along with this primary 
binding site, there is a secondary ubiquitin binding site formed by residues 309-320 and 
331 between α2 and α3. They hypothesised that when two or more ubiquitin molecules 
formed chains via K48 linkage, this gave rise to a confirmation where one ubiquitin 
could bind the primary site, and the other could bind the secondary site. This would 
make the UBA domain select for K48 chains, and would explain why mutating Phe-330 





Figure 3: Tertiary Structures of UBDs.   
Taken from Schreiner et al. (2008), cartoon representation of UBDs: a) Pru domain of Rpn13 b) α helices 
of CUE domain from Cue2 protein c) three α helices of DSK2s UBA domain d) single α helix of S5as 
UIM1 domain e) single α helix of Rabex-5 IUIM and f) GLUE domain of EAP45 interacting with 
ubiquitin (grey) at isoleucine 44 patch. 
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1.5 E3s & APC/C 
1.5.1 Ubiquitin Ligases 
E3 ubiquitin ligases are responsible for recognising and transferring ubiquitin from an 
E2 to a specific target protein. To do this there are hundreds of different E3s which can 
be classed into 3 groups depending on whether they contain a Homologous to E6-AP 
Carboxyl Terminus (HECT) domain, the Really Interesting New Gene (RING) finger 
and UFD2-Homology Domain (U-box) (Pickart 2001; Nakayama & Nakayama 2006).   
The different sub-classes act in different ways. E2s transfer ubiquitin to HECT E3 
ligases which contain conserved cysteines residues capable of forming covalent bonds to 
ubiquitin before transferring it to its substrate. However RING and U-box E3s act as a 
scaffold to hold the E2 and the substrate in the correct orientation, allowing the ubiquitin 
to be pass directly from the E2 without binding the E3 first (Figure 2).  
RING type E3s are the largest family of E3s and contain two of the most important 
RING E3s. The SKP1–CUL1–F-box-protein (SCF) and Anaphase Promoting 
Complex/Cyclosome (APC/C) are multimeric ligases involved in the UPS which are 
made of four components: i) a RING-finger containing protein which contain conserved 
cysteine and histidine residues. The RING protein interacts with the E2 and facilitates 
the movement of ubiquitin, ii) a scaffold protein such as a cullin, iii) a protein which 
recognises specific substrates; for example an F-box protein. F-box proteins can also be 
sub-classed into three types: WD40 repeats (FBXW); leucine-rich repeat (FBXL) and 
other (FBXO) and iv) an adaptor protein which recognises F-box proteins (Bai et al. 
1996; Pickart 2001; Nakayama & Nakayama 2006).  
1.5.2 APC/C 
One of the most well studied RING type E3 ligases is the Anaphase Promoting 
Complex/Cyclosome (APC/C), an important target of the spindle assembly checkpoint 
(Bastians et al. 1999; Jallepalli et al. 2001). In fission yeast APC/C is a 1.5MDa 
multimeric complex made of 13 core subunits (Table 1) and two co-activators Slp1 and 
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Ste9/Srw1 (commonly known as Cell Division Cycle 20 (Cdc20) and Cdh1/Hct1 
respectively) which are responsible for recognising substrates (Schwab et al. 1997; Fang 
et al. 1998). The catalytic core of fission yeast APC/C is made up of Apc11 and Apc2. 
Apc11 is a RING finger containing protein which, in humans, interacts with two E2s, 
UbcH10 (fission yeast Ubc11) and UbcH5 (Ubc4) (Rape & Kirschner 2004; Pickart & 
Fushman 2004). Apc2 is a cul1-related protein which acts as a scaffold and interacts 
with Apc11 (Gmachl et al. 2000; Tang et al. 2001). The subunits Nuc2, Cell Untimely 
Torn 9 (Cut9) and Cut23 act as adaptor proteins. They contain TrichotetraPeptides 
Repeats (TPR) motifs which bind to C-box domains and isoleucine-arginine dipeptide 
(IR) tails of the two co-activators. The co-activators can recognise substrates containing 
Destruction boxes (D-box) RxxLxxxxN and KEN-boxes KENxxxxN through WD40 
domains (Lamb et al. 1994; Burton & Solomon 2001; Yamano et al. 2004; Burton et al. 
2005; Kraft et al. 2005). Many of APC/Cs subunits do not have a catalytic role, but it is 
believed that they may be important in giving APC/C its “platform and arc lamp” 3D 
structure (Figure 4) (Passmore & Barford 2005).  
Although APC/C is active throughout the cell cycle and has many substrates, its most 
important role, from which it gets its name, is controlling the transition to anaphase from 
metaphase (Figure 5) (Bastians et al. 1999; Jallepalli et al. 2001). In S. pombe APC/C
Slp1
 
ubquitinates Cut2 (commonly called securin) which acts as an inhibitor of the enzyme 
Cut1 (seperase).When Cut2 is degraded, Cut1 is then free to cleave the Rad21 (SCC1) 
subunit of the cohesion complex that holds the sister chromatids together as 
chromosomes. After this cleavage, the two sister chromatids can separate and migrate to 
different ends of the cell to form two nuclei and complete mitosis (Chang et al. 2001).  
1.5.3 APC/C Co-Activators 
APC/Cs two co-activators bind to the ligase at different points of the cell cycle and are 
responsible for recognising different substrates at specific times. APC/C
Cdc20






































































































































































































































































Figure 4: Structure of APC/C 
Strucuture of APC/C obtained from EM. Panel B shows APC/CCDC20, panel C shows APC/CMCC whilst 






but its activity is suppressed by the Mitotic Checkpoint Complex (MCC). The MCC is a 
complex which binds to Cdc20 via a subunit called the Mitotic Arrest Deficient 2 
(Mad2). The MCC inhibits APC/C until all chromosomes are bound to spindles, at 
which point it dissociates and allows APC/C
Cdc20
 to act on substrates containing D-
boxes, many of which are associated with the onset of anaphase, such as securin (Cut2 in 
S. pombe) (Acquaviva & Pines 2006; Nakayama & Nakayama 2006). Around anaphase, 





recognises both D-boxes and KEN boxes causing 
ubiquitination of substrates involved in the cell cycle, such as CyclinA and CyclinB. 
APC/C
Cdh1
 also recognises Cdc20 and causes it to be degraded after anaphase. At late G1 
to S phase Cdh1 is phosphorylated by Cdk1-CyclinB causing Cdh1 to dissociate from 
APC/C and remain inactive until anaphase (Pfleger & Kirschner 2000; Peters 2006; 
Reddy et al. 2007; Skaar & Pagano 2008). 
1.5.4 Regulating APC/C Activity 
Unlike some RING type E3s, APC/C can always recognise its substrates, but its activity 
is regulated by phosphorylation and the MCC (Shteinberg et al. 1999; Kramer et al. 
2000; Rudner & Murray 2000; Kraft et al. 2003).  Phosphorylation can both activate and 
inhibit APC/C activity, depending on the kinases and the subunit it phosphorylates. For 
example, in fission yeast phosphorylation of Cut4 and Nuc2 by PKA inactivates APC/C 
(Yamada et al. 1997; Kotani et al. 1998; Acquaviva & Pines 2006). However, 
phosphorylation by Cdk1-CyclinB (homologous to S pombe Cdc2-Cdc13) and Polo Like 
Kinase 1 (Plk1) (Plo1 in S. pombe) causes activation.  In other organisms, these kinases 
have been shown to act on Cdc27 (S. pombe Nuc2), Cdc23 (Cut23) and Cdc16 (Cut9) 
and that these TPR containing subunits need to be phosphorylated in order to bind co-
activators (Rudner & Murray 2000; Golan et al. 2002; Kraft et al. 2003). Studies in 
fission yeast have shown that phosphorylation of Hcn1 by Cdc2-Cdc13 is required by 
cells to carry out the final stages of mitosis (Yoon et al. 2006). The phosphorylation of 
Cut9 has also been indicated to be important for regulating APC/C activity. Whole cell 
extracts from a strain in which endogenous cut9+ has been replaced with a HA tagged 
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gene revealed that the Cut9 protein exists in two different molecular weight forms when 
probed by Western blot. Further analysis concluded that the heavier molecular weight 
version of Cut9 was due to phosphorylation of the protein, and this phosphorylated form 
was only present in the APC/C complex at metaphase (Yamada et al. 1997).  
The type of ubiquitination performed by APC/C may also be regulated by the E2 it 
interacts with. For example, in budding yeast it has been observed that the E2 Ubc4 
causes mono-ubiquitiation of substrates, whilst the E2 Ubc1 causes poly-ubiquitination 
(Rodrigo-Brenni & Morgan 2007). 
The MCC is a multimeric complex (described in detail in section 1.6) which regulates 
APC/Cs activity (Sczaniecka et al. 2008). During metaphase, chromosomes are 
connected through their kinetochores to two spindle microtubules radiating from each 
end of the cell. This process is essential for the equal segregation of DNA into each new 
cell. The MCC is formed and loaded onto APC/C only in the presence of unbound 
kinetochores. The complex inhibits APC/C activity by binding to Slp1/Cdc20 which 
prevents it from interacting with substrate. This ensures that the cell does not enter 
anaphase until all the chromosomes have been completely attached to spindles (Yang et 
al. 2008).  
1.5.5 Mis-Regulation of APC/C and Disease 
Although inactivation of APC/C is lethal, temperature sensitive (ts) mutants of essential 
APC/C subunits have been constructed in fission yeast. Shifting these mutants to a 
restrictive temperature results in mis-regulation of APC/Cs activity and generates a 
distinctive phenotype caused by the failure to degrade Cut2 (securin) (Samejima & 
Yanagida 1994). As a consequence, Cut1 (separase) cannot cleave the cohesion complex 
holding the two sister chromatids together but the cells continue into anaphase. This 
gives rise to the Cell Untimely Torn (Cut) phenotype which appears in two forms. In the 
less severe case, the septa forms and severs the nucleus, splitting the DNA unequally 
between the daughter cells. In the more severe phenotype, all the DNA moves to one 
daughter cell giving rise to a cell with no DNA, and another which is polyploid (Toda et 
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al. 1981; Hirano et al. 1986; Yamashita et al. 1999). Since APC/C is also responsible for 
regulating cyclin levels, which control passage from metaphase to anaphase, it was not 
understood how disruption to APC/Cs activity allowed cells to carry on through to 
anaphase. Chang et al. (2001) showed that these mutations are hypomorphic since cyclin 
degradation is not affected in cut mutants. 
Since APC/C is a major component in regulating the cell cycle it is not surprising that it 
has been linked to many diseases. Mis-regulation of APC/C has a role in several types of 
cancer (Wang et al. 2003; Nakayama & Nakayama 2006). As stated above, deactivation 
of APC/C can cause aneuploidy, whereas APC
Cdh1
 has been shown to be particularly 
important for maintaining human genomic stability (Engelbert et al. 2008). However, up 
regulation in APC/C activity can also lead to cancer, as seperase needs a small amount 
of securin in order to function (Jallepalli et al. 2001). This makes APC/C and the UPS 
attractive targets for drug development. A proteasome inhibitor, called Bortezomib 
(marketed as Velcade), was approved by the FDA in 2003 and recommended for use in 
the UK by NICE in 2006, to treat relapsed and refractory multiple myeloma. In light of 
this drug approval, other proteasome inhibitors have been suggested as cancer 
treatments, including Salinosporamide A which is currently in trails (Feling et al. 2003; 
Nakayama & Nakayama 2006). However, it is now believed that proteasome inhibitors 
are specific to cancers of B cells as they increase stress put on the ERAD pathway and as 
a result cause the cells to die. Therefore, this type of treatment may not work on other 
forms of cancer (personal communication Rasmus Hartmann-Petersen). 
 
1.6 Spindle Assembly Checkpoint 
Separate from the DNA damage checkpoint, is another important mitotic checkpoint 
called the Spindle Assembly Checkpoint (SAC). This checkpoint occurs at the junction 
between metaphase and anaphase, and prevents cells from committing to nuclear 
division before they are ready.  This is achieved by regulating APC/C
Slp1
 activity via the 
MCC (Figure 5). The MCC is normally made of Budding Uninhibited by Benzimidazole 
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3 (Bub3), Mitotic Arrest Deficiency 2 (Mad2) and Mad3. However, in S. pombe, Bub3 is 
not present in the MCC as Mad3 lacks a sequence needed to bind Bub3 which is present 
in other organisms (Sczaniecka et al. 2008). The MCC can detect when kinetochores are 
not bound to a microtubule, causing the MCC to be loaded onto Slp1 attached to APC/C 
and blocks its ability to recognise substrates (Chung & Chen 2003; Burton & Solomon 
2007). The MCC is constantly being removed from APC/C
 Slp1
 but, as long as a 
kinetochore remains unbound, the complex will be loaded onto APC/ C
 Slp1
 to maintain 
the inhibition. When all the kinetochores are bound, MCC dissociates from APC/C
 Slp1
 
causing it to re-activate and degrade Cut2 leading to the onset of anaphase (Bharadwaj 
& Yu 2004). 
1.6.1 Mad2 
Mad2 exists in two different states, open (O-Mad2) and closed (C-Mad2). When a 
kinetochore is unbound it can be recognised by Mad1 which binds to it. O-Mad2 cannot 
directly bind to Mad1, as it is in a kinetically higher energy confirmation, but C-Mad2 
can. O-Mad2 binds to C-Mad2 in a C-Mad2-Mad1 dimer and is converted into an 
intermediate I-Mad2. The I-Mad2 then converts into C-Mad2 and dissociates from the 
C-Mad2-Mad1 dimer where it is then able to bind Mad1 or APC/C
Slp1
 via Slp1. Mad2 
bound to Slp1 then recruits other components of the MCC to inhibit APC/C
Slp1 
(Yang et 
al. 2008).   
Mad2 is phosphorylated at its C-terminus at several different serine residues. These 
modifications cause Mad2 to revert to its open confirmation preventing it from binding 
to Cdc20 and therefore cause Mad2 and the MCC to dissociate from APC/C (Wassmann 
et al. 2003; Kim et al. 2010). In addition the protein Cmt2/p31
COMET
 can bind to C-Mad2 
bound to APC/C
Cdc20
 and causes Cdc20 to be auto-ubiquitinated and degraded. This then 
removes the inhibition of the MCC and when a new Cdc20 protein attaches to APC/C it 
is free to act on its substrates. Cmt2/p31
COMET
 also prevents to O-Mad2 converting to C-
Mad2, by binding C-Mad2 in a dimer with Mad1, blocking it from binding O-Mad2. 




Figure 5: Schematic Diagram of the Spindle Checkpoint.  
During metaphase chromatids are bound to each other by a cohesin complex to form chromosomes. The 
chromosomes are attached to microtubules via kinetochore on each chromatid. Until all kinetochores are 
bound, APC/CCdc20 is inhibited by the MCC complex. When all of the kinetochores are bound, APC/CCdc20 
is released from its inhibition and can act on its substrate securin. When securin is ubiquitinated and 
degraded, the enzyme separase is released to cleave the cohesin complex holding the sister chromatids 
together. The cell can then progress to anaphase where the sister chromatids move to separate poles of the 










1.7 26S Proteasome 
The 26S proteasome is a 2.5mDa multi-subunit complex made up of a 19S regulatory 
particle and a 20S catalytic particle which degrade proteins in an ATP-dependent 
manner (Figure 6). In most organisms the proteasome is found in both the nucleus and 
cytoplasm (Hoffman et al. 1992; Hartmann-Petersen et al. 2003), except in fission yeast 
where it is concentrated at the nuclear periphery (Wilkinson et al. 1999).  
1.7.1 19S Regulatory Particle  
The 890 kDa 19S regulatory particle is found at either end of the proteasome. Under 
high salt conditions it can be sub divided into a lid and a base, which makes contact with 
the 20S core in the 26S complex (Miller & Gordon 2005; Bohn et al. 2010). The lid is 
made of non ATPase subunits: Rpn3 (S. cerevisiae Rpn3), Rpn5a/b (Rpn5), Rpn6 
(Rpn6), Rpn7 (Rpn7), Rpn8 (Rpn8), Rpn9 (Rpn9), Pad1 (Rpn11), Mts3 (Rpn12), and 
Rpn15/Dss1 (Rpn15/Sem1) (Wang et al. 2007; Jung et al. 2009; Bohn et al. 2010). The 
Pad1 subunit is a deubiquitinase which removes ubiquitin from substrates to be recycled 
and allows the substrate to fit into the proteasome (Verma et al. 2002).  
The base contains a class of ATPases known as the ATPases Associated with various 
cellular Activities (AAA) ATPases. These reverse chaperones utilise the energy they 
obtain from converting ATP to ADP, to unfold the deubiquitinated substrates before 
they enter the catalytic core. In fission yeast there are six AAA ATPases: Rpt1 (S. 
cerevisiae Rpt1), Mts2 (Rpt2), Rpt3 (Rpt3), Rpt4 (Rpt4), Pam2 (Rpt5) and Rpt6 (Rpt6) 
(Glickman et al. 1998; Navon & Goldberg 2001; Wang et al. 2007; Jung et al. 2009; 
Bohn et al. 2010). In addition Mts2 and Pam2 control entry into the 20S to prevent non 
specific degradation of proteins. They do this by controlling the N-terminus of α 
subunits which can move and block the central pore of the 20S (Braun et al. 1999; Unno 











Figure 6: Organisation of the 26S Proteasome.  
The top panel shows a cartoon depiction of the 26S proteasome which can be divided into a 19S 
Regulatory Particle (RP) and a 20S Core Particle (CP). The RP comprises of a lid and base which contains 
subunits which recognise ubiquitin chains and interact with shuttle factors. It is also responsible for 
deubiquitinating and unfolding proteins before they enter the core. The RP also regulates entry of proteins 
into the CP to prevent unspecific proteins being degraded. The 20S CP is made up of four rings, each 
containing seven subunits. The two internal rings are comprised of β subunits whilst the rings that cap 
either end of the core are made of α subunits. These rings form a cylinder with an inner pore in the middle 
through which proteins pass and are degraded. (Miller & Gordon 2005). The bottom panel shows the high 
resolution (9.1 and 6.7 Å at FSC of 0.5 and 0.3) structure of S. pombe 26S proteasome (Bohn et al. 2010). 
















The base also performs other functions, using its non ATPases subunits: Mts4 (Rpn1), 
Rpn2 (Rpn2), Pus1 (Rpn10) and Rpn13a/b (Rpn13). Rpn2, Mts4 and Pus1 interact with 
Mts5 and therefore join the lid and base together (Wilkinson et al. 1999). Rpn2 is a 
regulator that not only binds Rpn13 but together with Mts4 acts as scaffold proteins 
(Finley 2009). Mts4 can recognise the Ubl domains of shuttle proteins (see section 
1.81.8) (Elsasser et al. 2002; Seeger et al. 2003). Pus1 and Rpn13 act as ubiquitin 
receptors; although Pus1 can also act independently from the proteasome as a shuttle 
protein and can bind both the base and lid via Mts4 and Mts3 (Glickman et al. 1998; 
Wilkinson et al. 2000; Seeger et al. 2003; Husnjak et al. 2008; Schreiner et al. 2008; 
Bohn et al. 2010). The interaction between Pus1 and Mts3 requires the Pus1 vWA 
domain but is enhanced by Mts3 binding to the UIM of Pus1 (Riedinger et al. 2010).  
1.7.2 20S Core Particle 
The 720 kDa 20S catalytic particle is made up of 14 subunits that form a stack of two α 
and two β heptameric rings. The β rings reside in the middle, with an α ring at either 
end. This conformation forms a cylinder 15nm long and 11 nm wide with a 5nm central 
pore through the middle. This pore can further be divided into three chambers, two in 
between the α and β rings and one main chamber formed by the β rings. The pore is just 
wide enough for a single unfolded substrate to pass through before being degraded into 
small peptides (Zwickl et al. 1999; Groll et al. 2000; Unno et al. 2002; Miller & Gordon 
2005).   
The two alpha rings reside at either end of the core and consist of seven α subunits: α1 
SPBC646.16 (S. cerevisiae Prs2), α2 Pre8 (Pre8), α3 SPAC13C5.01c (Pre9), α4 Pre6 
(Pre6), α5 Pup2 (Pup2), α6 SPAC6G10.04c (Pre5) and α7 Pre10 (Prs1). These subunits 
can bind proteins which regulate the proteasomes activity. The α rings are also 
responsible for controlling the gated entry into the 20S via the N-terminus of the α2, α3 
and α4 subunits which can change their conformation to block the pore (Wang et al. 
2007; Jung et al. 2009).  
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The two β rings occupy the middle of the core and are also made up of seven subunits: 
β1 Pre3 (S. cerevisiae Pre3), β2 Pup1 (Pup1), β3 Pup3 (Pup3), β4 SPAC31A2.04c 
(Pre1), β5 Pts1 (Pre2), β6 Pam1 (Pre7) and β7 SPBC577.10 (Pre4) (Wang et al. 2007; 
Jung et al. 2009). Each ring contains three subunits with proteolytic activity: i) β1 
subunit which has peptidyl-glutamyl-peptidehydrolising-activity that recognises and 
cleaves at acidic residues, ii) β2 subunit which has trypsin-like activity which recognises 
and cleaves at basic residues and iii) β5 subunit which has chymotrypsin-like activity 
which recognises and cleaves at neutral residues. All three are members of the Ntn-
hydrolase family and have an N-terminal active threonine residue which faces into the 
pore (Groll et al. 2000; Unno et al. 2002; Jung et al. 2009). 
Purification and structural studies of S. pombe 26S proteasomes show that the level of 
α1-7, β1-7, Rpt1-6, Rpn1-3, Rpn5-9 and Rpn11-12 subunits remain constant, but the 
amounts of Pus1, Rpn13 and hydrolases Uch2 and Ubp6 vary due to their transient 
binding to the proteasome. The abundance of Rpn15/Dss1 is hard to determine since it 
only produced one unique peptide when analysed by mass spectrometry (Bohn et al. 
2010). 
 
1.8 Shuttle Factors 
Ubiquitinated proteins that have been marked to be degraded need to be transported to 
the proteasome, which can be done in a variety of ways. Some E3s can interact with the 
proteasome and deliver ubiquitinated substrates directly to the proteasome (Xie & 
Varshavsky 2000; Fu et al. 2010). The proteasome itself contains subunits which possess 
UBDs which can interact with substrates directly (Miller & Gordon 2005; Schreiner et 
al. 2008). Another well studied mechanism are the shuttle factors which, in S. pombe, 
are known as Rhp23 (budding yeast Rad23), Pus1 (Rpn10) and Dph1 (Dsk2). These 
proteins have an N-terminal domain which can recognise and interact with the 
proteasome. Pus1 contains a von Willebrand factor A (vWA) domain where as Rhp23 
and Dph1 contain an UBiquitin Like (Ubl) domain. They all also contain UBDs to 
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interact with ubiquitin. Pus1 has a UIM domain, Dph1 has a UBA domain and Rhp23 
has two UBA domains (Wilkinson et al. 2001; Seeger et al. 2003).  
These proteins share redundancy in S. pombe as single null mutants, of any of the three 
genes, are viable and do not display a phenotype. The two double mutants of 
dph1∆pus1∆ and dph1∆rhp23∆ are also viable, however, dph1∆rhp23∆ strain display an 
elongated phenotype when grown 36
o
C.  In contrast, the rhp23∆pus1∆ double mutant 
has a growth defect at 25
o
C and is lethal at 36
o
C due to excess strain put on the UPS. 
The triple mutant of dph1∆rhp23∆pus1∆ is never formed and is therefore synthetically 
lethal (Wilkinson et al. 2001). 
1.8.1 Rhp23 
The Ubl domain of Rhp23 has a similar structure to ubiquitin which allows it to be 
recognised by UBDs (Ryu et al. 2003; Mueller & Feigon 2003). The Ubl of Rhp23 and 
its budding yeast homologue Rad23, has been shown to bind the proteasome via the 
Mts4/Rpn1 subunit (Elsasser et al. 2002; (Seeger et al. 2003). This has lead to the 
hypothesis that after Rhp23 has taken an ubiquinated substrate to the proteasome, the 
Ubl domain binds to the UBA domains, causing Rhp23 to release its cargo (Rao & 
Sastry 2002).  
Rhp23 is different from Pus1 and Dph1, as it contains not one but two UBA domains. 
One is internal and is denoted as UBA1, the other resides at the C-terminus of the 
protein and is denoted as the UBA2 domain. This structure is not only in yeast but also 
conserved in all eukaryotes (Mueller & Feigon 2002; Hartmann-Petersen et al. 2003). 
Although these two domains share a similar structure, they differ greatly in their 
sequences (Mueller & Feigon 2002). In human Rhp23 (hHR23A) UBA2 is a Class 2 
UBA (refer to section 1.4.5) and preferentially binds to K48 chains where as UBA1 
selects K63 making it a Class 1. However the Ubl-UBA1 fragment of the protein 
converts the UBA1 from a Class 2 to a Class 1 domain (Raasi et al. 2005). This would 
suggest that the domains in isolation might behave differently than when they are in the 
full length protein. Rhp23 has also been shown to interact with APC/C through its UBA 
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domains suggesting that Rhp23 binds ubiquitinated substrates attached to APC/C 
(Seeger et al. 2003). 
1.8.2 Pus1 
Pus1 is not only a shuttle factor but also a subunit of the proteasome (Wilkinson et al. 
2000). It acts as an ubiquitin receptor allowing the proteasome to directly bind 
substrates.  Another proteasome subunit that also acts as a receptor is Rpn13 which 
binds ubiquitin via its Pru domains. Unlike other organisms fission yeast contains two 
forms of Rpn13: Rpn13a and Rpn13b (Husnjak et al. 2008; Schreiner et al. 2008; 
Wilkinson et al. 2000). 
Although Pus1 is a subunit of the proteasome, it can also exist as a free independent 
protein (Bohn et al. 2010). Pus1 binds to the proteasome via its N-terminal vWA 
domain. The vWA domain recognises the PC repeats of the proteasome Mts4, Rpn2 and 
APC/C subunit Cut4 (Seeger et al. 2003). Pus1 contains one UBD, a UIM at its C-
terminus which can bind both K48 and K63 (Fu et al. 1998; Wilkinson et al. 2000; 
Miller & Gordon 2005; personal communication Colin Gordon). Studies show that 
mutating the conserved LAL(M)AL motif in the UIM to N can disrupt ubiquitin binding 
(Wilkinson et al. 2000).  
 
1.9 Kinase Associated 1 Domains 
Kinase Associated 1 (KA1) domains were first identified in the Microtubule Affinity-
Regulating Kinase (MARK) family of kinases. They have since been identified in the C-
terminus of other serine/threonine kinases. The domain is defined as being 50-100 amino 
acids in length and many domains end in a conserved glutamic acid, leucine, lysine, 
leucine (ELKL) motif which is believed to be structurally important. They also contain a 
conserved aspartic or glutamic acid residue (Figure 7) (Tochio et al. 2006; Townley & 




Figure 7: Tertiary Structures of KA1 Domain.  
Cartoon representation of the structure of the KA1domain found in the MELK protein. Red residues fold 










The precise role of the KA1 domains has yet to be determined, but it has been suggested 
that they may have a role in localisation or autoregulation of the N-terminal kinase 
domain (Guo & Kemphues 1996; Beullens et al. 2005). Bioinformatics analysis, by Kay 
Hofmann (Miltenyi Biotec GmbH, Stoeckheimer), identified three S. pombe proteins 
which contain a KA1 domain: Ssp2 (SPCC74.03c), Ppk9 (SPAC23H4.02) and Kin1 
(SPBC4F6.06). He also discovered a similar domain, which he named KA2 in the 
fission yeast Chk1 (SPCC1259.13) protein (Personal communication Kay Hofmann).  
1.9.1 Kin1 
Kin1 is the only S. pombe member of the MARK family of serine/threonine kinases 
(Levin & Bishop 1990; Tassan & Le Goff 2004). MARKs have various functions 
including controlling cell polarity, cell cycle, protein stabilisation and microtubule 
stabilisation. Most MARKs phosphorylate the KXGS motif in Microtubule Associated 
Proteins (MAP), such as Tau. MAPs bind to non mitotic microtubules via a domain 
which overlaps with the KXGS motif. The binding of MAPs causes the stabilisation of 
microtubules. However, when MAPs are phosphorylated this causes them to dissociate 
from the microtubules which then become unstable (Ebneth et al. 1999; Tassan & Le 
Goff 2004). MARKs have been implicated in neurodegenerative diseases since 
hyperphosphorylation of the MAP Tau causes it to form aggregates which are found in 
high concentrations in Alzheimer patients (Drewes et al. 1998; Tassan & Le Goff 2004; 
Trinczek et al. 1995). All MARK kinases have a C-terminal KA1 (with the exception of 
some splice variants) and many also have UBA domains (Tassan & Le Goff 2004; 
Tochio et al. 2006). 
1.9.2 Ssp2 & Ppk9 
Suppressor of Sts5 and Ppe1 mutants 2 (Ssp2) was identified in a screen trying to 
identify new genes involved in the regulation of growth polarity by looking for 
suppressors of  ppe1Δ and sts5 cs mutants, which both have abnormal cell morphology 
(Matsusaka et al. 1995). Ssp2 is the S. pombe homologue of budding yeast Sucrose Non-
Fermenting 1 (Snf1) and mammalian AMP-activated Protein Kinase (AMPK) α subunits 
(Celenza & Carlson 1984). Little was known about the Putative Protein Kinase 9 (Ppk9), 
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except that it is similar to Ssp2 in sequence, until Hanyu et al. (2009) showed that Ssp2 
and Ppk9 are alternative α subunits of S. pombe AMPK.  
Although Ssp2, Ppk9 and fission yeast AMPK still remain relatively unstudied, AMPK 
has been well studied in other organisms due to its involvement in diabetes and Wolff-
Parkinson-White (WPW) syndrome which causes an irregular heartbeat (Hedbacker & 
Carlson 2008; OMIM 2011). AMPK is made up of three subunits: an α catalytic subunit, 
a β subunit which binds glycogens and holds the complex together and a γ subunit which 
regulates the α subunit (Dyck et al. 1996). In fission yeast AMPK consists of either Ssp2 
or Ppk9 as α subunits, one known β subunit SPCC1919.03C/Amk2 and the γ subunit 
Cbs2 (Figure 8) (Townley & Shapiro 2007; Hanyu et al. 2009). This is different from the 
well studied S. cerevisiae AMPK, known as SNF1, which consists of one α subunit 
Snf1, one of three alternative β subunits Sip1, Sip2 or Gal83 and Snf4 the γ subunit 
(Sanz 2003). AMPK is a serine/threonine kinase that is involved in metabolic 
homeostasis. During time of low glucose, the γ subunit undergoes conformational 
changes which causes the α catalytic subunit to be activated. This allows AMPK to act 
on its substrates which then causes the transcription of glucose repressible genes as well 
as regulating activity of certain enzymes. These changes allow the cell to obtain energy 
from alternative carbon sources (Hardie et al. 1998; Hedbacker & Carlson 2008). Under 
times of cellular stresses such as heat shock, salt, pH and oxidative stress, AMPK has 
also been shown to be activated to maintain cell function (McCartney & Schmidt 2001; 
Sanz 2003; Hedbacker & Carlson 2008). 
In budding yeast Snf1 has an Auto-Inhibitory Domain (AID), which is also found in 
mammalian homologues, that can bind to the N-terminal kinase domain and inhibit its 
activity (Crute et al. 1998; Hedbacker & Carlson 2008). The C-terminus of Snf1 can also 
bind Snf4 and the β subunits (Celenza et al. 1989). Studies also show that, removal of 
the C-terminus increases Snf1 activity and allows it to act independently from the β and 




Figure 8: Structure of S. pombe AMPK. 
The structure of AMPK from fission yeast. The α subunit is Ssp2 which has a N-terminal Kinase Domain 
(KD). The β subunit is SPCC1919.03C which has a Glycogen-Binding Domain (GBD) which allows it to 
interact with glycogens. Cbs2 is the γ subunit which contains four Cystathionine-Beta-Synthase domains 








Figure 9: Regulation of SNF1 Activity in S. cerevisiae.  
a) During times of high glucose the SNF1 complex is inactive. The Snf1 α catalytic subunit regulates its 
own kinase activity by binding to an Auto-Inhibition Domain (AID). The C-terminal of Snf1 binds to one 
of three β subunits via a Kinase Interacting Sequence (KIS) domain. The β subunits also bind the 
regulatory γ subunit Snf4 via another domain, the Associated with SNF1 kinase Complex (ASC). b) When 
glucose is limited, the SNF1 complex needs to be activated. This is achieved by Snf4 competing with Snf1 
kinase domain for binding to the AID. This releases the kinase domain, which is also activated by 
phosphorylation and allows it to act on its substrates (Hardie et al. 1998). 
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Thr210 in its activation loop by upstream kinases which stimulates Snf1 kinase 
activation (Estruch et al. 1992; McCartney & Schmidt 2001). Snf4 is believed to 
regulate Snf1 activity by competing with the kinase domain of Snf1 for binding to the 
AID (residues 381-518) and therefore acts to antagonise auto-inhibition (Figure 9) 
(Amodeo et al. 2007; Hedbacker & Carlson 2008; Amodeo et al. 2010). Snf4 is also 
responsible for binding adenosine derivates, such as AMP and ATP, using four 
Cystathionine-Beta-Synthase (CBS) repeats of its two Bateman domains. Structural 
analysis suggests that these domains form a hydrophobic pocket that can bind AMP and 
ATP (Amodeo et al. 2007). It should be noted that, unlike AMPK, SNF1 is not activated 
by the presence of AMP. However, like AMPK it is inhibited by high concentrations of 
ATP which creates a negative feedback loop. There is also evidence that Snf4 can 
regulate the phosphorylation of Snf1, but how it does this has not yet been fully 
understood.  
The β subunits share similarities in function, but signalling domains at their N-terminus 
cause them to occupy different cellular compartments during low levels of glucose. They 
bind the tip of the C-terminus of Snf1, in a region outside the AID via a C-terminal 
Kinase Interacting Sequence (KIS) domain and also bind Snf4 using an Associated with 
SNF1 kinase Complex (ASC) domain (Hardie et al. 1998; Hedbacker & Carlson 2008). 
They also contain Glycogen-Binding Domain (GBD) in the middle of the protein which 
interacts with glycogens (Amodeo et al. 2007). 
The structure of the S. pombe AMPK complex containing Ssp2 has been solved, which 
revealed that Ssp2 has a C-terminal KA1 domain which appeared to interact with the β 
subunits (Jin et al. 2007; Townley & Shapiro 2007). It is also interesting to note that the 
sequence of Ssp2 suggests it contains a putative UBA domain (Hanyu et al. 2009).  
1.9.3 Chk1 
Chk1 is a highly conserved serine/threonine kinase which plays a role in DNA damage 
checkpoints. If DNA is damaged or fails to fully replicate, Chk1 is activated by 
phosphorylation by the S. pombe ATM/ATR Rad3 kinase (Capasso et al. 2002). This 
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sets off a cascade in which Chk1 phosphorylates Cdc25, causing it to be bound and 
sequestered by Rad24, the homologue of the 14-3-3 protein. Cdc25 is then not available 
to dephosphorylate Cdc2 attached to Cdc13, which is needed for activation of the Cdk-
cyclin complex (Walworth et al. 1993; Furnari et al. 1997; Zeng et al. 1998). Chk1 also 
phosphorylates and stabilises the Cdc2 inhibitor Wee1 (O'Connell et al. 1997). This 
results in mitosis stalling until the problem can be rectified.  During DNA damage, 
budding yeast Chk1 has been seen to phosphorylate the orthologue of securin, Pds1, 
which results in a stabilised protein which then cannot be ubiquitinated by APC/C (Xiao 
et al. 2005). 
S. pombe Chk1 has a conserved kinase domain at its N-terminus which recognizes the 
motif Φ-X-β-X-X-(S/T) where Φ is a hydrophobic residue and β is a basic residue. The 
C-terminus contains a highly conserved domain within which a similar motif is found, 
but instead the phospho receptor has been replaced with a conserved aspartic acid 
residue (Palermo et al. 2008). This has lead to the hypothesis that this motif acts as a 
pseudo substrate and that the C-terminal of Chk1 may act as an auto-inhibitory domain 
for the N-terminal kinase. This is supported by the structure of the kinase domain and 
mutations studies which demonstrate that Chk1 kinase activity could be increased by 
point mutations in the C-terminal (Chen et al. 2000; Kosoy & O’Connell 2008). 
However, this is contradicted by other mutations which gave rise to loss of kinase 
function and yeast two hybrid analysis shows no interaction between the kinase domain 
and the C-terminus (Kosoy & O'Connell 2008). Never the less, it has been proven that 
the C-terminus of Chk1 is important for regulating kinase function, since removing the 
last 11 residues of the C-terminus is enough to render the kinase domain inactive (Kosoy 
& O'Connell 2008). It has also been shown that Chk1 regulates the MCC protein BubR1 
(Mad3) (Zachos et al. 2007; Royou et al. 2005) and that it may also play a role in the 
spindle checkpoint in a Mad2-dependent manner (Collura et al. 2005). 
1.10 Aims 
Previous unpublished work from our group had identified interactions between APC/C 
and both Ssp2 and Ppk9. It has been hypothesised that this interaction may be due to the 
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KA1 domain of the two kinases. The aim of this project was to test this hypothesis and 
to further characterise the four KA-domain containing proteins and their influence on 
APC/C in S. pombe using both biochemical and genetic techniques. 
The second part of this project was to enhance our understanding of the role the two 
UBA domains of Rhp23 play in the recognition of binding ubiquitin chains. The 
techniques employed looked closely at the UBA domains both as isolated moieties and 
within the full length of the Rhp23 protein. in vitro and in vivo assays were performed in 
order to study the UBA domains ubiquitin binding function and their role in the 















Material and Methods 
2.1 General Methods 
2.1.1  Sterilisation 
Media and chemicals were sterilised by autoclave were appropriate by heating to 121
o
C 
under pressure for 20mins. Otherwise chemicals were sterilised by passing through 
0.22µm sterile membrane for small volumes or 0.22µm cellulose acetate 250ml flasks 
for larger volumes  
2.1.2  Suppliers 
All chemicals were supplied by Sigma whilst all biological reagents were supplied by 
Roche, GE Healthcare and Invitrogen unless stated otherwise. 
 
2.2 Microbiological Methods 
2.2.1 Solid & Liquid Media 
All liquid media was made into solid media by addition of 2% (w/v) Bacto agar 
2.2.2 Luria-Bertani (L-Broth): 
1% (w/v) Tryptone 
0.5% (w/v) Yeast extract 
1% (w/v) Sodium chloride 
2.2.3 Antibiotic Selection 
Antibiotics were stored at -20
o
C and added to sterilised media. 




2.2.4 Transforming Bacteria 
DNA was mixed with the volume of cells stated and incubated on ice for 5-30mins. 
Cells were then heat shocked in a water bath at 42
o
C for time stated before being cooled 
on ice. L-broth was added and the cells allowed to grow at 37
o
C for 1hr. The 1ml 
cultures were then spun and resuspended in 100µl which was spread on selective plate. 
 
2.2.5 Growth Conditions  
Bacteria were spread on solid media by use of sterile glass beads or sterile loops. All 
bacteria were grown on plates at 37
o
C over night. Cultures were grown over night at 
37
o
C whilst shaking at 180rpm. 
2.2.6 Storage of Bacteria 
Bacteria were stored for short term on solid media at 4
o
C. Stocks were stored long term 
at -80
o
C in cryo tubes by adding 33.3% (v/v) glycerol to an overnight culture to make a 
final volume of 1ml. 
 
2.3 Schizosaccharomyces pombe 
2.3.1  S. pombe Strains 




 using the standard background 







2.3.2 Growth Conditions  
All strains were grown at the permissive temperature of 25
o
C on appropriate selective 
solid media. Temperature sensitive mutants were shifted to the restrictive temperature of 
36
o
C to induce a phenotype. Liquid cultures were seeded with 0.5-5ml of a saturated 
preculture and grown over night until cells were growing in log phase. 
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2.3.3 Storage of S. pombe 
S. pombe was stored for short term on solid media at 4
o
C. Stocks were stored long term 
at -80
o
C in cryo tubes by adding 33.3% (v/v) YES with 40% glycerol to a saturated 
culture to make a final volume of 1ml. 
2.3.4 Solid & Liquid Media 
All liquid media made into solid media by addition of 2% (w/v) Bacto agar 
2.3.5 Edinburgh Minimal Media (EMM) 
0.3% (w/v) Potassium hydrogen phthalate 
0.18% (w/v) Disodium hydrogen orthoposhate anhydrous  
0.5% (w/v) Ammonium chloride 
2% (w/v) Glucose 
0.02% (w/v) of appropriate markers Adenine, Histidine, Leucine, Uracil & Lysine  
2% (v/v) 50x Salts 
0.1% (v/v) 1000x Vitamin 
0.01% (v/v) 10,000x Minerals  
2.3.6 Pombe Glutamate Medium (PMG) 
0.3% (w/v) Potassium hydrogen phthalate 
0.22% (w/v) Disodium hydrogen orthoposhate anhydrous  
0.375% (w/v) Glutamic Acid 
2% (w/v) Glucose 
0.02% (w/v) of appropriate markers Adenine, Histidine, Leucine, Uracil & Lysine  
2% (v/v) 50x Salts 
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0.1% (v/v) 1000x Vitamin 
0.01% (v/v) 10,000x Minerals  
2.3.7 50X Salt Stock: 
5.33% (w/v) Magnesium chloride hexahdrate 
0.1% (w/v) Calcium chloride hexahdrate  
5% (w/v) Potassium chloride 
0.2% (w/v) Disodium sulphate 
2.3.8 1000x Vitamin Stock 
1% (w/v) Inositol  
1% (w/v) Nicotinic acid  
0.1% (w/v) Calcium pantathenate  
0.001% (w/v) Biotin  
2.3.9 10000x Mineral Stock 
0.5% (w/v) Boric acid  
0.51% (w/v) Manganese sulphate tetrahydrate  
0.4% (w/v) Zinc sulphate heptahydrate  
0.2% (w/v) Iron (III) chloride hexahydrate  
0.144% (w/v) Molybdic acid monohydrate  
0.04% (w/v) Copper (II) sulphate pentahydrate 
1% (w/v) Citric acid  
0.01% (w/v) Potassium (I) iodide 
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2.3.10  Yeast Extract with Supplements (YES): 
0.5% (w/v) Yeast extract (Difco) 
3.0% (w/v) Glucose 
0.02% (w/v) Adenine, Histidine, Leucine, Uracil & Lysine 
2.3.11  Malt Extract (ME) 
3% (w/v) Bacto-malt extract 
2.3.12  Antibiotic Selection 
Geneticin - G418 (Sigma, Ref: G-1279) and nourseothricin - NAT (Werner BioAgents 
Cat: 5005000) were used at 100μg/ml whilst hygromycin B - HYG (Roche; Cat: 
10843555001) was used at a concentration of 300μg/ml in both liquid and solid 
YES/PMG but not EMM. Solid media was stored at 4
o
C 
2.3.13  Transforming S. pombe 
20ml preculture of the strain were set up from selective plates into YES and incubated at 
25
o
C for two days. 100ml of YES was inoculated with 1-5mls of the saturated preculture 
and grown at 25
o
C over night to give an OD600 (WPA Biowave CO8000 cell density 
meter, Biochrom) of between 0.5-0.8. Cultures were pelleted and washed in dH2O then 
0.1M LiAc pH4.9. Cells were resuspended in 0.1M LiAc to give a final volume of 100µl 
for every 0.1 OD600. 1µg of plasmid was mixed with 100µl of resuspended cells along 
with 5mg of tRNA (Sigma) and 370µl of 50% PEG. The cells were incubated at 25
o
C 
for 50mins before heat shocking in a waterbath at 46
o
C for 20mins. After pelleting cells 
were resuspended in 1ml YES and incubated at 25
o
C for 3 hrs. 200µl were plated onto 
selective plates and grown at 25
o
C until single colonies were visible.  
2.3.14  Converting G418 to NAT & HYG 
Strains were converted from geneticin (G418/Kan) to either hygromycin B (HYG) or 
nourseothricin (NAT) resistance by amplifying the resistance genes in a MX6 cassette. 
PCRs were pooled and DNA precipated to allow 3mg of DNA to be transformed as 
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described previously. Cells were plated onto YES to recover overnight at 25
o
C before 
being replica plated onto selective plates. 
2.3.15  HA Tagging of S. pombe Genes 
Forward primers were designed which covered the last 80bp of the gene to be tagged 
and the stop codon sequenced was removed. To this a 20bp sequence was added which 
would align to the tagging cassette used. For the reverse primer an 80bp sequence that 
was 200bp from the end of the gene, which did not overlap the neighbouring gene, was 
used with a 20bp sequence which would align to the tagging cassette at the start of the 
primer. These primers were then used to produce 10 PCR reactions from the tagging 
cassette which has a G418 resistance marked associated with it. The pooled PCRs were 
ethanol precipitated before being used to transform the appropriate S. pombe strain 
which were recovered over night on YES before being replica plated onto G418 plates to 
select for successful intergrants. These positive cells were then tested by Western blot to 
confirm the presence of the tagged protein.  
2.3.16  Crossing Strains 
Strains of opposite mating types were crossed using ME plates lacking nitrogen since 
starvation induces mating. 30-40µl of sterile dH2O was pippetted onto the plate and a 
loop full of each yeast strain were mixed in the water before being incubated for 2-3 
days at 25
o
C. The cultures were then examined microscopically to identify successful 
crosses by looking for the presence of asci. 
2.3.17  Tetrad Analysis 
Tetrad analysis was carried out on successful crosses which were then dissected using a 
Singer Micromanipulator. 20µl of sterile water was pippetted onto a YES plate and a 
small amount of cells from the centre of the cross were mixed in it before being spread 
across the plate in a single line. The micromanipulator was then used to identify asci and 
using the fine needle asci were picked up and set out in an orderly grid. The plates were 
then incubated overnight at 20
o
C to allow the ascus to burst; the four spores were moved 
onto separate squares of the grid in an orderly fashion. The resulting cells were then 
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allowed to grow before being replica plated on to two plates each containing a selectable 
marker, or for temperature sensitive mutants, onto YES then place at 36
o
C. The results 
were then analysed to identify double mutants. 
2.3.18 Free Spore Analysis 
Strains of opposite mating types were mixed together on ME plates and incubated for 2 
days at 25
o
C as described above. For each cross 1ml of dH2O was mixed with 5µl β-
Glucuronidase (Sigma, Ref: G0876) before sterilising through a filter and aliquoted into 
1.5ml eppendorfs. A loop full of the crosses taken from the middle of the cross was 
added to the eppendorf and incubated over night at 25
o
C. The remaining spores were 
washed twice by spinning for 1min at 13,000rpm and resuspending in 1ml of dH2O. Six 
1:10 serial dilutions of each cross were made and 100µl were plated on YES for single 
colonies. These were then patched and replica plated onto selective plates.  
2.3.19 Spot Growth Assay 
5ml of media was inoculated with a yeast colony and incubated at 25
o
C overnight. The 
cultures were then adjusted so that each culture had the same OD600 of 0.5-0.8. Dilutions 
of each culture were set up so that 1# was 1:1 dilution of the original culture, 2# was a 
1:4 dilution of the original culture and 3# to 6# were 1:4 dilutions of the previous 
dilution. 5µl of the dilutions were spotted onto a selective media plate and allowed to 




C for 2-5 days. 
2.3.20 Chromosome Loss Assay 
Mutant strains were crossed so they contained the ade6-210 allele to allow them to be 
tested. These strains were then crossed to strain carrying the mini chromosome, Ch16 
which contains the allele’s ade6-216 m23::LEU2. The two ade alleles compliment each 




. The strains were tested by growing a 
culture to log phase in PMG-leu-ade to maintain the chromosome, then plating 200 cells 
(Z2 Coulter® Particle Count and Size Analyzer, Beckman Coulter™) on PMG 1/15ade. 
Cells were incubated at 30
o
C until colonies appeared then incubated at 4
o
C for 3 days to 
allow the colour to develop. Colonies with at least half their sector red were counted 
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along with the number `of white colonies. The percentage of chromosomes lost per 
division was calculated by dividing the number of red colonies by the total number of 
colonies and multiplied by 100.  
2.3.21 MMS Sensitivity 




C to log phase then 20µl of 1/1000 
dilution was plated out onto two YES plates. Methyl methanesulfonate (MMS) (Sigma, 
Ref: M4016) was added to a final concentration of 0.005% and the cultures were grown 
for a further four hours; after which 20µl of 1/1000 dilution of culture was plated onto 
YES plates and allowed go grow to single colonies. Viability after 4hr treatment was 
expressed as a percentage of the colonies of the corresponding 0hr plate.  
 
2.4 Saccharomyces cerevisiae 
2.4.1 S. cerevisiae Strains 
For all yeast two hybrid experiments the PJ69-4A MATa trpl-901 leu2-3,112 ura3-52 
his3-200 ga14A ga18OA LYSZ::GALl-HIS3 GAL2-ADE2 metZ::GAL7-lacZ strain was 
used. 
2.4.2 Solid & Liquid Media 
All liquid media made into solid media by addition of 2% (w/v) Bacto agar 
2.4.3 Yeast Extract-Peptone-Adenine-Dextrose (YPAD) 
1% (w/v) Bacto-yeast extract  
2% (w/v) Bacto-peptone  
2% (w/v) Dextrose  
0.01% (w/v) Adenine sulfate  
Made up with dH2O 
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2.4.4 Synthetic Complete (SC) 
0.67% (w/v) Yeast nitrogen base without amino acids 
5% (v/v) 20x Dropout Solution 
2% (w/v) glucose 
Made up with dH2O adjust to pH5.8 before autoclaving 
1% (v/v) of appropriate 100x Amino Acid Stock markers 
2.4.5 20x Dropout  
0.04% (w/v) L-Arginine HCl 
0.04% (w/v) L-Methionine 
0.04% (w/v) L-Uracil 
0.06% (w/v) L-Isoleucine 
0.06% (w/v) L-Lysine HCl 
0.06% (w/v) L-Tyrosine 
0.1% (w/v) L-Phenylalanine 
0.3% (w/v) L-Valine 
0.4% (w/v) L-Threonine 
Made up with dH2O and autoclave 
2.4.6 100x Amino Acid Stock 
0.2% (w/v) L-Adenine 
0.2% (w/v) L-Histidine HCl Monohydrate 
1.0% (w/v) L-Leucine 
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0.2% (w/v) L-Tryptophan 
Filter sterilise 
2.4.7 Yeast Two Hybrid Direct Interaction 
pJ69 4A were grown in 10ml of YPAD at 30
o
C over night before making up to 50mls in 
YPAD and growing for another 2-3 hours. Cells were pelleted and washed in 40mls of 
TE before being resuspended in 2mls 0.1M Lithium Acetate/0.5xTE. 100µl of cells were 
mixed with 5µl of ssDNA and ~150ng of plasmids from the Matchmarker™ (Clontech; 
Cat: K1605-1) with 700µl of 0.1M lithium acetate/40%PEG/TE and incubated for 
30mins at 30
o
C. Cells were then heat shocked at 42
o
C for 7min before spinning and 
resuspended in 200µl dH2O and 20µl spots were plated  on to SC-Leu-Trp, SC-Leu-Trp-
His and SC-Leu-Trp-His-Ade. Plates were incubated at 30
o
C 
2.4.8 Yeast Two Hybrid Screen 
pJ69 4A were transformed with pGBT9 constructs containing genes to be tested and 
plated on SC-Trp. A positive colony was grown in 2.5ml of SC-Trp media overnight at 
30
o
C, 180rpm before being scaled up to 50ml YPAD and grown in the same conditions 
for 4 hours. After centrifuging for 3 mins at 3,000rpm the cells were washed with 25ml 
dH2O and resuspended in 1ml 0.1M LiAc pH 8.5 and spun for 1min at 14,000rpm and 
resuspended in 500µl 0.1M LiAc pH 8.5. To 200µl of cells, 100µl of DNA library was 
added along with 10µl ssDNA, 500µl 50% PEG and 72µl 1M LiAc pH 8.5. Cells were 
incubated at 30
o
C for 30mins before heat shocking at 42
o
C for 20mins, and then pelleted 
by spinning at 6,000rpm for 5mins. After resuspending in 1ml YPAD the cells were 
allowed to recover at 30
o
C for 45mins before being pelleted again and resuspending in 
3mls of dH2O. 100µl were plated on a small SC-LW plate whilst the remaining 
suspension was split evenly between 5 large SC-LWHA plates. Plates were incubated 





2.4.9 DNA Extract from S. cerevisiae 
10ml cultures of positive colonies were grown for 30hrs at 30
o
C and 280rpm, from 
which 3mls was taken and pelleted by spinning for 5min at 3000rpm. The pellet was 
then resuspending in 120µl of Buffer P1 from QIAprep® Spin Miniprep Kit (QIAGEN; 
Cat: 27106) and lysied by adding 130µl of acid washed beads and put in a Ribolyser for 
10 sec at 6.5 three times with 5min incubation on ice in between. The lysate was spun 
for 5 mins at 14,000rpm and the supernatant was placed into a fresh tube. 120µl of 
Buffer P2 was added and mixed by inverting the tube before incubating for 4mins at 
room temperature. 180µl of Buffer P3 was added and mixed before a 5 min incubation 
on ice. The mixture was centrifuged at 14,000rpm for 10mins then the plasmids were 
isolated as described in the QIAprep® Miniprep handbook. 
 
2.5 DNA Methods 
2.5.1 Plasmids 





Primers design in accordance with manufacturer’s instructions. All primers were 
produced by Sigma Genosys (Appendix E). 
2.5.3 PCR 
All PCR reactions were carried out on a Dyad™DNA Engine Thermal Cycler with 
heated lid.  PCR reactions which did not require accurate transcription were performed 
in a final volume of 25µl containing 1 unit of Platinum Taq (Invitrogen, UK; Cat: 
10966-018), 1x reaction buffer, 3µM Magnesium chloride, 0.2mM dNTP, 0.72µM 
primers and made up with dH2O. DNA was then amplified using the following 
conditions: 
 
PCR for cloning was performed with either High Fidelity PCR Master (Roche, Ref: 
12140314001) or 2x Phusion HF Master Mix (New England BioLabs, Inc; Cat: F-531L). 
For High Fidelity PCR Master each reaction consisted of 0.9µM primers, 50ng DNA, 
with sterile water to make the final reaction volume 50µl and 25µl Master Mix in this 




For Phusion HF Master Mix (New England BioLabs, Inc; Cat: F-531L) the following 
conditions were used. To a total volume of 50µl 0.36µM primers were added with 1x 
Master Mix and DNA. For conversion 3% DMSO was used to amplify pClone Nat-1 
and pClone Hyg-1 which contained resistance in a MX6 cassette under the following 
conditions:  
 
2.5.4 PCR of Bacteria Colonies 
To screen transformation colonies for the correct insert the same mixture was made 
minus Platinum Taq. 12.5µl of this mixture was aliquoted into tubes and cells added 
using a pipette tip. Bacteria were lysed by one round of 94
o
C for 10 mins. The reaction 
was then cooled to 54
o
C for 10mins in which time 1 unit of Platinum Taq was added to 




2.5.5 Site Directed Mutagenesis 
Oligios were constructed in accordance to instructions of the QuikChange® Site-
Directed Mutagenesis Kit (Stratagene; Cat: 200518). A 50µl reaction was set up 
containing 2.5ng/µl of each primer, 5-50ng of dsDNA, 0.2mM dNTP and 1x reaction 
buffer. To this 2.5U of PfuTurbo was added and run on a cycles devised by following 
manufacturers recommendations. 10U of Dpn1 was used at 37
o
C over night to digest the 
parental DNA. The remaining DNA was precipitated and transformed into DH5α. 
2.5.6 Agarose Gel 
To analysis DNA from PCRs and digestion a 1.5% (w/v) agarose gel was then cast with 
0.5 µg/ml Ethidium Bromide and 1x TAE buffer [50x TAE 2M TRIS, 5.71% (v/v) 
Glacial Acetic Acid, 0.05mM EDTA pH 8.0] added. The PCR product was mixed with 
loading dye [20% (w/v) Ficoll 400, 100mM EDTA, Orange G to colour] were run at 
100V along with a 1Kb DNA Ladder (Invitrogen; Cat: 15615-016). Photographs were 
taken under UV illuminator.  
2.5.7 Bacteria DNA Extraction 
DNA was extracted from 5ml overnight cultures of bacteria using QIAprep® Spin 
Miniprep Kit (QIAGEN; Cat: 27106) according to manufacturer’s instructions. 
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2.5.8 DNA Agarose Gel Extraction 
PCR products for pDONR™221 cloning and domain swap were purified after separation 
on agarose gel using QIAquick® Gel Extraction Kit (QIAGEN; Cat: 28704) according 
to manufacturer’s instructions. 
2.5.9 DNA Precipitation 
DNA was mixed with 1/10 volume 3M sodium acetate pH5.2,then 2 volumes of 100% 
ethanol were added and incubated at -20
o
C for at least one hour. The DNA was then 
pelleted by centrifuging at 14,000rpm for 15mins at 4
o
C. The supernatant was removed 
and the pellet was washed with 200µl of ice cold 70% ethanol and centrifuged for 5mins 
at 14,000rpm at 4
o
C. The remaining supernatant was removed and the pellet was dried in 
a 37
o
C heat block before being resuspended in an appropriate volume of water or TE 
buffer. 
2.5.10  Restriction Enzyme Digests 
After preparing DNA using QIAquick® PCR Purification Kit (QIAGEN; Cat: 28104) 
DNA was cut with appropriate enzymes from either Roche or NEB, according to 
manufacturer’s instructions. If a double digest was needed but the enzymes were 
incompatible, DNA was cut with one, cleaned using QIAquick® PCR Purification Kit 
and then digested with the second. Enzymes were deactivated before proceeding to 
ligation 
2.5.11  Dephosphorylation 
When only a single digest was possible vectors were dephosphorylated using either 
Antarctic Phosphatase (NEB; Cat: M0289S) or Calf Intestinal Alkaline 
Phosphatase (Invitrogen; Cat: 18009-019) according to manufacturer’s instructions. 
2.5.12  Ligations 
Ligations were carried out using Quick Ligation™ Kit (NEB, Cat: M2200L) according 
to manufacturer’s instructions. 
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2.5.13  Sequencing 
Sequencing was carried out in house by MRC HGU technical Services before being 
loaded into an Applied Biosystems DNA sequencer (Model 373A or 377) and operated 
in according to manufacturer’s instructions. 
Sequencing data was analysed with ClustalW2 alignment tool. 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html). 
2.5.14  Gateway® Cloning 
To construct the entry vector pENTR™ TOPO® (Invitrogen, Cat: 2435-20) or 
pDONR™ 221 (Cat: 12536-017) primers were designed in accordance with Invitrogen 
instructions. For pENTR™ TOPO® 1-5ng of PCR product was mixed with 1µl salt 
solution, 15ng of pENTR™ TOPO® and made up to 5µl with sterile water and 
incubated at 25
o
C between 5mins are over night. The reaction was then transformed into 
Transforming One Shot® Mach1™-T1® Competent E.coli (Invitrogen) and the 
remaining reaction was stored at -20
o
C for up to a week.  
For pDONR221™ PCR products were gel purified and 150ng of PCR and vector were 
incubates at 25
o
C over night with 2µl of BP Clonase™ II and made up to 8µl in TE. 
Reactions were stopped by adding 1µl of proteinase K and incubating at 37
o
C for 10 
mins. Ligations were then transformed into DH5α and selected for on Kan plates. Both 
plasmids were sequenced with M13 primers. 
2.5.15 Gateway® Switching to Destination Vector 
To move the cloned genes from the enter vector to the destination vector, a similar 
reaction was set up as stated for pDONR221™ but LR Clonase™ II was used, and the 





2.6 Protein Methods 
2.6.1 Protein Induction 
10ml L-broth precultures containing 100μg/ml ampicillin were inoculated with a single 
colony of BL21 contain the pGEX 6P1 plasmid and incubated over night at 37
o
C. The 
cultures were added to 200mls of L-broth containing ampicillin and incubated at 37
o
C 
until the culture had reached an OD600 of 0.4-0.8. IPTG was added to give a 




C for 4 hours. Cultures 
were pelleted by spinning at 12,000rpm for 5mins and removing the supernatant. 
Pelleted cells were kept at -80
o
C overnight before undergoing GST bead purification. 
2.6.2 Late Log Phase Protein Induction 
For GST-Slp1, the method described by Galloway et al. (2003) was employed. Briefly, 
BL21 contain the pGEX 6P1 plasmid was grown over night at 37
o
C. The cultures were 
added to 100mls of L-broth containing ampicillin and incubated at 37
o
C until the culture 
had reached an OD of ~1.7. Cultures were placed on iced water for 5mins then IPTG 
was added to give a concentration of 0.1mg/ml and incubated at 25
o
C for 1 hour. 
Cultures were pelleted by spinning at 12,000rpm for 5mins and removing the 
supernatant. 
2.6.3 GST Bead Purification 
Bacterial pellets from protein inductions were resuspended in freshly made cold GST 
Binding Buffer [50mM TRIS pH7.5, 100mM NaCl, 10% glycerol, 1% triton and 1 
Complete Tab (Roche, Ref:11697498001) per 50ml] and sonicated twice for 45secs on 
ice. After rotating for 30mins at 4
o
C debris was spun down at 12,000rpm for 30mins at 
4
o
C. The supernatant was transferred into a 50ml Falcon™ tube with 200µl Glutathione 
Sepharose™ 4B beads (GE Healthcare, Ref: 17075601) and rotated for 1hr at 4
o
C. The 
beads were then spun down at 3000rpm for 3mins and transferred to a fresh eppendorf. 
To wash the beads 1ml of GST binding buffer was added and inverted before spinning at 
8,000rpm, this was done a total of 3 times. Induced proteins were then separated on 
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SDS-PAGE gels and visualised using Coomassie Blue to validate the protein was of the 
correct size. 
2.6.4 Eluting GST Tagged Protein  
To removed GST tagged protein from Glutathione Sepharose™ 4B beads, the beads 
were packed into a polyprep column (Biorad, Cat: 731-1550). 5mls of 100mM L-
Glutathione Reduced (Sigma, Ref: G6529) in 50mM TRIS pH8 was added and collected 
in 1ml fractions. The samples were then analysed by separating on a 10% SDS PAGE 
gel and stained to see which fraction contained the eluted protein. 
2.6.5 SDS-PAGE Gels  
SDS-PAGE gels were cast as follows:  
 
 
Samples were mixed 1:1 with loading dye [2% (w/v) SDS, 62mM TRIS pH7.5, 10% 
(v/v) glycerol and 0.0125% (w/v) bromophenol blue] was boiled with 5% (v/v) β 
mercaptoethanol and loaded onto the SDS-PAGE gel with Broad Range Marker (New 
England Biolabs; Ref: P7708S ). Gels were run in 1x Running Buffer [5x Running 
Buffer 1.25M Glycine, 125mM TRIS and 0.5% (v/v) SDS] at 160Volts for 1hr and 
either used for Western blots (See section) or stained for protein  
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2.6.6 Visualisation of Protein on SDS PAGE Gels 
SDS PAGE gels were stained either with GelCode® Blue Stain Reagent (Pierce; Ref: 
24592) according to manufacturer’s instructions, or with Coomassie stain [40% (v/v) 
methanol, 10% (v/v) acetic acid, 0.1% (v/v) Coomassie blue] and then destained [25% 
(v/v) methanol, 7.5% (v/v) acetic acids].  
For visualisation of proteins at a level too low to be detected by either of these methods, 
such as Tap Tag purified APC/C, gels were silver stained using GelCode® 
SilverSNAP® Stain Kit II (Pierce, Cat: 24612). 
2.6.7 Transfer of Western Blots 
Proteins were transferred via wet blotting using the mini trans-blot cell (Biorad). The 
cassettes were loaded with one pad followed by two layers of Whatman 3MM paper, the 
SDS-PAGE gel, a sheet of  Hybond-P membrane (GE Healthcare, Ref: RPN303F) 
soaked in methanol, another two layers of Whatman paper and another pad all pre 
soaked in transfer buffer [24mM TRIS,  186.5mM Glycine, 20% (v/v) methanol]. 
Transfers were performed at 200mA for 1hr 30 mins, changing the ice block half way 
through or were blotted over night at 40mA. 
2.6.8 Probing Western Blots 
 Membranes were blocked overnight at 4
o
C or for 1hr at room temperature (RT) for 
1hour in 5% Sainsbury’s dried skimmed milk in PBS with 0.1% Tween-20 (Sigma) or 
5% BSA (Melford, Cat: A1302) in TBS with 0.1% Tween-20. The membrane was 
probed with primary antibody in 5% milk/BSA made in PBST/TBST for 1hr then 
washed for three times for 10mins in PBST/TBST whilst being shaken. The secondary 
horse radish peroxidise (HRP) antibody was added in 5% milk/BSA in PBST/TBST for 
30mins then washed three times for 10mins in PBST/TBST. The membrane was then 
drained on tissue and the proteins were visualised using ECL Western Blotting 
Detection System (GE Healthcare; Ref: RPN2132) according to manufacturer’s 
instructions. The membranes were the exposed to Hyperfilm™ ELC (GE Healthcare) in 
a dark room for 5sec-30min depending on antibody. 
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2.6.9  Antibodies 
 
2.6.10 Blot stripping 
Membranes were placed in an airtight container with 100ml of stripping buffer [62.5M 
Tris pH8.6, 2% (v/v) SDS, 100mM β mercaptoethanol] and heated to 50
o
C in a 
waterbath for 40mins. Blots were then washed six times for 5mins with PBST before re-
blocking. 
2.6.11 Whole Cell Protein Extract from S. pombe 
100ml of culture was grown overnight at 25
o
C to an O.D600 of 0.5-1.0. Cells were 
pelleted in two 50ml Falcon™ tubes by centrifugation at 3,000rpm for 3mins. After two 
washes in dH2O cells were washed in 1ml lysis buffer [50mM TRIS pH 7.5, 50-100mM 
NaCl, 10% glycerol, 1% triton, 1mM PMSF, 1 complete per 50ml]. The pellets were 
then resuspened in 200µl lysis buffer and 200µl acid washed beads. A ribolyser was 
used to disrupt the cells by 10secs at 6.5 with 2 mins incubation on ice three times. A 
further 200µl lysis buffer was added for a fourth round. Beads and debris was removed 
by spinning for 5mins at 8,000rpm at 4
o
C. The supernatant was transferred to a fresh 
tube then spun at 14,000rpm for 30mins at 4
o
C. The clarified supernatant was then 
pooled to make a whole cell extract. 
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2.6.12 Native PAGE 
To run a native gel for far Westerns, S. pombe extracts were made as stated in 2.6.11, 
without detergents. Samples were prepared by adding a equal volume of Novex® Tris-
Glycine Native Sample Buffer (Invitrogen, Cat: LC2673) and 50ng-100ng of protein 
were run on NuPAGE® Novec® Tris Acetate 3-8% gels (Invitrogen, Cat: EA0375BOX) 
in ice cold Tris Glycine Native Running Buffer (Invitrogen, Cat: LC2672) at 150V for 3 
hours whilst keeping the unit as cold as possible. 
2.6.13 Transfer of Native PAGE 
Proteins were transferred via semi dry blotting using the MilliBlot™ Graphite 
Electroblotter II (Millipore, Cat: MBBDGE002). Two layers of Whatman 3MM paper 
with a sheet of  Hybond-P membrane soaked in methanol, the SDS-PAGE gel and 
another two layers of Whatman paper all pre soaked in 2xTris Glycine Transfer Buffer 
(Invitrogen, Cat: LC3675) were layered onto the blotter and run at 100mAmps per blot 
for 1hour. 
2.6.14 Probing Native Far Western 
Far western were performed using the ProFound Far-Western GST-Protein:Protein 
Interaction Kit (Pierce, Cat: 23505) according to manufacturer’s instructions. Briefly, 
membranes were blocked over night at 4
o
C in dilution buffer or 5% BSA. 1-5ng/ml of 
eluted GST protein was added to dilution buffer, or dilution buffer on its own was added 
as a negative control. To probe tagged protein, the appropriate antibody was added. 
Membranes were incubated for 1 hour at room temperature with shaking then washed 3 
times for 15mins in PBST. αGST- HRP antibody was added to test and negative control 
membranes in dilution buffer whilst the appropriate secondary antibody was added to 
the tag control. After one hour membranes were washed 3 times for 15mins in PBST. 
Blots were then visualised with UniBlot provided and exposed to x-ray film.  
2.6.15 APC/C Interaction Assay 
The strain cut9::cut9-3HALeu2+(leu1.32)h
-
 was used since there are no antibodies that 
can accurately detect APC/C. This strain has a C-terminal HA tag cut9 under control of 
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its native promoter. These cells are viable and since cut9 is an essential gene it can be 
assumed that the HA tag does not affect Cut9s function. 
200mls of YES was inoculated with 1-3mls of a 20ml preculture and grown overnight at 
25
o
C to give an OD600 of 0.8-1.0. The cultures were pelleted at 3000rpm for 3mins at 
4
o
C and washed twice in cold dH2O. After resuspending in 1ml of lysis buffer [50mM 
TRIS pH7.5, 100mM NaCl, 10% glycerol, 1% triton, 1mM PMSF, 1mM DDT, 2mM 
ATP and 1 Complete Tab per 50mls] cells were transferred to screw capped tubes and 
spun at 8000rpm for 3min before being suspended in 200µl lysis buffer. 200µl of ice-
cold acid washed glass beads were added to each tube before undergoing three rounds of 
lysis in the Fastprep for 10sec at 6.5 followed by 2min incubation on ice. A further 
200µl of lysis buffer was added before one final round of lysis. The preparations was 
then spun for 5min at 8000rpm and the supernatant transferred to a fresh tube then spun 
twice for 30min at 13000rpm and the supernatant collected.  
Protein concentration was measured on a NanoDrop ND-1000 Spectrophotometer set at 
an absorbance of 280nm and adjusted to give 50mg/ml. 20µl of the extract was mixed 
with 20µl of 2xSDS loading buffer as the input sample. GST tagged proteins bound to 
GST beads were washed twice in lysis buffer and 5-30µl of the beads were rotated 
overnight at 4
o
C with 100µl of protein extract. Beads were then washed 5 times with 
freshly made lysis buffer before being prepared for Western blots. 
2.6.16 TEV Purification 
400ml of 6xHis TEV amp resistant BL21 (DE, no pLysS) was grown to an OD of 1 and 
induced for 4 hours at 37
o
C with 20mg of IPTG. The pellet was weighed and 
resuspended in 4 volumes per gram of cell in lysis buffer [20mM TRIS Cl pH8, 1mM 
EDTA, 8U/ml DNase I, 400µg/ml lysozyme, 1 complete tablet/50ml] and incubated at 
room temperature for 20mins. The cells were lysed by sonication three times for 45 secs 
with 1min incubation on ice in between. After another 5min incubation at room 
temperature Triton-100 was added to 1% concentration and NaCl to 300mM. Cells were 
pelletted by centrufication at 10,000rpm for 20mins at 10
o
C. The pellet was resuspended 
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using a homogeniser in 8-10 volumes per gram of cell resuspension buffer [50mM TRIS 
pH8, 300mM NaCl, 1% Triton-100, 1 complete tablet/50ml], then centrifuged. This 
process was repeated before the pellet was resuspended in 4 volumes per gram of cell  
6M guanidine HCl 3% buffer B [25mM TRIS pH8, 300mM NaCl] 97% buffer A 
[25mM TRIS pH8, 300mM NaCl, 300mM Imidazole] using a homogeniser. The 
suspension was heated to 65
o
C for 20mins and an equal volume of 3%B/97%A was 
added. After spinning at 15,000rpm for 20mins at 10
o
C the supernatant was collected 
and placed onto 5ml Ni-NTA agarose pack in a column equibrilated with 2 column 
volumes of 3%B/97%A. The column was washed 4 times with column volume of 8M 
urea 3%B/97%A then 4 times with column volume of 8M urea 10%B/90%A. To elute 
the columns were washed 4 times with column volume of 8M urea 30%B/70%A then 4 
times with column volume of 8M urea 100%B. The first 33% of the columns volume 
from the elute, which is the void volume, was discarded and the TEV proteins was 
collected in 4 fractions of column volume. A 10% SDS PAGE gel was run and stained 
with Coomassie to confirm with fractions contain the TEV and to check the purity. 
These fractions were pooled and put through a PD-10 buffer exchange column 
(Pharmacia Biotech; Code No: 17-0851-01) to transfer the TEV into Dialysis Buffer 
[100mM TRIS pH 8.5, 0.5M NaCl, 5mM DTT, 0.5mM EDTA, 50% glycerol].  TEV 
activity was tested and aliquots were stored at -80
o
C 
2.6.17 TAP Tag Purification 
To 50ml of NP-40 buffer [6mM Na2HPO4, 4mM NaH2PO4
.
H2O, 1% NP-40, 150mM 
NaCl, 2mM EDTA, 50mM NaF] 1 complete EDTA free, 1.3mM benzamidine and 1mM 
PMSF was added fresh before use. Pellets were resuspended in 1ml of this buffer and 
cells were disrupted by adding 200µl of acid washed glass bead to 200µl of the cell 
suspension and ribolysed using a Hybaid RiboLyser at a power of 6.5 for 10second. This 
was repeated three times with 2 min incubation on ice in between. A further 100µl of 
buffer was added before a fourth round in the ribolyser. Debris was then removed by 
centrifugation at 8,000rpm for 5mins at 4
o
C, whilst the supernatant was pooled and 
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incubated with 200µl of IgG Sepharose 6 Fast Flow beads (GE Healthcare, Cat:17-0969-
01) which had been prequilibrated with NP-40 buffer overnight at 4
o
C. 
The lysate and the beads were then transferred to a polyprep column and the lysate was 
drained off. Beads were then washed with 10ml of  IPP150 [10mM TRIS-HCL pH8.0, 
150mM NaCl, 0.1% NP-40] followed by 5ml of  TEV cleavage buffer (TEV CB) 
[10mM TRIS-HCL pH8.0, 150mM NaCl, 0.1% NP-40, o.5mM EDTA, 1.0mM DTT]. 
The proteins were then cleaved off the IgG beads by addition of 1ml of TEV CB and 
100U of TEV overnight at 4
o
C.  The proteins were then eluted into a fresh column and 
the beads washed with 0.5ml TEV CB. Three volumes of IPP150 Calmodulin binding 
buffer (CBB) [10mM TRIS-HCL pH8.0, 150mM NaCl, 1mM Mg
2+
 acetate, 1mM 
Imidazole, 2mM CaCl2, 10mM βME, 0.1% or0.02% NP-40 ] was added to the elute 
along with 3µl of 1M CaCl2 per 1ml of elute.  
Protein was then bound to Calmodulin Affinity Resin (Stratagene, Cat: 214303-52) 
prequilibrated with CBB overnight at 4
o
C. Beads were washed twice with 1ml CBB 
0.1% NP-40, once with 1ml CBB 0.02% NP-40 before the final purified protein was 
eluted with 500µl of IPP150 Calmodulin elution buffer (CEB) [10mM TRIS-HCL 
pH8.0, 150mM NaCl, 0.02% NP-40, 1mM Mg
2+
 acetate, 1mM Imidazole, 20mM 
EGTA, 10mM βME]  
2.6.18  Ubiquitin Binding Assay 
To 50ml TBS [12.5mM TRIS pH7.5, 37.5mM NaCl] one complete – EDTA tablet was 
dissolved. Either K48 tetra ubiquitin (Enzo life science, Cat: UW8645) or K48 chains 
(Enzo life science, Cat: UW8860 or Boston Biochem, Cat: UC-230) or K63 chains 
(Boston Biochem, Cat: UC-320) was made up to a concentration of 6.25mg/l or 
12.5mg/l. 100µl of the ubiquitin chains were added to 15-30μl of GST tagged proteins 
bound to Glutathione Sepharose™ 4B beads, or 2-5μl for GST alone. Samples were 
rotate for at least 2 hrs or overnight at 4
o
C before being washed 5 times by inverting tube 
with 1ml of TBS.  
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The protein was the boiled off the beads using SDS PAGE loading buffer and an equal 
amount of GST tagged protein was loaded onto two 10% SDS PAGE gels. One was 
strained to show proteins loading whilst the other was blotted for use in Western 




Interaction of KA1 and KA2 Domains with APC/C 
3.1 Introduction 
APC/C is a RING type E3 ubiquitin ligase which is part of the regulation process in the 
cell cycle. One of the ligases most important roles is to mark crucial proteins for 
destruction. These proteins include cyclins, which are involved in each stage of the cell 
cycle and the cohesion complex, which hold the sister chromatids together before 
entering anaphase (Jallepalli et al. 2001; Bastians et al. 1999). In fission yeast APC/C 
recognises the protein Cut2 (commonly called securin), an inhibitor of the enzyme Cut1 
(separase). When separase is released from its inhibition, it cleaves the Rad21 (Scc1) 
subunit of the cohesin complex, allowing the sister chromatids to separate and move to 
opposite poles of the dividing cell (Chang et al. 2001).  
The activity of E3 ligases are regulated in two ways. Some ligases are always in an 
active state e.g. SCF, and depend on the phosphorylation state of the substrate as a 
trigger to recognise their targets. Where substrate recognition is predetermined the ligase 
activity is regulated, as in the case of APC/C.  
APC/C always recognises its substrates through two co-activators, Slp1 (commonly 
known as Cdc20) and Ste9/Srw1 (Cdh1) (Acquaviva & Pines 2006) but is tightly 
regulated to dictate when the ligase is activated to ubiquitinate its substrates. In higher 
eukaryotes APC/C is a target for kinases such as PKA and PLK1 (Acquaviva & Pines 
2006). The resulting phosphorylation can either positively or negatively affect the ligase 
activity. Another form of regulation is provided by the Mitotic Checkpoint Complex 
(MCC) which inhibits APC/C
Slp1
 by binding to the co-activator, possible preventing 
APC/C from binding its substrates (Chung & Chen 2003; Burton & Solomon 2007). 
These layers of regulation along with the two co-activators; Slp1, which is active from 
metaphase to anaphase and Ste9, which is active from anaphase to telophase, allow for 
APC/C to be active and to recognise the correct substrate at the precise time, preventing 
cells from becoming aneuploidy (Engelbert et al. 2008).   
65 
 
A study by Yamada et al. (1997) used an S. pombe strain in which endogenous cut9+ 
had been replaced with a HA epitope tagged cut9+ gene under the control of the cut9+ 
promoter. They showed by Western blot analysis that APC/C from this strain contains 
two forms of Cut9-HA corresponding to a higher molecular weight modified form and a 
lower molecular weight unmodified form. Protein extracted from synchronised cultures 
demonstrated that during most of the cell cycle APC/C contained the lower molecular 
weight Cut9 except through metaphase when Cut9 appears modified, and suggested that 
this modification was important to APC/C activity. APC/C was immunoprecipitated 
from extracts using anti-HA antibodies and treated with alkaline phosphatase, which 
caused the higher molecular weight Cut9 species to disappear, and alkaline phosphatase 
plus an inhibitor which maintained the higher weight Cut9 proving this modification was 
due to phosphorylation (Yamada et al. 1997). Ongoing studies within this group have 
shown that two related fission yeast kinases, Ssp2 and Ppk9, are capable of binding 
APC/C containing just the unphosphorylated form of Cut9-HA. To determine if both 
proteins share a common domain which could be responsible for this interaction, the 
protein sequences were sent for bioinformatics analysis to Kay Hofmann (Miltenyi 
Biotec GmbH, Stoeckheimer). He concluded that both kinases contain a novel Kinase 
Associated 1 (KA1) domain at their C-terminus. This domain is also present in another 
S. pombe kinase called Kin1 (Tassan & Le Goff 2004). In attempts to identify other 
kinases which may contain a KA1 domain, it was revealed that a very similar domain 
existed at the C-terminus of the kinase Chk1 which has now been designated as the 
Kinases Associated 2 (KA2) domain. 
The KA containing kinases belong to three different groups. The first group include 
Ssp2 and Ppk9, which are alternative catalytic α-subunits of S. pombe AMPK, a 
multimeric enzyme that in other organisms is involved in energy homeostasis 
(Matsusaka et al. 1995; Hanyu et al. 2009). However, very little work has been carried 
out on these kinases in fission yeast. During times of glucose limitation, AMPK is 
activated and drives the transcription of glucose repressible genes which allow the cell to 
compensate for these low levels of glucose.  
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The second group is the MARK family of kinases, where Kin1 is the only S. pombe 
homologue. These kinases are responsible for governing cell polarity and were the first 
family of proteins to have a defined KA1 domain at their C-terminus (Levin & Bishop 
1990). The primary role of these kinases is to phosphorylate MAP proteins. MAP 
proteins bind to microtubules and stabilise them using a domain that is also a target for 
phosphorylation by MARKs. This phosphorylation event causes the MAP proteins to 
dissociate from the microtubules which in turn become less stable (Trinczek et al. 1995; 
Drewes et al. 1997; Ebneth et al. 1999).  
The third group is the KA2 containing Chk1 kinase, which is involved in the DNA 
damage response cascade (Walworth et al. 1993). When Chk1 is activated it inhibits the 
dephosphorylation of the Cdc2 (Cdk1) and as a result the Cdc2-Cdc13 (CyclinB) 
complex remains inactive, causing a delay in the G2/M phase transition giving the cell 
time to repair any DNA damage (Karlsson-Rosenthal & Millar 2006).   
The MARK family of kinases are found in many organisms from yeast and 
Caenorhabditis elegans up to humans. They are identified as containing an ~50 amino 
acid KA1 domain which previously was defined by i) a conserved aspartic acid residue 
and ii) a C-terminal Glu-Leu-Lys-Leu (ELKL) motif at the end of the protein (Tassan & 
Le Goff 2004). However, this original definition has been modified as more KA1 
domains have been discovered, some from their sequence others by their structure. 
Several KA1 domains are up to 100 amino acids in length and it is believed that the 
extended sequence is important for the domain structure. Similarly KA1 domains such 
as the ones found in Ssp2 and Ppk9 lack the conserved ELKL C-terminal motif found in 
other KA1 domains, which had also been thought to play an important role in the 
domains structural fold. Surprisingly others do not contain a conserved aspartic acid, 
although some have a conserved glutamic acid (Tochio et al. 2006; Townley & Shapiro 
2007; Sanger 2010).  
This chapter confirms the interaction of these four kinases with APC/C in vitro by using 
the S. pombe cut9-HA tagged strain. Results show that the KA domain is responsible for 
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the observed interaction with APC/C and unlike the shuttle factors Pus1 and Rhp23, the 
KA domain specifically recognises APC/C containing the unphosphorylated form of 
Cut9. To identify which subunit of APC/C is responsible for the interaction with the KA 
domain, the yeast two hybrid protein/protein interaction assay was used. Unexpectedly, 
the data demonstrated that the KA domains do not interact directly with any of APC/Cs 
core subunits. A yeast two hybrid screen suggested that the KA domains may, in fact, 
bind to the co-activator Slp1. In order to confirm this interaction; native far Westerns 
were performed using GST tagged KA domains which confirmed that the KA domains 
bound to GFP tagged Slp1.  
 
3.2 KA Domains Bind Specifically to APC/C with Unphosphorylated 
Cut9 
Studies by Yamada et al. (1997) showed that using whole cell extracts from a cut9-HA 
strain, two bands of different molecular weight were present when analysed by Western 
blots. They demonstrated that the higher molecular weight band was due to 
phosphorylation of Cut9 whilst the lower molecular weight protein was 
unphosphorylated Cut9. 
In order to determine if the KA domain was responsible for the binding of the kinases to 
APC/C, full length and deleted version of the kinases were cloned into the Gateway® 
entry vectors pDONR™221 and pENTR™ D-TOPO®. The three versions of the 
proteins cloned were: i) full length kinase, ii) KA domains only which were taken to be 
residues: 445-576 for Ssp2, 421-532 for Ppk9, 751-891 for Kin1 and 393-496 for Chk1 
and iii) the full length kinases with the KA domain deleted (∆KA). Although chk1+ full 
length DNA could be amplified by PCR no entry vector containing a WT full length 
chk1+ could be constructed. These were then transferred into Gateway® modified 
pGEX 6P1 AH vector (gift from Andrew Jackson) to express GST tagged proteins in 
BL21strain of E.coli and purified onto Glutathione Sepharose™ 4B beads. The protein 




Figure 10: Kin1 KA1 Domain Binds to Unphosphorylated Cut9 Form of APC/C.  
GST fusion proteins were expressed in bacteria and purified onto glutathione beads. Next they were 
incubated with whole cell lysate from a strain carrying a HA tagged form of Cut9 before unbound protein 
was removed by washing. Top panel showing a Coomassie stained SDS PAGE gel of the input GST 
tagged protein. The bottom panel shows the corresponding Western blot for Cut9-HA probed with anti-
HA antibody (α HA). Protein extracts from the cut9-HA tagged strain (input) produces two bands 
corresponding to phosphorylated and unphosphorylated protein. The GST control did not bind APC/C 
whilst the shuttle proteins, Rhp23 and Pus1 can bind APC/C containing the phosphorylated form of Cut9. 




to remove unbound protein. The GST fusion proteins were separated by 10% SDS 
PAGE and Coomassie stained to show equal loading of the input GST protein. Western 
blot analysis was carried out on the samples probing with anti HA antibody (αHA) to 
detect APC/C binding by the presence of the Cut9-HA protein. 
To determine if the KA1 domain was responsible for the interaction with APC/C, the 
KA1 domain of Kin1 was tested since it appeared to be the best defined and it is the only 
KA domain, from the four kinases, which contains the ELKL motif. The KA1 domain of 
Kin1 is predicted to be 15.6kDa and Coomassie stained gel showed that the expressed 
GST tagged protein runs at just under 47.5kDa (Figure 10) which is consistent with the 
predicted size of the tagged domain. The Western blot of the APC/C binding assay 
concluded that GST alone could not bind to APC/C and that just the KA1 domain of 
Kin1 was sufficient to bind APC/C. This experiment also confirmed that the KA1 
domain only recognises APC/C containing unphosphorylated Cut9, compared with the 
shuttle factors Rhp23 and Pus1 which only recognised APC/C containing 
phosphorylated Cut9. The full length proteins of Ssp2, Ppk9 and Kin1 were then tested 
for their APC/C binding ability using the same assay (Figure 11 a).  
All three full length proteins bound to APC/C containing unphosphorylated Cut9. The 
same result was produced when only the KA domain of kinases was used (Figure 11 b). 
Although not quantitative, another observation from this data was that the Kin1 KA 
domain bound APC/C better than the other three domains. Ssp2 full length, ΔKA1 and 
KA1 were tested to confirm that the KA domain was responsible for the interaction. 
Both full length and KA1 domain of Ssp2 bound APC/C, but the ΔKA1 protein could 
not (Figure 11 c), supporting the theory that only the KA domain is responsible for the 
observed interaction. 
Sequence comparisons predict that Ssp2 has a putative UBA domain. It is known that 
kinases in Kin1 family of kinases also possess UBA domains. The interaction of the 
shuttle factor Rhp23 with APC/C is reliant on its UBA domains and it has been 




Figure 11: Full Length Protein and KA Domains Binds to Unphosphorylated Cut9 Form of APC/C. 
GST fusion proteins were expressed in bacteria and purified onto glutathione beads. They were then 
incubated with whole cell lysate from a strain carrying a HA tagged form of Cut9 before unbound protein 
was removed by washing. a) GST tagged full length protein for Ssp2, Ppk9 and Kin1 (top panel 
Coomassie stained) were capable of binding APC/C containing unphosphorylated Cut9 (bottom panel α 
HA blot). b) The same result was observed when all four isolated KA domains were tested for the ability 
to interact with APC/C. c) Full length, ∆KA1 and KA1 proteins of Ssp2 was expressed in bacteria and 
tested for their ability to bind APC/C to confirm no other region of the protein was responsible for 
binding. Full length and the KA1 domain of Ssp2 could bind APC/C, however Ssp2 ∆KA1was unable to 





Figure 12: Full Length Proteins Do Not Bind Ubiquitin Chains.  
GST tagged full length proteins were expressed in bacteria and coupled onto beads. After incubation with 
K48 (a) or K63 (b) ubiquitin chains, the beads were washed and separated on 10% SDS PAGE to stain 
with Coomassie (top panels) and analysed by Western blot for their ability to bind ubiquitin chains 
(bottom panels). None of the three full length proteins tested could bind ubiquitin chains unlike Rhp23, 
confirming that any bind to the APC/C complex is not via ubiquitin chains, and suggesting that the UBA 







(Seeger et al. 2003). To rule out this possibility the three full length proteins were tested 
for their interaction with K48 and K63 chains (Figure 12). These results showed that 
none of the proteins could bind ubiquitin chains; therefore the interaction with APC/C is 
not due to ubiquitin recognition. 
 
3.3 The KA Domains Do Not Bind Directly to a Core APC/C Subunit 
Although the binding assays confirmed that the KA domains bind APC/C and 
specifically APC/C containing unphosphorylated Cut9, the actual subunit of APC/C 
involved in this interaction has not been determined. Using the direct yeast two hybrid 
assay system, interactions between the four KA domains and the APC/C subunits could 
be observed. In this assay the strain J69-4A (James et al. 1996) was used which contains 
in its genome three binding sites: GAL1, GAL2 and GAL7 which are upstream of the 
selective markers: HIS3, ADE2 and lacZ respectively. Bait proteins were produced by 
cloning genes into the pGBT9 vector which encodes a binding domain for the above 
promoters. Prey constructs were produced by the pGAD424 vector which encodes a 
transcription activation domain. When the fusion proteins are translated the binding 
domain recognises the binding site and holds the bait protein in close proximity to the 
selective gene. If the prey protein interacts with the bait, it will allow the activation 
domain to transcribe the selectable marker which leads to a visible read out.    
The KA domains and APC/C subunits were cloned into the pGBT9 binding domain 
vector and pGAD424 activation domain vector. However the two APC/C subunits 
apc2+ and apc15+ could not be cloned into either vector so could not analysed. 
Initially, the ability of the different subunits to self activate was tested. To do this the 
vector containing the test gene and the opposite empty vector were transformed into 
PJ69-4A and spotted onto selective media lacking leucine and tryptophan (SC-LW) to 
test for successful transformation; media lacking leucine, tryptophan and histidine (SC-
LWH) to test for weak interaction and media lacking leucine, tryptophan, histidine and 
alanine (SC-LWHA) to test for strong interaction. None of the KA domains self 
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activated or interacted with each other (data not shown). pGBT9 apc13+ showed self 
activation when tested with empty pGAD424 however the reverse experiment with 
pGAD424 apc13+ did not. All four KA domains were tested against APC/C subunits 
which did not self activate along with SNF1 and SNF4 as a positive control (See 
Appendix A). Unexpectedly none of the subunits showed interaction with the different 
KA domains. Proteins that make up the MCC were also tested since this complex binds 
to APC/C and regulates its activity. The four KA domains did not interact with Mad2, 
Mad3 or Bub3 (Table 2).  
As an alternative approach to identify proteins which interact with the KA domains, the 
pGBT9 constructs were used as bait for a yeast two hybrid screen using the Beach pACT 
cDNA library. J69-4A cells were transformed with a KA containing pGBT9 first, then 
cells containing the binding domains vector were transformed with the activation 
domain library to maximise efficiency and then screened on SC- LWHA to find strong 
interactors. These positive colonies were then re-tested before being cultured and their 
DNA extracted. Activation domain primers were used to perform PCR from these DNA 
sources and then only the single band products were sequenced to identify the 
interactants (Table 3).  
The largest number of interactors was seen with Chk1 KA2 which gave 81 colonies. Of 
these 66 appeared to be a result of a colony containing a singly transformed pACT 
construct which gave good sequence. 42 encoded ribosomal proteins, the most common 
being rps002 which was responsible for 32 positive hits. Ribosomal proteins are 
common interactors in yeast two hybrid screens which are often confirmed as false 
positives. For the results of this study these proteins were not seen as interesting 
candidates so were not validated by other methods. 10 colonies were initially thought to 
be the KA1 domain of Ppk9. However, further sequencing showed these clones had been 
inserted in the vector incorrectly to give a nonsense construct. Direct testing showed no 
interaction between any of the KA domains (data not shown). The transcription factor 
eIF5A gene tif51 gave one positive colony, although this is a protein which is highly 




Table 2: Results of Direct Yeast Two Hybrid Between KA Domains and APC/C Subunits.   
KA domains from all four kinases were cloned into pGAD424 and pGBT9 yeast two hybrid vectors along 
with subunits of APC/C and the MCC. Interactions were tested by co-transforming the vectors into J69-
4A. To test for successful transformation the cells were spotted onto SC-LW as well as SC-LWH to test 
weak interaction and SC-LWHA to identify strong interaction. SNF1 and SNF4 were used as positive 
controls and each construct was tested for self activation with the corresponding empty vector. Y 




Table 3: Results of Yeast Two Hybrid Screen Between KA Domains.  
pGBT9 containing KA domains were transformed into J69-4A cells and selected for on SC-W. Cells were 
then transformed with Beach cDNA library and selected for strong interaction on SC-LWHA. After re 
testing on fresh SC-LWHA DNA was extracted and the insert amplified by PCR in order to be sequenced 
and identified.  
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the positive colonies analysed, the most likely to be true positives include another gene 
linked to transcription mbf1, a transcription factor co activator. A pair of interesting hits 
were gpm1 which encodes monomeric 2,3-bisphosphoglycerate (BPG)-dependent 
phosphoglycerate mutase (PGAM) and eno1 which encodes enolase, two enzymes that 
act consecutively in the glycolysis pathway (Sternberg et al. 1981; Moreno-Sánchez et 
al. 2008). trx1 thioredoxin-1 also produced one hit and is involved in redox reactions 
that protect the cell from stress (Holmgren & Lu 2010). Whilst the gene qcr8 is a subunit 
of ubiquinol-cytochrome-c reductase which is found in mitochondria and is involved in 
electron transport (Trumpower & Edwards 1979).  
Several of the positive interactors appear to have links to the Ubiquitin Proteasome 
System (UPS). Although the alpha subunit of the Nascent polypeptide-Associated 
Complex (NAC) Egd2 has not been well studied in S. pombe, a search of the database 
BioGRID revealed that the S. cerevisiae homologue (with the same name) has been 
shown to interact with ubiquitin, several subunits of the proteasome and the E2 
conjugating enzyme Ubc4 (BioGRID 2010a). Interestingly S. pombe ubc4+ was also 
identified in our screen. This E2 has many genetic links to APC/C and the proteasome in 
S. cerevisiae (BioGRID 2010a) which may suggest that Chk1 has a role in linking the 
NAC to the UPS. Two other ubiquitin related proteins include UBA/EH/EF hand 
domain protein encoded by ucp8 which also contains a UBA domain (Hartmann-
Petersen, C. A. M. Semple, Ponting, et al. 2003b) as well as ribosomal-ubiquitin fusion 
protein gene ubi1.  
The most interesting interaction was the APC/C co-activator slp1 which gave the 3
rd
 
greatest number of hits, which may explain how the KA domains interact with APC/C. 
Since Slp1 is not a core subunit; it may also account for the specific binding of APC/C 
containing unphosphorylated Cut9. For this reason Slp1 was the sole candidate from this 
screen used for further study. According to the BioGRID (2010b) database this is the 
first time a kinase has been shown to interact with Slp1 via yeast two hybrid. slp1 has 
already been linked by phenotypic suppression to rad3, the kinase responsible for 
activating Chk1 at the beginning of the DNA damage checkpoint (Sugimoto et al. 2004). 
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All of these interactions appear to be novel. This is most likely due to the fact that to 
date most yeast two hybrid screens have been performed using full length protein, not 
just the KA2 domain, which would explain why none of these genes have been 
identified before.  
No colonies were seen for Kin1 KA1 and only one colony appeared for both Ssp2 and 
Ppk9. The Ssp2 KA1 interactor was identified as the β-subunit of S. pombe AMPK 
which was predicted to interact with the KA1 domain of Ssp2 from the crystal structure 
of AMPK (Townley & Shapiro 2007). Ppk9 KA1 was shown to interact with β-
glucosidase cell wall protein Psu1, which appears to be a novel interaction which needs 
further validation.   
 
3.4 The KA Domains Bind Directly the APC/C Co-Activator Slp1 
Expression of GST-Slp1 proved difficult in bacteria and resulted in multiple bands being 
products when analysed by SDS PAGE, a common problem seen with Slp1 homologues 
from other organisms (Sironi et al. 2001). It has been speculated that this may be due to 
Slp1 requiring chaperones to allow the protein to fold correctly. However, a method 
devised that induces protein at late log phase and also involves cold shock (2.6.2) was 
tested since it had been demonstrated to produce proteins which are otherwise difficult 
to purify from bacteria (Galloway et al. 2003). This method showed good induction of a 
single band GST-Slp1 fusion protein (Figure 13 a, arrow). The GST coupled beads were 
consequently used to test for interaction with whole cell lysate from S. pombe cells 
expressing HA tagged Ssp2, Ppk9 and Chk1. After separation on 10% SDS PAGE gels 
and transferred onto membranes, samples were blotted with αHA antibody to detect the 
presence of the KA containing kinases. Of the kinases tested only Chk1-HA was able to 
be recognised and bound by recombinant GST-Slp1 (Figure 13 b) 
Possible explanations as to why Ssp2 and Ppk9 HA proteins were not bound by GST-
Slp1 were i) the HA tag hinders the interaction, ii) the recombinant GST protein has not  
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Figure 13: Binding if Chk1-HA by GST-Slp1.  
a) Coomassie stained 10% SDS PAGE gel of expressed GST-Slp1 (arrow) using log phase method (see 
section 2.6.2). b) GST-Slp1 expressed in bacteria and purified onto sepherose beads was incubated with 
lysate from a S. pombe strain containing a HA tagged form of Chk1. Excess protein was removed by 
washing and the proteins separated on 10% SDS PAGE. The top panel shows Coomassie staining of the 
input GST proteins whilst the bottom panel shows Western blot analysis using anti HA. GST-Slp1 






folded properly and iii) Slp1 is unable to interact with these proteins when it is bound to 
APC/C. To test this further, a native far Western was performed by making native whole 
cell lysate from GFP-slp1 strain. 100µg and 50µg of total extract was loaded and 
separated using native PAGE. The proteins were then transferred onto a membrane and 
blocked over night in either dilution buffer or 5% BSA. Purified GST fusion KA domain 
proteins were then added at a concentration of 1µg per ml to 4µg per ml. No GST 
protein was added to the negative control and 1:1000 αGFP was used to visualise the 
GFP-Slp1 fusion protein. A αGST HRP was used as a secondary antibody 1:100,000 for 
test substrates and the negative control, and α mouse HRP was used for the GFP control.  
The results in Figure 14 show that the native far Western negative controls were blank, 
proving that the αGST HRP antibody could not recognise any protein in the lysate. The 
αGFP positive control showed a single band at lower exposure (Figure 14 a), with a 
higher molecular weight band of lower concentration appearing at higher exposure 
(Figure 14 b), indicating the position of GFP-Slp1. All four GST-KA domains strongly 
bound to a single band of the same size recognised by the αGFP control, some showed 
weaker binding to a band consistent with that also seen in the αGFP control for 1µg per 
ml. Therefore, all four KA domains are able to recognise and bind to Slp1. Higher 
concentrations of KA proteins were tested for Ppk9, Kin1 and Chk1 (Figure 14 c, d & 
e); again all bound to a band of the same size recognised by the αGFP-Slp1 control. 
Since whole cell lysate from GFP-slp1 strain was used, any other proteins that may bind 
the KA domains should also be present. The far Westerns probed with the purified KA 
domains only produced one band; this suggests that Slp1 is the principal target for the 
KA containing kinases. 
 
3.5 Discussion 
KA1 domains have been described in the MARK family of kinases which include S. 
pombe Kin1 (Drewes & Nurse 2003) but as yet, no function has been assigned to this 






Figure 14: Far Western of GST-KA Protein with GFP-Slp1.   
Whole cell lysate from cells expressing GFP-Slp1 were made using non denaturing conditions and run on 
a NuPAGE® Novec® Tris Acetate 3-8% gels under native conditions and transferred onto a membrane. 
Far Westerns were then performed with purified GST-KA domain proteins at various concentrations or 
with anti GFP antibody. Membranes were then probed with HRP GST or secondary antibodies. For a 
negative control, no protein was added to determine if the anti GST antibody recognised any unspecific 
proteins in the lysate. a) When 1µg/ml of GST-KA protein was used to probe, a shorter exposure showed 
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that the KA domains of Ppk9, Kin1 and Chk1 all bound a single band of the same size, which was 
equivalent to the band produced by the GFP antibody (arrow); however Ssp2 KA did not produce a band 
at this level of exposure. b) A longer exposure of the same blot produced two bands (asterisks and arrow) 
for the KA domains of Ssp2, Ppk9 and Kin1. Again these were the same size as the GFP control which 
also produced two bands. At this level of exposure the KA2 domain of Chk1 was over exposed. c, d & e) 
Higher concentration of protein from 2-4µg/ml were used to test Ppk9KA1, Kin1KA1 and Chk1 KA2, 
which all recognised and bound a band which was also recognised by the GFP antibody. In all 
experiments the negative control of no primary protein followed by the HRP GST secondary antibody was 
blank, proving that the bands seen were not due to unspecific antibody binding but as a result of the KA 

















number of proteins described as having a KA1 domain has increased due to the 
structural motif rather than the sequence of the domain. As a result, the definition of the 
KA1 domain has expanded. Up to this point the function of the KA domain has 
remained elusive; however, it has been speculated that this domain could be involved in 
localisation or have a role in regulation of the N-terminal kinase domain (Guo & 
Kemphues 1996; Beullens et al. 2005). The data presented provide in vitro evidence that 
one of the functions of the KA domains is to allow a subset of kinases to interact with 
APC/C. 
Cut9 is only phosphorylated when it is part of the 20S APC/C complex and not in a free 
form. Synchronised cells of the cut9-HA strain showed that the upper phosphorylated 
band was only present in metaphase cells - a stage in the cell cycle when APC/C is most 
active. However genetic studies showed that the double mutant of cut9-665 with the 
fission yeast PP1 phosphatase mutant dis2-11 was lethal. Alternatively, the double 
mutant cut9-665 pka1∆ that lacked the catalytic subunit of the PKA kinases could rescue 
the temperature sensitive phenotype of the cut9-665 mutant (Yamada et al. 1997). This 
suggests that PP1 positively regulates APC/C activity whilst PKA inhibits activity, 
although direct interactions were not proven. Regardless, this data showed that the 
phosphorylation state of Cut9 is important in regulating APC/C activity. Since the KA 
domains specifically bind APC/C with unphosphorylated Cut9 there must be something 
specific, such as a conformational change or co-activator, that the domains can 
recognise.  
The direct yeast two hybrid results rule out an interaction with core APC/C subunits or 
the MCC. However, a library screen revealed that the KA2 domain of Chk1 could 
interact with the co-activator Slp1, and far Westerns confirmed that the KA domains all 
bound to a protein the same size as native GFP-Slp1. Although other proteins were 
identified in the library screen, only binding to the GFP-Slp1 band was observed in the 
native far Westerns which would indicate that Slp1 is the main or preferred target for 
KA domain interaction. This was a surprising result indicating that the phosphorylation 
state of Cut9 has some bearing on the ability of Slp1 to bind to APC/C. In budding yeast, 
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mutations in the Cut9 homolog CDC16, that converted the phosphorylation sites to 
alanine, produced an APC/C complex with severely reduced ability to bind the Slp1 
homolog CDC20. Similar mutations to the Nuc2 subunit CDC27 reduced binding to a 
lesser degree (Rudner & Murray 2000). Taking these findings into account, it may be 
that in S. pombe, the KA containing kinases bind to APC/C (which contains 
unphosphorylated Cut9) through Slp1 which is bound to Nuc2. Further investigation 
may identify the link between the Cut9 phosphorylations effect on APC/C activity and 
the interaction with Slp1 in fission yeast.    
This is the first observed direct interaction of a KA domain with another protein and is 
the first confirmed role of the KA domain. However, the crystal structure of Ssp2 in the 
pombe AMPK complex suggested an additional function of the KA1 domain is to 
interact with the β subunit (Townley & Shapiro 2007). Interestingly the yeast two hybrid 
results are consistent with this function. This would lead to the conclusion that the KA 
domains are involved in other interactions which as yet remain unidentified. The KA 
domain of Kin1 did not yield any positive colonies, even through the best defined KA 
domain is that of Kin1. Kin1 KA1 domain also appears to have a stronger interaction 
with APC/C from the Cut9-HA Western blots.  
Chk1 KA2 domain is slightly different to the KA domains of Ssp2, Ppk9 and Kin1 and 
may account for the fact that it yielded many more interactions and indeed the only KA 
domain that gave a positive interaction with Slp1 in the yeast two hybrid screen. Chk1-
HA protein interacted with GST-Slp1 whereas Ssp2 HA and Ppk9 HA proteins could 
not. Perhaps the Chk1 KA2 may bind to a different site of Slp1 or the confirmation of 
Slp1 in the context of APC/C is important for KA1 domain binding. This theory is 
supported by the native far Western results which show all KA domains could bind GFP 
Slp1 in its native form. However, further analysis of the binding site in Slp1, which the 
KA domains interact with, is required to deduce if the two different types of KA 
domains recognise the same motif. 
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In all analyses, there are always the limitations of the techniques used and the yeast two 
hybrid is no exception, and may account for Kin1 KA1 domain being unable to interact 
and Ssp2 and Ppk9 KA1 domains yielding a low return. The cDNA library used may 
have an under representation of those proteins expressed at low levels, or very large 
proteins whose RNA’s reverse transcribes inefficiently and produce incomplete proteins. 
To propagate a cDNA library constructs may be lost and high stringency of selection 
may not identify transient interactions. It should be noted that the two hybrid screen is 
carried out in S. cerevisiae, and therefore binding partners or post-translational 
modifications may not occur and interaction partners cannot be observed and identified. 
It is known that the Chk1 C-terminus is well conserved and is essential for controlling 
kinase function as well as its role in the DNA damage checkpoint (Kosoy & O'Connell 
2008; Palermo et al. 2008). Our proposed KA2 domain (residues 323-496) contains the 
two areas of high conservation (residues 394-400 and 468-477) identified by Kosoy & 
O'Connell (2008). They showed that point mutations and deletions in these regions can 
lead to both increases and decreases in kinase activity in vivo. They did this by testing 
the ability of the mutants to rescue the chk1Δ phenotype when exposed to MMS. It is 
possible that the KA2 domain is needed to bind regulators or substrates and that these 
mutations strengthen or weaken the interactions accordingly. Another controversial 
theory is that the C-terminus acts as an auto-inhibitory domain. A region of fission yeast 
Chk1 identified by Palermo et al. (2008) appears to encode a pseudo substrate domain 
(residues 464-469) which may bind the kinase domain and regulate its activity. 
However, this theory is not supported by yeast two hybrid data which shows no 
interaction between the isolated kinase domain and the C-terminus and cannot explain 
why some of the mutations cause loss of function. 
Several of the positive yeast two hybrid proteins have a link to UPS, such as Slp1, Ucp8, 
Ubc4 and Ubi1. A library screen with full length Chk1 has also identified proteins with 
links to ubiquitin such as a potential E3 ligase containing a RING finger domain and 
another protein containing an EF-hand domain (Kosoy et al. 2007). A number of 
different observations indicate that the DNA damage checkpoint and the control of 
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cohesin cleavage appear to be linked; the double mutant of a compromised cut2
EA2 
and 
chk1Δ has an increased sensitivity to UV damage than either of the single mutants. In 
addition, cells carrying a form of Rad21 (a subunit of cohesion) which cannot be cleaved 
were slower to repair thymine dimers after UV radiation compared to WT (Nagao et al. 
2004). If the binding of Chk1 to APC/C, which is ultimately responsible for the 
destruction of Rad21 though Cut2, allows Chk1 to regulate its activity, it could influence 
when Cut2 gets ubiquitinated and could delay or bring forward the cohesin cleavage 



















Phosphorylation of Mad2 
4.1 Introduction 
Unlike some E3 ligases such as SCF which are periodically activated, APC/C can 
always recognise its substrates, however, its activity is tightly regulated by 
phosphorylation and inhibition by the Mitotic Checkpoint Complex (MCC) (Vodermaier 
2004). Kraft et al. (2003) demonstrated that in human APC/C, there are over 43 sites of 
phosphorylation and that 34 are specific to mitosis. It has also been shown that adding 
phosphatases to active APC/C preparations results in a reduction of ligase activity 
(Kramer et al. 2000).  
Multiple subunits of APC/C are phosphorylated at several sites by cyclin dependent 
kinases (Cdks). Cdk phosphorylation of APC/C between G2 to M phase is required to 
bind Cdc20, the homologue of co-activator Slp1, and causes activation of APC/C
Cdc20 
at 
prophase through to anaphase. The reduction of Cdk activity at mid anaphase causes the 
formation of APC/C bound to the second co-activator Cdh1 (Ste9 in S. pombe). Cdh1 
can bind APC/C regardless of the enzymes phosphorylation state. However, when Cdh1 
is phosphorylated by Cdk1-CyclinB this causes dissociation from APC/C at late G1 to S 
phase and corresponds to a loss of ligase activity (Vodermaier 2004; Skaar & Pagano 
2009). 
Phosphorylation has been shown to have both a positive and negative effect on APC/C 
activity. In fission yeast PKA phosphorylates the Cut4 and Nuc2 subunits of APC/C 
causing inaction of the complex. Phosphorylation of Cut9 has also been shown to be 
important for regulating APC/C activity at metaphase (Yamada et al. 1997; Acquaviva 
& Pines 2006). Cdk1-CyclinB (Cdc2-Cdc13 in S. pombe) and Plk (Plo1 in S. pombe) 
have been shown to phosphorylate APC/C subunits including Cdc27 (S. pombe Nuc2), 
Cdc23 (S. pombe Cut23), Cdc16 (S. pombe Cut9) and S. pombe Hnc1 (Rudner & Murray 
2000; C. Kraft et al. 2003; Yoon et al. 2006). Hnc1 is an essential subunit needed to 
assemble the APC/C complex and is phosphorylated at serine 48 by Cdc2-Cdc13. To 
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show this phosphorylation is critical for function, mutations were made to change serine 
48 to alanine which resulted in a delay in the final stage of cell division and causes an 
increase in cells which have not separated properly (Yoon et al. 2006). 
APC/C is also regulated by the MCC, usually made up of Mad2, Mad3 and Bub3 
(Sczaniecka et al. 2008). During metaphase to anaphase conversion the kinetochores of 
the chromosomes undergo bipolar attachment to microtubules in order to be separated 
into daughter cells. Unbound kinetochores are recognised by the spindle checkpoint. In 
this checkpoint the Mitotic Arrest Deficiency 1 (Mad1) protein binds to kinetochores 
and recruits the Mad2 protein. Mad2 exists in two different states, the open O-Mad2 or 
closed C-Mad2. O-Mad2 is in a kinetically higher energy confirmation and cannot bind 
Mad1 or the Slp1 homologue Cdc20. O-Mad2 can bind to C-Mad2 in a dimer complex 
with Mad1 at the kinetochore and is converted from O-Mad2 to an intermediate I-Mad2. 
This intermediate protein converts to C-Mad2 which dissociates from C-Mad2- Mad1 
dimer and can then bind Mad1 or Cdc20 attached to APC/C (Yang et al. 2008). The 
binding of C-Mad2 to Cdc20 initiates the formation of the MCC which inhibits APC/C 
activity stopping the progression through to anaphase until all the kinetochores are 
bound to microtubules.     
To reverse the inhibition of APC/C the cell utilises two different mechanisms. The 
protein Cmt2/p31
COMET
 binds to C-Mad2 in the Mad1 dimer blocking its ability to bind 
and convert O-Mad2 and therefore Mad2 cannot be loaded onto APC/C. In addition 
p31
COMET
 has been shown to bind to C-Mad2 attached to APC/C and causes auto-
ubiquitination and degradation of Cdc20 bound to C-Mad2 which leads to activation of 
the E3 (Reddy et al. 2007; X. Luo & Yu 2008). Mad2 is also phosphorylated at several 
serine residues at its C-terminus which renders it unable to bind Cdc20 and causing it to 
dissociate from APC/C. It has also been demonstrated that mutations that mimic 
phosphorylation of Mad2 at several serine residues causes the protein to adopt the open 
confirmation. In addition phosphorylation of human Cdc20 at S195 prevents conversion 
to C-Mad2 (Wassmann et al. 2003; Kim et al. 2010). When APC/C is released from 
inhibition it is then free to act on targets which promote the onset of anaphase.  
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All four KA containing kinases are involved in processes which are important for cell 
division. Chk1 is part of the DNA damage pathway which blocks the cells passage from 
G2 to M phase in response to DNA damage (Walworth et al. 1993). Chk1 has also been 
implicated with the spindle checkpoint (Zachos et al. 2007). Ssp2 and Ppk9 are part of 
the 5' AMP-activated Protein Kinase (AMPK) complex involved in regulating 
metabolism and are activated during times of glucose limitation, conditions which are 
not favourable for cell division (Hanyu et al. 2009), whilst Kin1 regulates microtubule 
stability and cell growth (Drewes & Nurse 2003).  
Although not much is known about Ssp2 and Ppk9 in fission yeast, their orthologue in S. 
cerevisiae, Snf1, has been well studied due to AMPKs implication in diabetes (Iseli et al. 
2008). Snf1 is the α catalytic subunit which along with the γ regulatory Snf4 and either 
one of the β subunits Sip1, Sip2 or Gal38 forms the heterotrimer enzyme SNF1. Studies 
have shown that along with an N-terminal kinase domain, Snf1 contains a C-terminal 
regulatory domain which can bind to and inhibit the kinase domain in the presence of 
high amounts of glucose. However, when glucose levels are low, this domains ability to 
bind the kinase domain decreases and instead, it interacts with the γ regulatory subunit 
Snf4 leading to activation of the SNF1 complex. Interestingly, genetic and biochemical 
studies have shown that the Snf1 regulatory domain is needed for the formation of the 
SNF1 complex, although Snf1 on its own does retain some kinase activity which can be 
increased by removal of the regulatory domain (Hardie et al. 1998; Elbing et al. 2006).  
The C-terminus of Chk1 is also very important in regulating its own N-terminal kinase 
domain. Kosoy & O’Connell (2008) demonstrated that the deletion of the last 11 amino 
acids of Chk1 C-terminus was enough to cause inactivation of Chk1 kinase activity. 
Consistently many mutations in the C-terminus have been shown to effect kinase 
activity. Exactly how this happens is still controversial. One of the most attractive 
hypotheses is that the C-terminus interacts with the kinase domain and inhibits its 
activity in a similar manner to Snf1. A pseudosubstrate domain was identified in the C-
terminus inside our proposed KA2 domain in which the phosphoacceptor site had been 
replaced with a conserved aspartic acid. This motif should be recognised by the kinase 
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domain of Chk1 providing a possible mechanism for auto-inhibition (Palermo et al. 
2008). However mutations have been made to the C-terminus that decreased activity 
which contradicts this model. Also yeast two hybrid assays failed to show interactions 
between the two domains suggesting that the C-terminal does not provide a mechanism 
for regulation (Palermo et al. 2008; Kosoy & O'Connell 2008; Tapia-Alveal et al. 2009). 
Since all four of these protein kinases are capable of binding APC/C, it was important to 
investigate if they could phosphorylate, and therefore regulate, APC/C. The results in 
this chapter show that the kinases can phosphorylate a ~30kDa protein associated with 
APC/C, and that this protein is Mad2, part of the MCC complex not APC/C. This data 
also suggests that the KA domains may have an additional role in regulating kinase 
activity by acting as auto-inhibitors to the N-terminal kinase domains. 
 
4.2 Full Length Proteins Phosphorylate a 30kDa band of Tap Tagged 
Purified APC/C 
In order to investigate if the KA containing kinases were involved in regulating APC/C 
activity the APC/C complex was purified from an integrated Tandem Affinity 
Purification (TAP) tag cut20/lid1 strain. The TAP tag consists of a Calmodulin Binding 
Peptide (CBP) and Protein A separated by a Tobacco Etch Virus (TEV) protease 
cleavage site. The APC/C complex was purified as described in Material and Methods 
2.6.17. The complex was then separated on SDS PAGE gels and silver stained which 
gave a similar banding pattern to that previously published (Figure 15 a, Appendix B) 
(Yoon et al. 2002). GST tagged full length Ssp2, Ppk9 and Kin1 where bacterially 
expressed and purified by coupling to Glutathione Sepharose™ 4B beads before eluting 
using L-glutathione in order to test for kinase activity. 
First the activity of the kinases was tested by looking for autophosphorylation by 




Figure 15: Phosphorylation of Purified Tap Tagged Cut20 APC/C by Full Length Proteins.  
a) A strain in which endogenous cut20+ has been replaced with a TAP tag form was used to purify APC/C 
and visualised using silver staining. This complex was then used to perform phosphorylation assays with 
radio labelled ATP and bacterially expressed GST fusion proteins of Ssp2, Ppk9, Kin1 and CKII. b) The 
three KA containing kinases phosphorylated a protein of ~30kDa which was not present in the water 










Professor Wolfgang Dubiel. Proteins were then separated by SDS PAGE and transferred 
to a membrane which was exposed to x-ray film. This result showed that none of the 
kinases appeared to be active (data not shown). However this could be due to the KA 
domain inhibiting the N-terminal kinase domain. The kinases, along with CKII as a 
positive control, were incubated with APC/C and radiolabelled ATP then separated on 
SDS PAGE gel before transferring onto membranes. Overnight exposure showed that 
CKII phosphorylated several proteins whilst the three kinases only phosphorylated one 
specific 30kDa protein which was not seen in the water control (Figure 15 b). However, 
the molecular weight of this protein does not correspond to any of APC/Cs core 13 
subunits or its co-activators suggesting that these kinases act on a protein associated to 
APC/C.  
 
4.3 Ssp2 and Ppk9 Phosphorylate Mad2 
Previous published work has used the cut20 TAP tag strain to purify APC/C in order to 
identify new subunits and proteins transiently associated with APC/C. NMR analysis 
showed that along with the co-activator Slp1, Mad2 and Mad3 of the MCC were also 
purified with the complex. The third MCC subunit Bub3 is not present in S. pombe 
APC/C-MCC complex because fission yeast Mad3 lacks the motif that bind Bub3 
present in other organisms. In these preparations of APC/C Mad2 was identified by 
Western blots and appeared to migrate at a molecular weight of ~30kDa (Sczaniecka et 
al. 2008). Since the formation of the MCC is regulated by phosphorylation of Mad2, this 
made Mad2 a candidate for phosphorylation by KA containing kinases. 
Full length and ∆KA GST fusion proteins were purified from bacteria and eluted from 
beads. They were again tested for their ability to autophosphorylate in collaboration with 
Professor Wolfgang Dubiel’s group, and as shown in Figure 16, both Ssp2 and Ppk9 full 
length proteins could not autophosphorylate, but the ∆KA proteins could. This is 




Figure 16: Autophosphorylation of Full Length and ∆KA Proteins and Phosphorylation of Purified 
GST Mad2.  
Full length and ∆KA GST tagged proteins were purified from bacteria extracts onto Glutathione 
Sepharose™ 4B beads and eluted. They were tested for their ability to autophosphorylate by addition of 
radiolabelled ATP. a) Ssp2 and Ppk9 appear to be able to autophosphorylate in the absence of the KA 
domains, but not in the presence of the full protein (bottom panel). b) The ability of full length and ∆KA 
proteins to phosphoylate GST-Mad2 was tested by a similar assay. Ssp2, Ppk9 and Kin1 appear able to 




Figure 17: Structure of Ssp2 and Ppk9.  
a) The structure of Ssp2 based on the solved crystal structure (Townley & Shapiro 2007) shows the 
binding site in magenta and everything apart from the KA1 domain in green. b) When the KA domain is 
added,  it appears to shut off the access to the kinase binding surface. c) Although Ppk9 structure has not 
been solved, a model based on its sequence and structure of similar proteins show the binding site in 
magenta and everything except the KA domain in blue. d) Again the KA1 domain seems to restrict access 
to the binding site. This may suggest that the KA1domains act as an auto-inhibitor of the N-terminal 







domain for the N-terminal kinase domain. The structure of the AMPK subunits Ssp2 and 
Ppk9 seem to support the auto-inhibition hypothesis. Modelling based on the crystal 
structure of the S. pombe Ssp2 as part of the AMPK complex solved by Townley & 
Shapiro (2007) was performed by Konstantinos Paraskevopoulos (MRC HGU) and 
shows that the protein without the KA domain has a binding site (Figure 17 a magenta) 
surrounded by α helices except on one side. The KA1 domain occupies this free space 
and appears to close off access to the ATP binding site (Figure 17 b). Although the 
structure of Ppk9 has yet to be determined, hypothetical modelling was performed based 
on similar proteins (Figure 17 c & d). Again it appears that the binding site is blocked by 
the KA1 domain, lending weight to the auto-inhibition role of KA1 domain. 
Kin1 full length and ∆KA proteins of Kin1 and Chk1 did not appear to be active. When 
tested with GST-Mad2 the kinases Ssp2∆KA, Ppk9 and Ppk9∆KA phosphorylate Mad2. 
This data also showed that Kin1may possibly phosphorylate Mad2; however this protein 
appeared to have been degraded by the time it was tested.  
 
4.4 Mad2 is Not Needed for KA Domains to Interact with APC/C 
Since we have shown that the KA domains can interact with APC/C via the co-activator 
Slp1, we wanted to determine if the presence of Mad2 was a requirement for this 
interaction. To do this the cut9-HA strain was crossed to the mad2∆ mutant and the 
APC/C interaction assay repeated with KA domains to see if the presence of Mad2 was 
important for binding. The KA domains were still able to interact with APC/C 
containing unphosphorylated Cut9 (Figure 18), which would suggest that any 
phosphorylation of Mad2 by these kinases is transient and does not require binding to 




Figure 18: KA Domains Binds to Unmodified Cut9 Form of APC/C in the Absence of Mad2. 
Protein extracts from the cut9-HA mad2Δ strain produces two bands corresponding to phosphorylated and 
unphosphorylated Cut9-HA protein. After incubation with GST tagged KA domains excess protein was 
removed by washing, and samples separated on 10% SDS PAGE gel. Analysis by Western blot using an 
anti HA antibody revealed that the KA1 domains can still bind the unphsophorylated band exclusively 














The precise role of the KA domain has yet to be defined, although several functions, 
including localisation and auto-inhibition of the kinase domain, have been proposed 
(Guo & Kemphues 1996; Beullens et al. 2005). The structure of the AMPK subunits 
Ssp2, Ppk9 and Chk1 seem to support the auto-inhibition hypothesis. Modelling 
performed by Konstantinos Paraskevopoulos (MRC HGU) showed that the KA domain 
of both Ssp2 and Ppk9 appear to block access to the kinase domains binding site (Figure 
17). This would be in keeping with the S. cerevisiae homologue Snf1, which uses its C-
terminus as an auto-inhibitory domain to bind to the N-terminal kinase domain and 
prevents it from acting on its substrates (Hardie et al. 1998). The C-terminus of the Chk1 
protein, in which we have defined a KA2 domain, plays an important role in regulating 
kinase activity (Kosoy & O'Connell 2008). Although it has yet to be proved 
conclusively, it is believed that the C-terminus of Chk1 can also bind the N-terminal 
kinase domain causing inhibition (Palermo et al. 2008).  
Initial experiments showed that bacterially expressed GST tagged full length Ssp2, Ppk9 
and Kin1 could not autophosphorylate; however, these kinases were then proved to be 
active when incubated with APC/C (Figure 15). As the KA domains bind to Slp1 this 
would suggest that the KA domains may be acting as auto-inhibitory domains. Further 
experiments showed that full length Ssp2 and Ppk9 proteins lacking the KA1 domain 
could autophosphorylate, but the full length proteins could not (Figure 16). This data 
would support the notion that a secondary role for the KA domains is to regulate kinase 
activity. The same results were not seen for Kin1 or Chk1. However, full length Chk1 
protein was not available for testing and the preparation of Kin1 full length appears to 
have degraded every time it was tested, and the two ΔKA proteins did not appear to be 
active. Further work is needed to confirm that all of the KA domains behave in the same 
way, preferably using protein expressed in S. pombe. These proteins are more likely to 
be active since they will contain post translational modifications and binding partners 
which are not present in bacterially expressed protein, and will give a more accurate 
reflection of the proteins behaviour in the cell.  
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Chapter 3 presented evidence that the KA domain binds to the APC/C co-activator Slp1, 
potentially giving kinases access to the E3 ligase APC/C and allowing them to influence 
the cells transition from metaphase to anaphase. It was therefore important to determine 
if these KA containing kinases could phosphorylate APC/C. Full length Ssp2, Ppk9 and 
Kin1 all phosphorylated an ~30kDa protein present in TAP tagged purified APC/C. 
Previous reports showed that the only protein present in these preparations of this 
molecular weight was Mad2. The ability of the full length and ΔKA kinases to 
phosphorylate GST-Mad2 was tested and proved that the active kinases, Ssp2 and Ppk9 
could phosphorylate Mad2. It is known that the phosphorylation state of Mad2 controls 
its ability to form the C-Mad2 conformation and, therefore, controls Mad2 binding to 
Mad1 and Slp1/Cdc20. However, to date the kinases responsible for these modifications 
have yet to be identified. This makes the observed phosphorylation by some of the KA 
containing kinases novel. Therefore, if these kinases phosphorylate Mad2 attached to 
APC/C this could cause dissociation of the MCC from APC/C. The data also shows that 
binding of the KA domain to APC/C is not dependent on the presence of Mad2 (Figure 
18).  
From this evidence we propose that the KA domain can bind to the N-terminal kinase 
domain of the protein, inhibiting phosphorylation of their substrates. After some cellular 
event the KA domains can recognise APC/C containing the unphosphorylated Cut9 
subunit via the co-activator Slp1. This then leaves the kinase domain free to act on 
Mad2, which also binds Slp1. Phosphorylated Mad2 then dissociates from Slp1 and 
cannot bind Mad1 or Slp1 again until it is dephosphorylated. Thus the kinases can 
control the binding of Mad2 to APC/C and the formation of APC/C
MCC
 and, therefore, 
can regulate APC/C activity (Figure 19). This is consistent with the involvement of the 
kinases in pathways needed for cell division. Ssp2 and Ppk9 monitor glucose levels and 
act on their substrates in times of low glucose, which is an unfavourable condition for 
cell division. Similar situations exist for Chk1, which is activated after DNA damage 
allowing cells to repair or halt cell division, and Kin1 regulates microtubule stability, 
effects cell morphology and cell division. It is plausible to believe that at times when 
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these kinases are not needed for their primary roles they could be available to bind to 
and regulate activation of APC/C. On their own these phosphorylation events may not 
have a drastic effect but each of these kinases may be able to adjust the regulation 







Figure 19: Model of APC/C Regulation by KA Domain Containing Kinases.                                                           
A diagram showing the proposed mechanism of the KA domains functions. The KA domains bind to and 
inhibit the N-terminal kinase domains until some cellular event causes them to recognise and interact with 
Slp1 attached to APC/C. This then frees the kinase domain to phosphorylate Mad2, causing dissociation of 




Characterisation of Kinase Mutants  
5.1 Introduction 
Post-translational modifications play an important role in altering the function and fate 
of proteins. Of all the post translational modifications known, phosphorylation of 
proteins has been the most extensively studied. The ability of kinases to recognise 
substrates and utilise ATP to transfer phosphate to a serine, threonine or tyrosine residue 
has been implicated in controlling protein activity in pathways ranging from immunity 
to behaviour (Tarrant & Cole 2009). To do this, proteins use a catalytic kinase domain 
which has a well conserved structure which can be used as a marker to identify kinases. 
The N-terminus of the kinase domain consists of a glycine rich subdomain made of β-
sheets and is joined by a linker region to a larger C-terminal subdomain made of α-
helices. The pocket created between these two subdomains binds ATP and can be 
rotated to form either an open or closed confirmation depending on the kinases 
activational state. This domain also contains conserved residues involved in binding 
ATP as well as the transfer of phosphate from ATP to the target residue (Scheeff & 
Bourne 2005). 
Systematic study of the genome revealed that S. pombe encodes 106 kinases, 47 of 
which are conserved in humans. Genetic studies showed that 17 of these kinases are 
essential in fission yeast (Bimbó et al. 2005). Of these 106 kinases, three contain a 
Kinase Associated 1 (KA1) domains and one possesses a related KA2 domain (personal 
communication Kay Hofmann).  
In order to link the results seen by the in vitro biochemistry experiments, performed in 
the previous chapters, to in vivo studies, mutants of all four KA containing kinases were 
obtained. All four of these null mutants are viable, and therefore are not essential genes. 
These strains were then subjected to genetic analysis by crossing to different null and ts 
strains. Their response to exposure to different drugs and stresses was also observed.  
The results, presented in this chapter, did not reveal any phenotype that was exclusively 
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common to all four kinases which could be exploited as a way to assay the function of 
the kinases KA domains. 
 
5.2 Phenotype and KA Kinase Mutants 
Null mutants of all four kinases have either been published (chk1∆, ssp2∆ and kin1∆) 
(Walworth et al. 1993; Matsusakal et al. 1995; La Carbona et al. 2004) or are 
commercially available from Bioneer (ssp2∆ no:BG-5025 & ppk9∆ no:BG-1105). The 
mutants, ssp2∆, ppk9∆ and kin1∆ all carry the G418R selectable marker. To perform the 
genetic studies, multiple mutant strains needed to be created, and each mutant type 
represented with a traceable marker. To this end, ssp2∆ and ppk9∆ G418R markers were 
changed to natR and hygR respectively via homologous recombination (See Material 





C. The mutants were then crossed to one another to create every 
possible variation of double, triple and finally a quadruple mutant, all of which were 
viable (data not shown, Figure 20). The single mutants were used to express proteins, 
crossed to other strains or tested for sensitivity against drugs which will be described in 
the following sections. 
5.2.1 kin1∆ 
kin1∆ has the most severe growth phenotype of the four KA containing kinases. In 
addition to a cell wall defect which causes the cells to stick together, kin1∆ cells display 
a septation defect which leads to the septa forming off centre during cell division. As a 
result two populations of cells arise; one is small and spherical whilst the other 
resembles WT cells with one end broader than the other, which has led to these cells 
being described as “ice-cream cone” shaped (Figure 20) (La Carbona et al. 2004). These 
cells are slow growing at 25
o
C with a doubling time of 5 hrs compared to 4 hrs for WT 
(Figure 22) and also display a ts phenotype at 36
o
C, however, this phenotype appears to 
be “leaky” and cells can grow for some time before they die (Figure 20 & Figure 21) 








C.   
Colonies of WT and single null mutants of KA containing kinases used in this study along with double 
and quadruple mutants. ts mutants of proteasome mts3.1 and APC/C cut9-665 subunits also shown at 25oC 









Serial dilutions of WT and single nulls all grown to the same OD600 were plated on YES and incubated at 
25oC and 36oC. As reported previously ssp2Δ and kin1Δ both appear to be ts, however, kin1Δ ts 









Figure 22: Growth Curve of Relative Optical Density for ssp2∆, ppk9∆, kin1∆ and chk1∆ Compared 
to WT.  
Cultures were grown in YES at 25oC over night to a starting OD600 of at least 0.2. The OD was then 
measured every hour for 8 hours. The OD600 was then compared to OD600 at time 0 to give the relative 





Figure 23: Localisation of Overexpressed Kinases.  
Images taken the from Riken database. Open reading frames of genes were put into Gateway® vectors and 
used to overexpress tagged protein in S. pombe for all known genes. The localisation of Ssp2 is in nucleus 
and cytoplasm and appears as cytoplasmic spots. Ppk9 forms spots in both the cytoplasm and nucleus but 
is at a higher concentration in the nucleus. Kin1 is found at the cell tips and along filaments and also 
associates with the septum. Chk1 is found mainly in the nucleus.  
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database (Figure 23) show that Kin1 localises to filamentous structures at the cells tips 
and at the septa during division. When kin1∆ was crossed to ts mutants of essential 
APC/C subunits such as cut9-665, the resulting double mutants displayed a kin1∆ single 
mutant phenotype, but with an increase in the severity of the ts phenotype.  However, 
when kin1∆ was crossed to the ts proteasome mutant mts3.1, the double mutant was 
never observed using tetrad analysis, confirming that the kin1∆mts3.1 mutant is 
synthetically lethal (Figure 24). This would suggest that Kin1 is involved in the 
Ubiquitin Proteasome System (UPS), and that disruption to both Kin1 function and the 
proteasome renders cells inviable due to their inability to degrade proteins. 
5.2.2 ssp2∆ & ppk9∆ 
Ssp2 and Ppk9 are alternative α subunits of the S. pombe homologue of mammalian 5' 
AMP-activated Protein Kinase (AMPK) (Hanyu et al. 2009). AMPK is a heterotrimer 
enzyme complex consisting of an α catalytic subunit, a β subunits which can bind 
glycogens and a γ subunit which regulates the α subunit. AMPK is activated in times of 
limited glucose and other stress conditions. It is responsible for stimulating the 
transcription of glucose repressible genes which allow cells to use other carbon sources. 
Although this pathway is well defined in many organisms, the mechanism in S. pombe is 
less well understood (Hedbacker & Carlson 2008). The null mutants of these kinases 
have no morphological defects (Figure 20); however, ssp2∆ is ts at 36
o
C whilst ppk9∆ is 
not (Figure 21) (Matsusaka et al. 1995; Bimbó et al. 2005). Overexpression of YFP 
tagged protein performed by Riken shows that Ssp2 is present throughout the cell, 
forming cytoplasmic dots (Figure 23). Ppk9 is also present thought out the cell and 
formed spots; however it is more concentrated in the nucleus. Crossing to the cut9-665 
APC/C ts mutant showed no obvious morphological increase in phenotype for either 
ssp2∆ or ppk9∆. Unlike kin1∆ crossing mts3.1 proteasome ts with ssp2∆ and ppk9∆ 
resulted in viable double mutants (Figure 24). 
Spot assays were performed by growing strains over night at 25
o
C (See Material and 
Methods 2.3.19). These experiments showed no noticeable difference in growth of 




Figure 24: Tetrad Analysis of KA Containing Kinase Nulls Crossed with mts3.1 ts.  
28 sets of spores from null kinase mutants crossed with the mts3.1 ts strain were separated using a Singer 
Micromanipulator. They were then allowed to grow to colonies on YES at 25oC then replica plated onto 
the appropriate selective plate and YES grown at 36oC. ssp2Δ, ppk9Δ and chk1Δ could form double 
mutants with mts3.1 ts. However kin1Δ crossed to mts3.1 ts only produced four viable colonies at 25oC for 
parental ditype (P), the tetra type (T) and non-parental ditype (N) only contained three or two viable 




Figure 25: Growth of ssp2∆, ppk9∆, mad2∆, bub1∆ and ssp2∆ppk9∆ on Limited Glucose.  
Cultures of test strains were grown to the same OD600 then equal volumes of serial dilutions were plated 
on YES or PMG plated with various amounts of glucose and grown at 25 oC -36oC. ssp2Δppk9Δ retained 




Figure 26: Growth of ssp2∆, ppk9∆, ssp2∆ppk9∆, mad2∆ and bub1∆ on Limited Sucrose.  
Cultures of test strains were grown to the same OD600 then equal volumes of serial dilutions were plated 









Figure 27: Growth of ssp2∆, ppk9∆, cbs2∆, βsub∆, ssp2∆ppk9∆ and ssp2∆ppk9∆ βsub∆ on Non-
Fermentable Carbon Source.  
Cultures of test strains were grown to the same OD600 then equal volumes of serial dilutions were plated 
on YES with different carbon sources and grown at 25 oC. The γ subunit, cbs2Δ and the β subunit 






Figure 28: Viability of AMPK Mutants After Entry Into Stationary Phase.                                       
Triplicate 20ml cultures were made using YES for each strain and grown at 25oC with shaking at 180rpm.  
After 1, 3 and 7 days a small volume was taken and random cells were placed in a 9x10 grid using a 
Singer Micromanipulator (top panel). Cells were then allowed to grow for 3-5 days and the percentage 
viability calculated (bottom panel). No significant difference was seen between viability of WT and the 
single ssp2∆ and ppk9∆ mutants or double mutant, error bars are ± SE. 
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non fermentable carbon sources galactose and glycerol/ethanol (Figure 25, Figure 26 & 
Figure 27). 
To question if these two proteins are important for viability after entry to stationary 
phase the single mutants and double mutant were grown in YES at 25
o
C for 7 days. 
After 1, 3 and 7 days a small volume of culture was taken. For each culture 90 random 
single cells were separated into a 9x10 grid using a Singer Micromanipulator on YES 
plates and allowed to form colonies. The percentage of colony forming cells was 
calculated from two plates for each of the three replicas, but no significant difference 
was noted in comparison to WT (Figure 28). 
5.2.3 chk1∆ 
Chk1 is involved in the DNA damage checkpoint, and overexpressed YFP tagged Chk1 
performed by Riken, shows that it localises to the nucleus (Figure 23) which is 
consistent with its function, in addition Chk1 also forms dots in the cytoplasm. The 
chk1∆ null mutant has no morphological defects, displays no ts phenotype (Figure 20 & 
Figure 21) and can form viable double mutants with cut9-665 (data not shown) and 
mts3.1 at permissive temperature (Figure 24). However, chk1∆ has increased sensitivity 
to DNA damaging agents such as HU and MMS (Figure 29 & Figure 30) (Walworth et 
al. 1993).  
Sugimoto et al. (2004) demonstrated that Checkpoint DNA Synthesis 1(Cds1), a kinase 
that performs the same function as Chk1 at a different stage of the cell cycle (Rhind & 
Russell 2000), acts synergistically with Mad2. The cds1∆mad2∆ double mutant entered 
mitosis early when exposed to HydroxyUrea (HU), and displayed a similar phenotype to 
rad3∆, which has no active DNA replication checkpoint, and this double mutant has an 
increased sensitivity to Methyl MethaneSulfonate (MMS). This was not seen with any 
other double mutant of the MCC complex and would suggest that Mad2 specifically has 
a role in the DNA damage response pathway.  To see if this was specific to Cds1 or if 
Chk1 also shared this apparent interaction with Mad2, a chk1∆mad2∆ double mutant 
was created and the experiments performed by Sugimoto et al. (2004) repeated. First 
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spot assays were performed and grown on YES with 1mM or 2mM HU (Figure 29) 
since chk1∆ appeared to be more sensitive to HU than cds1∆ and could not grow on 
5mM HU at a similar rate to WT (Sugimoto et al. 2004). The chk1∆mad2∆ was not able 
to grow as well as either single mutant at 2mM HU, dminstration that Chk1 also 
displayed a synergistic relationship with Mad2. 
To test for MMS sensitivity, cultures of all four single KA containing kinases and 
double mutants with mad2∆ were grown to mid log phase at 25
o
C. A small volume of 
culture was taken and plated onto two YES plates, and MMS was then added to the 
culture to make a final concentration of 0.005%. The cultures were grown for 4 hours 
before the same volume of culture was plated onto another two YES plates. Colonies 
were then allowed to form by incubating at 25
o
C and the viability of the strains, after 4hr 
exposure to MMS, expressed as a percentage of the colonies at time 0hr. Figure 30 
shows the average results of three cultures of each strain using WT and rad3∆ as 
controls. In culture neither chk1∆ nor chk1∆mad2∆ viability showed any significant 
deviation from WT unlike the control rad3∆ (p=0.0129 and 0.0067). This appears to be 
contradictory to the spot assays which show chk1∆ and chk1∆mad2∆ can grow at 
0.001% but not 0.005% MMS (Figure 31). The only strain which showed a loss in 
viability, apart from rad3∆, was kin1∆mad2∆. However, statistical analysis showed that 
this change was not significant.    
 
5.3 kin1∆ Shows an Increase in Mis-Regulation of Chromosome 
Segregation 
APC/C is responsible for regulating the activity of the enzyme Cut2 (separase) which 
cleaves the cohesion complex which holds the sister chromatids together during the 
metaphase stage of mitosis. When APC/Cs activity is disrupted this process is then not 
carried out to completion which leads to unfaithful chromosome segregation. If KA 
containing kinases are regulating APC/Cs activity, it is possible that these mutants will 




Figure 29: Effects of HU on chk1∆, mad2∆ and chk1∆mad2∆.  
WT, single mutants and the chk1Δmad2Δ double mutants were grown to the same OD600. Serial dilutions 
were then made of each culture. Equal volumes of these dilutions were then plated onto YES or YES with 
HU and grown at 25oC. The rad3Δ control displayed sensitivityat 1mM/ chk1Δ shows some sensitivity to 
2mM HU, however, chk1Δmad2Δ displayed sever sensitivity even at 2mM HU suggesting that Chk1 and 




Figure 30: Survival of Mutant Strains After 4 Hours Exposure to MMS at 25
o
C.  
WT and mutant strains were grown overnight to lag phase. A fixed volume of culture was plated onto 
YES plates at time 0hr. The MMS was added to the cultures to a final concentration of 0.005% and 
allowed to grown for 4hrs. The same volume of culture was then plated onto YES plates and colonies 
grown at 25oC. The viability was calculated as a percentage of colonies after 4hrs treatment compared to 
0hrs. No significant decrease in viability was seen for double mutants of mad2Δ with the kinase nulls. 
rad3Δ was used as a positive control which gave a significant decrease in viability with P=0.0129 for the 
ssp2Δ/ppk9Δ experiment and P=0.0067 for kin1Δ/chk1Δ. The results shown are an average of three 




Figure 31: Growth Assay of Mutant Strains on Exposure to MMS.  
Strains used for testing viability to MMS in culture were grown to the same OD600 and serial dilutions 
made. Equal volumes were plated onto YES containing 0%, 0.001% and 0.005% MMS and grown at 










A well established assay set up in S. pombe calculates the loss of chromosomes per cell 
division. The strain ade6-210 leu1-32 ura4-DS/E [Ch16 ade6-216 m23::LEU2] h-, used 
by Allshire et al. (1995) which contains an extra mini chromosome 16 containing the 
ade6-216 allele in a non mutant background containing ade6-210. On their own either 
one of these alleles would render the cells unable to grow without adenine. When grown 
on media containing a low amount of adenine, colonies containing one of these alleles 
appear pink to dark red. However these two alleles complement each other, so when 
they are both present in the same cell, the cell displays an adenine prototrophic 
phenotype and will appear off white when grown on low adenine.  
The ade6-210 allele was initially crossed into the kinase mutants then the strains were 
crossed to the mini chromosome strain. Cultures of kinase mutants, containing the extra 
chromosome, were grown first in PMG-Leu-Ade to select for mutant cells carrying the 
mini chromosome, next the cells were plated onto PMG 1/15 Ade and grown at 30
o
C 
until colonies appeared. In order to allow the red colour to deepen, plates were stored at 
4
o
C before analysis. Since every colony derives from a single cell, only colonies with 
more than half their sector red were counted (Figure 32 closed arrow heads, R) as this 
indicates that the chromosome loss must have occurred during the first division. Taken 
together with the colonies with less than half their sectors red (Figure 32 open arrow 
heads, r) and the white colonies (W) the percentage of chromosome loss per division 
can be calculated:  
 
                          R               x  100  =  % chromosome loss per cell division 
                    (R+W+r) 
 
At least 1000 colonies were counted per strain and the average percentage of 
chromosome loss per division calculated. These results showed the only strain which 






Figure 32: Measuring the Percentage of Chromosome Loss per Cell Division of KA Kinase Mutant 
Strains.   
Null mutants carrying an ade6-210 allele were crossed to a strain containing an artificial mini 
chromosome containing the ade6-216 allele. The resulting cells were grown in PMG-leu-ade to maintain 
the extra chromosome and then plated out onto PMG 1/15 ade and allowed to grow. Cells which lost the 
mini chromosome appear red (top panel) on low ade plated. The number of colonies with at least half their 
sector red was counted and expressed as a percentage of total cells counted to give the percentage of 
chromosome losses per cell division. Only kin1∆ showed a significant increase compared to WT with 





kin1∆ which has a percentage loss of 2.41% (P value of 0.0109). As a control swi6∆ was 
used which showed an 18.72% of chromosome loss per division (P value of <0.0001). 
 
5.4 Overexpression of Kinases Does Not Rescue the ts Phenotype of 
APC/C or Proteasome Mutants 
The rescue of a ts phenotype by overexpression of another protein can be an indication 
that these two proteins interact, causing stabilisation of the ts mutant protein (Forsburg 
2001). Since the KA containing kinases interact with APC/C via Slp1, it would be 
reasonable to assume that the overexpression of the kinases rescue the ts phenotype. To 
test this, full length and ∆KA proteins were moved from Gateway™ entry vectors into 
Gateway™ converted pREP1, pREP41 and pREP81. These plasmids contain different 
strength nmt promoters: pREP1 is the strongest; pREP41 is intermediate whilst pREP81 
is low strength. These were transformed into WT, cut9-665 and slp1-362 and spot assays 




C (Figure 33).  
In the WT strain all cells grew normally under every strength nmt promoter (Figure 33 
a). In the cut9-665 strain, pREP1 expressing Ppk9 and Ppk9∆KA maybe slightly toxic to 
the cells, however none of the constructs rescued the ts phenotype, unlike pREP1 Cut9 
(Figure 33 b). Also no rescue was observed for the slp1-362 ts phenotype (Figure 33 c).  
Since a synthetic lethal phenotype was observed between kin1∆ and mts3.1, pREP1 
constructs were transformed into mts3.1 to test for rescue of the ts phenotype. Again, no 
rescue of the ts phenotype was observed (Figure 34). 
 
5.5 TBZ Sensitivity 
In the study by Bimbó et al. (2005), the sensitivity of all viable S. pombe kinase mutants 
to a range of different drugs and stresses were analysed. Reviewing the results they 










Figure 33: Over-Expression of Full Length and ∆KA Proteins Under the Control of Different 
Strength nmt Promoters in WT, cut9-665 and slp-362.  
a) WT, b) cut9-665 and c) slp1-362 cells transformed with pREP1, pREP41 and pREP81 constructs 
containing full length or ΔKA cDNA. They were grown to the same OD600 and serial dilutions made of 
each strain. Equal volumes were plated onto PMG-leu and grown at 25oC or 36oC to determine if 
overexpression of the KA kinases could rescue the ts phenotype. a) showed that overexpression did not 
affect WT cell growth at either temperature. However (b) and (c) demonstrated that they could not rescue 













Figure 34: Over-Expression of Full Length and ∆KA Proteins Under the Control of High Strength 
nmt Promoters in mts3.1.  
pREP1 constructs containing full length and ΔKA kinases were transformed and expressed in mts3.1 
strains to test if any could rescue the ts phenotype. Strains were grown to the same OD600 and serial 












was sensitivity to the microtubule poison ThiaBendaZole (TBZ). These findings are 
constant with the results of this work, since the SAC is activated by TBZ (Peralta-Sastre 
et al. 2010). This assay was repeated with WT and the four KA kinase mutants 
transformed with pREP1 containing full length or ∆KA. Spot assays were performed 
with YES media containing 0µg/ml, 5µg/ml and 10µg/ml TBZ (Figure 35). Again, the 
overexpression of Ppk9 and Ppk9∆KA appears to be toxic to WT cells, whilst ppk9∆ 
transformed with Ppk9 showed a lower growth rate on 5µg/ml TBZ compared to ppk9∆ 
transformed with empty pREP1. Of the four mutants only kin1∆ had any noticeable 
sensitivity to TBZ, which contradicts the findings of Bimbó et al. (2005), which 
suggested that ssp2∆, ppk9∆ and chk1∆ only displayed mild sensitivity to TBZ. The 
expression of full length Kin1 did not completely rescue the phenotype, but Kin1∆KA 
appeared to decrease sensitivity. This may be due to the overexpression of the protein 
using the pREP1 strong promoter. La Carbona et al. (2004) demonstrated that the strong 
overexpression of Kin1 can give rise to a kin1∆ phenotype. 
It has also been demonstrated that mad2Δ shows TBZ sensitivity (Tange & Niwa 2007). 
The full length and ∆KA constructs for the four kinases were transformed into 
mad2Δ::ura and expressed using the pREP41 plasmid to test if overexpression had any 
effect on TBZ sensitivity (Figure 36). These results showed that on plates lacking TBZ, 
all of the strains appeared to grow at a similar rate. Exposure to 5µg/ml TBZ showed 
that mad2Δ::ura expressing the ∆KA constructs of Ssp2, Ppk9 and Chk1 grew better 
than full length or pREP41 control. Kin1 did not share this phenotype; in fact the ∆KA 
construct grew poorly compared to the full length. Again this may be due to 
overexpression causing a dominant negative effect.  
 
5.6 Discussion 
Of the 106 kinases encoded in S. pombe, only three have a KA1 and one has a proposed 
KA2 domain. Single null mutants of ssp2∆, ppk9∆, kin1∆ and chk1∆ have been made 




Figure 35: Effects of TBZ on WT and Kinase Mutants Over-Expressing Full Length and ∆KA 
Protein.  
WT and kinase null strains were transformed with empty pREP1 of pREP1 containing full length and 
ΔKA constructs. Cultures were grown to the same OD600. Then equal volumes of serial dilutions were 






Figure 36: Effects of TBZ on mad2Δ Mutants Over-Expressing Full Length and ∆KA Protein.  
mad2Δ null strain was transformed with empty pREP41 or pREP41 containing full length and ΔKA 
constructs. Cultures were grown to the same OD600 the equal volumes of serial dilutions were plated onto 
PMG-leu containing 0µg/ml or 5µg/ml TBZ.
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et al. 2004). All of these mutants are viable, as is every combination of double, triple and 
even the quadruple mutant. Chapter 3 demonstrated that the KA domain can bind 
APC/C and the results of Chapter 4 would suggest that the reason for this binding is to 
regulate APC/Cs activity. These genetic results show that this function is not essential 
for cell survival.  
As the KA domains have been shown to bind to APC/C, the null mutants were crossed 
to the APC/C ts mutant cut9-665 to see if the double mutants displayed any additional 
phenotype. Nothing was seen for cut9-665, however, when the null mutants were 
crossed to the proteasome mts3.1 ts strain, the kin1∆ mts3.1double mutant was 
synthetically lethal at 25
o
C. This suggests that Kin1 has a role in protein degradation via 
the proteasome and that both of these proteins need to be active for efficient degradation, 
otherwise the cell cannot survive. This was not seen for the other four kinases. It is 
known that if overexpression of one protein rescues the ts phenotype of another protein 
mutant strain, this can be an indication that the two proteins interact, and that the 
overexpressed protein can stabilise the ts mutant protein (Forsburg 2001). To look for 
evidence of interaction between the KA containing kinases and UPS, full length and 
∆KA protein were overexpressed in cut9-665, slp1-362 or mts3.1 mutant strains. None 
of the constructs tested could rescue the ts phenotype of these mutants.  
Controlling APC/Cs activity is essential for regulating the segregation of chromosomes. 
A disruption to the normal regulation of APC/C activity would allow cells to enter 
anaphase before all the kinetochores have been bound by microtubules and therefore can 
lead to mis-segregation of chromosomes. The experiments using the extra chromosome 
Ch16 strains showed that the kin1∆ displayed an increase in chromosome loss not seen 
in the other mutants, again proving a link between Kin1 and the UPS. Although none of 
the other mutants showed an increase in mis-regulating chromosome segregation it 




Despite Bimbó et al. (2005) reporting that all four null mutants has some degree of TBZ 
sensitivity; this study demonstrated that kin1∆ was the only strain which had any 
noticeable sensitivity. Unexpectedly, expressing full length Kin1 did not rescue this 
phenotype; this may be due to the protein being too highly overexpressed in pREP1. It 
has been previously reported that Kin1 is expressed at low levels in the cell and that 
overexpression can mimic the null phenotype (La Carbona et al. 2004). mad2∆ has also 
been shown to be sensitive to TBZ because the SAC has been deactivated. Interestingly 
the ∆KA constructs of Ssp2, Ppk9 and Chk1 seemed to partially rescue the mad2∆ 
sensitivity to TBZ. Although ∆KA constructs cannot bind APC/C, our hypothesis that 
the KA domain also acts as an auto-inhibiting domain for the N-terminal kinase domain 
would also mean that these protein have increased kinase activity.  
An interesting observation is that ssp2∆ is ts but ppk9∆ is not. Ssp2 and Ppk9 have not 
been well studied in fission yeast, so it is not known how they differ when they are part 
of the AMPK complex, but this difference in phenotype would suggest they may have 
different targets and may perform different functions.   
Cds1 is the fission yeast homologue of Chk2 a similar protein to Chk1. Cds1 is activated 
in the same manner as Chk1 and causes a similar delay in the cell cycle. However the 
difference between the two kinases is that Cds1 is activated at the S phase replication 
checkpoint, where as Chk1 is activate at the G2-M phase boundary. Studies have shown 
in the absence of Cds1, Chk1 can also activate this pathway, demonstrating that the two 
proteins have some overlap in function (Rhind & Russell 2000; Paparatto et al. 2009). 
Cds1 has been shown to phosphorylate the APC/C co-activator Ste9 during S phase 
which causes inactivation of APC/C. This in turn prevents the ubiquitination and 
degradation of factors whose presences inhibits the onset of G2 (Chu et al. 2009). 
Sugimoto et al. (2004) showed that Mad2 and Cds1 act in a synergistic manner. A 
double null mutant of mad2∆cds1∆ acted similar to rad3∆ when exposed to HU and 
entered mitosis early producing short cells. Mad2 was the only MCC component to 
produce this phenotype. They also suggest that a similar mechanism may exist for Chk1. 
To test this, the MMS experiments performed by Sugimoto et al. (2004) were repeated 
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with all the kinase mutants. Contrary to expectation chk1∆ and chk1∆mad2∆ did not 
show a decrease in viability. The only mutant that had any decrease in viability after 4 
hours of 0.005% MMS exposure was kin1∆mad2∆, although this was not statistically 
significant. However growth assays showed that chk1∆ and chk1∆mad2∆ could not 
grow on plates containing 0.005% MMS. One explanation is that a 4 hour exposure to 
0.005% MMS may be enough to cause loss of viability in cds1∆ mad2∆ but not in 
chk1∆mad2∆. 
Although these experiments did not identify a phenotype that all these four kinases 
share, the kin1∆ often displays a phenotype that the other three null mutants did not. The 
KA1 domain of Kin1 is the best defined, and in addition, Kin1 is the only protein that is 
expressed under normal conditions whereas the remaining three kinases are only 
expressed under certain conditions. Chk1 is activated during DNA damage, whilst Ssp2 
and Ppk9 are part of the AMPK complex which is activated at times of limited glucose 
and cellular stress. It may be the case that phenotypes will only present themselves when 
the cells are exposed to conditions in which these proteins would become activated. 
Therefore, under the conditions used during this study, a phenotype may not be 












Function of Rhp23 UBA Domains  
6.1 Introduction 
The next stage in the UPS, after ubiquitination by E3s such as APC/C, is for the 
substrates to be recognised and transported to the proteasome. This can be done in a 
variety of ways. Some E3 ligases can interact with the proteasome (Xie & Varshavsky 
2000; Fu et al. 2010), others utilise proteins, know as shuttle factors, which in S. pombe 
consist of Pus1 (budding yeast Rpn10), Rhp23 (Rad23) and Dph1 (Dsk2) which 
chaperone substrates to the proteasome. These proteins have domains which recognise 
and bind the proteasome and also possess the ability to recognise the ubiquitin chains 
tagging substrates using ubiquitin binding domains. At their N-terminus Pus1 has a von 
Willebrand factor A (vWA) domain whilst Rhp23 and Dph1 have a UBiquitin Like 
(Ubl) domain which they use to interact with the proteasome. At the C-terminus, Pus1 
contains a Ubiquitin Interacting Motif (UIM) forms a single alpha helix able to bind K48 
and K63 chains whilst the UBiquitin Associated (UBA) domains found in Rhp23 and 
Dph1 form three consecutive alpha helices which are also capable of binding either 
chain type (Seeger et al. 2003); Hartmann-Petersen et al. 2003; Schreiner et al. 2008). 
After successful delivery to the proteasome, the substrates are deubiquinated and 
unfolded in order to be loaded into the proteasome and degraded. 
It is interesting to note that Pus1 is also a subunit of the proteasome and can act as a 
proteasome based receptor for ubiquitin binding along with two other subunits, Rpn13a 
and Rpn13b which recognise ubiquitin via a Pleckstrin-like Receptor for Ubiquitin (Pru) 
domain (Husnjak et al. 2008). In budding and fission yeast, it has been demonstrated that 
the remaining shuttle factors use their Ubl domains to interact with homologues of S. 
pombe Mts4 (Rpn1) and Rpn2 (Rpn2) to recognise and interact with the proteasome 
(Elsasser et al. 2002; Seeger et al. 2003; Schreiner et al. 2008). The Ubl domain 
possesses a similar structure to ubiquitin and as a result in some cases, they too are also 
capable of interacting with ubiquitin binding domains (Ryu et al. 2003). This has led to 
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the hypothesis that after delivery of substrates to the proteasome the UBA domains then 
bind to the Ubl domain causing the protein to dissociate (Hai Rao & Sastry 2002). As 
shown in Chapter 3, the shuttle factors have also been shown to bind E3 ligases such as 
APC/C (Seeger et al. 2003; Kim et al. 2004) which allow them to bind to substrates 
whilst still attached to a ligase.  
Genetic experiments show that shuttle factors display a certain amount of redundancy in 
fission and budding yeast since null mutants in any one of these three genes result in 
viable cells. However, genetic assays show that double mutants of shuttle factors display 
a more severe phenotype in S. pombe. Crossing rhp23∆ to pus1∆ results in a double 
mutant that displays a growth defect at 25
o
C and becomes inviable when grown at 36
o
C 
due to the extra stress put on the UPS under these conditions. The double mutants of 
dph1∆pus1∆ and dph1∆rhp23∆ do not result in the same phenotype indicating that Dph1 
is not as important as Pus1 and Rhp23. However, the triple mutant of 
rhp23∆pus1∆dph1∆ is synthetically lethal resulting in spores which cannot form cells at 
any temperature indicating that import of substrates to the proteasome via the shuttle 
factors is critical for cell survival (Wilkinson et al. 2001).  
Rhp23 is of particular interest because, unlike most ubiquitin binding proteins, it 
contains not one but two domains capable of binding ubiquitin, an interior UBA1 and a 
UBA2 at its C-terminus. This structure is conserved to humans, which would suggest 
that both UBA domains are important for Rhp23 to carry out its function. Studies show 
that both minimal domains are capable of binding ubiquitin which has lead to the 
question of why Rhp23 requires two UBA domains. Do they have different functions 
and, if so, what are their individual roles? Analysis of the protein showed that these 
domains differ greatly in sequence but have the same structure (Mueller & Feigon 
2002). 
Previous work in this group studied the function of the two domains before the structure 
had been solved. To do this, a conserved lysine residue found in all UBA domains was 
mutated to proline which disrupted ubiquitin binding. However, this also resulted in 
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major changes to the structure of the protein which may be responsible for any observed 
change in function rather that the ubiquitin binding (Wilkinson et al. 2001). In order to 
determine if both UBA domains are involved in the Rhp23 ability to recognise ubiquitin, 
point mutations were made that are predicted to abolish ubiquitin binding without 
changing the structure of the protein. These proteins were used to test the ability of each 
domain to bind K48 and K63 chains. Domain swap chimeric proteins were made to 
further dissect the ubiquitin binding affinities of each UBA and to help determine if the 
position of the domain can affect its binding affinity. Finally the constructs were then 
used to rescue the rhp23∆pus1∆dph1∆ phenotype to test the UBA function in vivo for 
the first time in S. pombe. 
 
6.2 Design of UBA Mutant and Domain Swap Constructs 
Previous studies have looked at the role of the UBA domains in Rhp23 by making point 
mutations in the domains to substitute a residue with proline, which destroyed the helical 
structure of the protein (Wilkinson et al. 2001). In order to improve on these studies, it 
was important to make point mutations which would disrupt the ability of the domains to 
bind ubiquitin but maintain the integrity of the protein structure. Our collaborator Jane 
Endicott, a structural biologist from Oxford, used the structure of the UBA domain 
published by Ryu et al. (2003) and identified suitable candidate residues. From this 
structure, she predicted that M157 and L183 in UBA1 and the corresponding residues in 
UBA2, L332 and F358 should be important for ubiquitin binding. These residues were 
mutated to alanine by site directed mutagenesis of full length rhp23+ to give full length 
rhp23 with either the UBA1 domain mutated (rhp23 M157AL183A), UBA2 domain 
mutated (rhp23 L332AF358A) or both domains mutated (rhp23 M157AL183A 
L332AF358A). 
These constructs were used to subclone full length protein into pREP to express protein 





Figure 37: Constructs Made in GST and nmt Expression Vectors.   
Full length rhp23+ was used to carry out site directed mutagenesis on two residues in the UBA1 and 
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UBA2 domains. UBA1 domain was taken to be amino acids 146-190 of Rhp23, whilst UBA2 was 314-
368. Homologous PCR was used to replace the UBA2 domain of rhp23+ with the UBA1. The same 
technique was used to replace the UIM of pus1+, residues 196-243, with either a UBA1 or UBA2 domain 





















consisting of amino acids 146-190 and UBA2 residues 314-368 were cloned into pGEX 
6P1 to express GST protein in order to study the domains (Figure 37). After expression 
of GST fusion proteins in BL21 cells, the protein was coupled to Glutathione 
Sepharose™ 4B beads and analysed by separating on 10% SDS PAGE gels and staining 
with Coomassie. This produced single bands of proteins that ran at the expected size 
(Figure 38 & Figure 39). NMR analysis by Jane Endicott’s group confirmed that the 
mutations in the full length Rhp23 protein did not change the structure of the protein 
(data not shown).  
Domains swaps were performed using homologous PCR to produce constructs with no 
additional enzyme sites at the junctions. Briefly, primers were designed that would allow 
the N-terminus and C-terminus of the chimeric protein to be cloned into pGEX 6P1. 
Reverse primers for the N-terminal fragment were designed to contain the beginning 
region of the C-terminal fragment, whilst the forward primer of the C-terminal fragment 
contained the end region of the N-terminal fragment. Two separate PCRs were 
performed to amplify the regions to be joined which were then both used as templates. 
The regions of homology allowed the fragments to pair up so that the new domain swap 
gene could be amplified and cloned into a vector.  
For the Pus1ΔUIM amino acids 1-195 of Pus1 were used and the UBA domains 
described above were added to the C-terminus to produce the chimeric proteins. For the 
Rhp23M157AL183AΔUBA2+UBA1 amino acids 1-313 of Rhp23 were used which 
contained M157A and L183A mutations, then amino acids 146-190 of UBA1 were 
added to the end (see Figure 37). These GST tagged proteins were expressed and 
analysed as stated above to show they produced a single product of the correct size 




6.3 Point Mutations in Isolated UBA Domains Inhibits Ubiquitin 
Binding 
To test if these mutations affected ubiquitin binding, GST tagged full length Pus1 and 
Rhp23 were expressed and coupled onto Glutathione Sepharose™ 4B beads along with 
WT and mutated UBA1 and UBA2 domains. These proteins were incubated with K48 or 
K63 chains as described in 2.6.18 and excess unbound chains removed by washing.  
After separating on 10% SDS PAGE gels the GST fusion proteins were visualised by 
Coomassie staining to show equal loading of GST input protein (Figure 38 top panel). 
Western blot analysis with anti ubiquitin antibody (Figure 38 bottom panel) shows that 
the GST negative control did not bind chains, whilst the Pus1 and Rhp23 positive 
controls bound both types of ubiquitin chains. When tested, the isolated UBA1 and 
UBA2 domains of Rhp23 were able to bind the chains but not at the same level as 
Rhp23. However, when the domains were mutated they could no longer bind either 
chain type thereby confirming that the two point mutations abolished the domains ability 
to recognise ubiquitin chains without changing the structure.  
 
6.4 Point Mutations in Rhp23 UBA1 Domain Inhibit or Decrease 
Ubiquitin Binding but Mutations in UBA2 Allow Binding. 
To analyse the role of these domains set within their natural context of the full length 
protein, a non-mutated full length Rhp23 along with the following mutated full length 
versions were created: in UBA1 M157A and L183A, in UBA2 L332A and F358A and 
for both domains (UBA1 and UBA2) M157A, L183A, L332A and F358A. To test these 
mutant proteins for their ability to bind ubiquitin K48 and K63 chains, the same 
experiment was carried out as described for the isolated domains. These GST fusion 
proteins were of the correct size and appeared to be equally loaded (Figure 39 top 
panel). Again the Western blot shows that the GST control could not bind chains, whilst 




Figure 38: Ubiquitin Binding Assays for Isolated UBA Domains.  
GST tagged proteins were expressed in bacteria and coupled to Glutathione Sepharose™ 4B beads. After 
incubating with either K63 or K48 ubiquitin chains, unbound protein was removed by washing. Proteins 
were then separated on 10% SDS PAGE and either Coomassie stained (top panel) or transferred onto 
membranes to be probed with anti ubiquitin antibody (bottom panel). The stained SDS PAGE gels of input 
GST fusion protein shows equal loading for full length Pus1, Rhp23 as well as WT and mutated UBA 
domains. The bottom panel show that full length protein and WT domains can bind both types of chains, 




Figure 39: Ubiquitin Binding Assays for Mutated UBA Domains in Full Length Rhp23.  
K48 or K63 ubiquitin chains were incubated with GST tagged proteins coupled to beads then washed to 
remove unbound chains. Proteins were separated on 10% SDS PAGE and either Coomassie stained to 
show equal loading (top panel) or transferred onto membranes to be probed with anti ubiquitin antibody 
(bottom panel). The Western blots in the bottom panel show that WT full length protein and the UBA2 
mutated protein can bind both types of chains whilst the point mutations in just the UBA1 domain or both 
domains reduce or inhibit ubiquitin chain binding.  
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As predicted this experiment demonstrated that when the UBA1 M157A L183A 
mutations were tested in the full length Rhp23 protein it could no longer bind K63 
chains and its ability to bind K48 chains was severely reduced (Figure 39). When both 
domains were mutated this caused the protein to completely fail to bind either type of 
chain. Against expectation, the L332A F358A mutation in UBA2 showed no effect on 
the proteins ability to bind either type of chains. This data suggests that UBA1 is more 
important in binding ubiquitin chains than UBA2 in the context of the whole protein. 
This data also implies that the addition of the rest of Rhp23 effects UBA2 function. 
 
6.5 Domain Swap of Pus1 UIM with UBA1 Can Bind Ubiquitin  
To further characterise the UBA domains outside of Rhp23 but not in isolation, chimeric 
constructs were made with Pus1. Amino acids 1-195 of Pus1 were created as a GST 
fusion constructs, which did not contain the ubiquitin binding UIM domain. This protein 
was tested for its ability to bind K48 and K63 chains and as seen in Figure 40, no 
binding was observed. Using homologous PCR the UBA1 or UBA2 domains were 
grafted onto the end of this construct to create a chimeric protein (Figure 37).  
When these proteins were tested for ubiquitin binding, the Pus1ΔUIM+UBA1 construct 
could bind both chains at a similar level to WT Pus1 and Rhp23 (Figure 40). This 
showed that the UIM could be replaced with another ubiquitin binding domain. It also 
demonstrates that the UBA1 domain can be active at the C-terminus and not just as an 
internal domain. However the Pus1ΔUIM+UBA2 showed little to no chain binding, 
suggesting that the UBA2 domain does not bind ubiquitin efficiently at the C-terminal of 





Figure 40: Ubiquitin Binding Assays for UBA Domains Transferred onto Pus1.  
GST tagged proteins were coupled to beads and incubated with either K63 or K48 ubiquitin chains. The 
beads were then washed to remove unbound chains. Proteins were separated on 10% SDS PAGE and 
either Coomassie stained (top panel) or transferred onto membranes to be probed with anti ubiquitin 
antibody (bottom panel). The Coomassie stained SDS PAGE gel of input GST fusion protein show equal 
loading. Western blots within the bottom panel show that WT full length protein could bind both chains 
but the Pus1 without the UIM could not. The domain swapped Pus1/Rhp23 chimeric proteins show that 
the UBA1 domain bound both types of chain similar to WT Rhp23 whilst the UBA2 shows little or no 




Figure 41: Ubiquitin Binding Assays for Rhp23 M157AL183AΔUBA2+UBA1.  
GST tagged proteins were coupled to beads and incubated with either K63 or K48 ubiquitin chains then 
washed to remove unbound chains. Proteins were the separated on 10% SDS PAGE and either Coomassie 
stained (top panel) to show equal loading of the input GST fusion proteins or transferred onto membranes 
to be probed with anti ubiquitin antibody (bottom panel). Western blots show that 




6.6 The UBA1 Domain Can Bind Ubiquitin When Placed at the C-
terminus 
It has been reported that the UBA2 domain may have another function that is not related 
to ubiquitin binding but instead to protect Rhp23 from becoming a substrate for the 
proteasome when it is acting as a shuttle factor (Heessen et al. 2005). To test whether it 
is the context of the domain within the protein, or if it is the domain itself which is 
important, Rhp23 was constructed with M157A L183A mutations in the internal UBA1 
domain. Using the same technique employed to make the Pus1 chimeric proteins, the 
UBA2 domain was replaced with a non mutated UBA1 domain (Figure 37).  
When tested for ubiquitin chain binding, this mutated chimeric protein could bind both 
chain types equally well, if not better, than WT Rhp23 (Figure 41). Since the mutations 
in the internal UBA1 abolishes or severely reduced ubiquitin binding, even in the 
presence of an active UBA2 domain, it can be concluded that the binding seen is due to 
the UBA1 domain in the UBA2 domain position. This correlates with the Pus1 chimeric 
protein since both show that the UBA1 domain can carry out its ubiquitin binding 
function at the C-terminal of a protein which is not its normal protein environment. This 
result also suggests that there is something unique about the UBA2 domain which causes 
it to behave in this way. 
 
6.7 UBA1 Activity is more Important in vivo than UBA2 
The function of the UBA domains has to date normally been studied in vitro by 
producing GST tagged minimal domains in isolation to perform binding assays. The 
study of the individual domains functions in vivo has never been performed in S. pombe. 
Previous studies by our lab have shown that the double null mutant rhp23∆pus1∆ 
displays a growth defect at 25
o
C and that shifting the cells to a restrictive temperature of 
36
o
C causes cell to die. This study also showed that the rhp23∆pus1∆dph1Δ mutant was 






Figure 42: Rescue of pus1∆rhp23∆dph1∆ Lethal Phenotype Requires an Active UBA1 Domain.                                                                                                                                            
rhp23∆dph1∆ double mutant was transformed with pREP81 contained WT Rhp23, Rhp23M157AL183A, 
Rhp23L332F358A, Rhp23M157AL183AL332F358A or an empty vector. These cells were then crossed to 
pus1∆dph1∆ and the asci digested with β-glucuronidase. Spores were plated PMG-Leu-Ura-Arg +G418 to 
select for pus1∆rhp23∆dph1∆ carrying the plasmid and allowed to grow at 25oC. Although a few colonies 
grew for pREP81, microscopic examination determined that all of these colonies were a result of diploid 
cells. pRep81 could not rescue the lethality of the triple mutant, neither could the pREP81expressing 
Rhp23M157AL183A. The pREP81 Rhp23M157AL183AL332F358A gave rise to some colonies, most of 
which were diploid as seen with empty pREP81, although two colonies appeared to be haploid. Rescue 
was only observed for pREP81 expressing Rhp23 and Rhp23L332F358A, demonstrating that the UBA1 
















In order to test the function of the two UBA domains in vivo pREP81 constructs were 
made containing the WT and mutant forms of rhp23 and transformed in rhp23∆ dph1Δ 
double mutant. These strains were the crossed to pus1∆dph1Δ and the asci digested with 
β-glucuronidase to perform free spore analysis. The spores were then plated on PMG-
Leu-Ura-Arg +G418 to select for rhp23∆pus1∆dph1Δ triple mutants carrying the 
pREP81 plasmid (Figure 42). 
This assay revealed that the empty pREP81 plasmid could not rescue the lethality of the 
triple mutant. Although some colonies grew when expressing empty pREP81, 
microscopic examination determined that all these colonies contained diploid cells. WT 
Rhp23 gave rise to colonies formed by haploid cells, indicating that Rhp23 could rescue 
the rhp23∆pus1∆dph1Δ phenotype. Further more, Rhp23 carrying the point mutations in 
the UBA2 domain were also able to rescue this phenotype, proving the importance of the 
UBA1 domains role in ubiquitin binding. The corresponding mutations in just the UBA1 
domain transformed into the triple mutant resulted in lethality. However, Rhp23 with 
both UBA domains mutated gave rise to colonies, most of which were due to diploid 
cells as seen with pREP81, but two colonies appeared to haploid cells. This result was 
not seen in earlier repeats experiments in which Rhp23 M157AL183AL332AF358A 
could not rescue the rhp23∆pus1∆dph1Δ phenotype. This data correlates with the results 
of the binding assays and shows for the first time in vivo that the UBA1 domain of 
fission yeast Rhp23 is responsible for recognition and binding of ubiquitin chain and that 
the UBA2 domain in the context of the whole protein is not enough to allow Rhp23 to 
perform this process. 
 
6.8 Discussion 
In the study of ubiquitin the most common way of investagating into the role of 
ubiquitin binding domains has been to produce GST tagged minimal domains and assay 
their ability to bind chains in vitro. Recent studies have suggested that this may not be an 
accurate way of measuring the affinity of domains for different types of chains. There 
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has been evidence that domains in isolation behave differently than when they are part 
of a protein. For example, Raasi et al. (2005) showed that hHR23A UBA2 binds K48-
Ub4 chains better than K63-Ub4 whilst UBA1 prefers K63-Ub4 to K48-Ub4. They then 
went on to show that the addition of the UBL containing N-terminus to UBA1 causes a 
shift in preference from K63-Ub4 to K48-Ub4.  
Another major issue was highlighted by Sims et al. (2009), where they demonstrated that 
GST tagged UBA domains show higher binding affinities for K63 chains due to an 
artefact of the assay caused by the GST tags forming dimers. When domains were tested 
for chains binding by NMR comparing GST to non GST tag, the results for the hHR23A 
UBA1 domain produced a change in Kd values from 4.7µM and 13µM for K63-Ub4 and 
K48-Ub4 respectively to 30µM and 9µM. This was not the only example they found, and 
they speculate that a vast amount of the data for ubiquitin binding domains may be 
inaccurate since nearly all studies are carried out using GST tagged protein. They also 
argue that NMR analysis of untagged protein yields the most accurate reflection of 
ubiquitin binding.    
In light of these finding, further work is needed to accurately determine the functions of 
UBA domains in their native proteins. Since the data presented here was produced with 
GST tagged proteins and was not quantitative, Konstantinos Paraskevopoulos from our 
group and Jonas Boehringer from Jane Endicott’s group performed similar studies using 
fluorescently labelled Ub2. They tested the same constructs used in this study, but first 
removed the GST tag then measured the interactions with K48-Ub2 and K63-Ub2 using 
fluorescence anisotropy experiments (Appendix C & Appendix G). The results mirrored 
what was observed in the binding experiments proving that the interactions were real 
and not an artefact of the assay.   
In order to study the difference in function of isolated and native domains, point 
mutations were constructed that would inhibit ubiquitin binding but not alter tertiary 
structure in both isolated domains and full length Rhp23. The GST tagged proteins were 
then assayed for their ability to bind K48 and K63 chains. The results of the two isolated 
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UBA domains showed that both were capable of binding to K48 and K63 chains at a 
lower affinity compared to WT Rhp23 and that the point mutations abolished this 
binding. This proved that both Rhp23 UBA domains have the ability to recognise 
ubiquitin chains, as seen in other studies, and in different homologs (Wilkinson et al. 
2001; Raasi et al. 2005). It also showed that the mutations predicted to cause a loss of 
ubiquitin recognition did indeed abolish binding (Ryu et al. 2003). 
Unexpectedly, when these assays were repeated with full length proteins, mutations to 
the UBA1 domain resulted in loss of K63 binding and a dramatic reduction in the ability 
to bind K48 chains; whereas, corresponding mutations to the UBA2 domain had no 
visible effect on binding to either chain. The conclusion from these experiments is that 
the UBA1 domain is responsible for the majority of ubiquitin chain binding, something 
that would not be predicted from the isolated domain study. This mirrors results 
produced by Chen & Madura (2002) in S. cerevisiae where they used Flag-RAD23 to 
purify the protein and analyse ubiquitin conjugates bound to WT, mutated and truncated 
proteins. When they put a single point mutation in the UBA1 domain this caused an 80% 
reduction in ubiquitin binding whilst a mutation in the UBA2 domain only caused a 20% 
reduction. However they never showed the effects of these mutations to the domains in 
isolation or that these mutations had no effect on the protein structure.  
The result of this study suggests that the UBA2 domain in isolation behaves differently 
compared to the full length protein. The difference in results between the isolated 
domains and the full length protein with mutations suggest that the context of the 
domain in relation to the protein as a whole may influence its function. This hypothesis 
has been raised before by Raasi et al. (2005) as they observed a change in chain linkage 
preference, not a complete loss of ubiquitin binding activity. Therefore to properly 
understand the UBA domains function they must be studied in the context of the whole 
protein. 
To better dissect the role of the UBA1 and UBA2 domains, their function outside of 
Rhp23 was tested by forming Pus1∆UIM chimeric fusion proteins. Pus1 is another 
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shuttle factor, as well as a subunit of the proteasome, which contains domains of similar 
function as Rhp23. The removal of the UIM domain rendered the protein unable to bind 
ubiquitin chains. Therefore, any ubiquitin chain binding affinity generated by grafting a 
minimal UBA onto this protein would be due to the domain. These chimeric proteins 
showed that UBA1 again binds both K48 and K63 linked ubiquitin chains with better 
affinity than UBA2. This is an important result as it shows that the UBA1 domain can 
bind ubiquitin whether it is internal or at the C-terminus of a protein. However, the 
UBA2 still cannot recognise chains, even though it is occupying the same protein 
position as it does in Rhp23. This result, along with the Rhp23 mutation studies, 
suggests that ubiquitin recognition is not the main function of the UBA2 domain. One 
explanation for this difference is that the addition of protein to the N-terminus of the 
UBA2 changes its ability to bind ubiquitin chains. Although they have the same 
structure, the two domains have very difference sequences. This difference may be the 
reason why the UBA1 domain’s ubiquitin binding function appears to be unaffected by 
the addition of protein at either end of the domain, yet the addition of protein to the N-
terminus of UBA2 dramatically effects its binding ability.  
Another interesting observation that arises from this experiment is the UIM domain can 
be replaced by the UBA1 domain, showing that the main function of both of these 
domains is to act as receptors for ubiquitin chain binding even though they have a 
completely different structure. Originally these constructs were cloned into the fission 
yeast expression vector pREP1 to perform the in vivo assay used to test the function of 
inactive UBA domains. This yielded an unexpected yet very interesting result. When 
Pus1ΔUIM was transformed into pus1Δ a crossed to rhp23Δ as a negative control, this 
protein was able to rescue the growth phenotype rhp23Δpus1Δ (Appendix D). When the 
more stringent assay with rhp23Δpus1Δdph1Δ was tested Pus1ΔUIM also rescued the 
lethal phenotype (data not shown). This protein cannot bind ubiquitin and the only other 
functional domain present was the vWA domain. The vWA domain interacts with the 
proteasome and it has been shown that removal of the first 83 amino acids of Rhp23 
disrupts this interaction. When N83ΔPus1 and N83ΔPus1ΔUIM constructs were tested 
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neither could rescue the phenotype. This suggests that the vWA domain plays an 
important role in the UPS which has yet to be defined, possibly interacting with a yet 
undiscovered ubiquitin receptor. Since the Pus1ΔUIM could rescue the triple mutant, the 
chimeric Pus1 proteins could not be tested in vivo. 
Other functions outside of ubiquitin binding have been proposed for the UBA2 domain. 
Heessen et al. (2005) presented evidence that the C-terminal position of the UBA2 
domain allows it to protect Rhp23 from being degraded by the proteasome when 
delivering substrates and that removal of the UBA2 domain drastically decreases the 
half life of Rhp23 in vivo. This may explain why UBA2 appears to have no ubiquitin 
binding ability in the Rhp23 protein. In order to dissect whether it is the position of the 
UBA2 domain or the domain its self which causes this inactivation, an Rhp23 chimeric 
protein was created which contained the M157AL183A mutations in the internal UBA1. 
UBA2 was removed and a WT UBA1 domain put in its place. This 
Rhp23M157AL183AΔUBA2 +UBA1 protein seemed to bind K48 and K63 chains at a 
level similar or exceeding WT Rhp23. Since the mutations have been shown to 
completely abolish ubiquitin binding, this data suggests that the C-terminal UBA1 is 
responsible for binding. Taken along with the Pus1 chimeric protein results this 
concludes that it is the UBA1 domain itself which is responsible for its binding 
efficiency, not its location. This is also consistent with the finding of Heessen et al. 
(2005) where the UBA2 but not the UBA1 domain could cause stability of UPS 
substrates when added to the C-terminus. If the UBA2 domain is responsible for 
protecting Rhp23 from degradation it may be due to a combined result of its sequence 
and its location, not just its location.  
In order to understand the UBA2 role fully Rhp23M157AL183AΔUBA2+UBA1 should 
be tested for its ability to protect Rhp23 from degradation. This data could explain if any 
UBA domain at the C-terminal is capable of this function or whether the sequence of 
this domain plays an important role. Another key experiment would be to swap around 
the UBA1 and UBA2 domains so that the UBA2 is internal then carry out mutation 
experiments in a similar manner as previously described in this work. This would allow 
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further analysis into how the protein environment of a domain affects its function. 
However, one major problem with this approach would be that swapping the domains is 
likely to have a severe impact on the protein structure, and it might be unclear how much 
this would affect ubiquitin binding affinities.  
This study is the first time the ubiquitin binding abilities of the two UBA domains have 
been tested individually in S. pombe. Whilst empty pREP81, Rhp23 M157AL183A and 
Rhp23 M157AL183AL332AF358A could not rescue lethality, Rhp23 and Rhp23 
L332AF358A could. The results thereby show that only the UBA1 domain activity is 
essential for Rhp23s function in the UPS whilst the UBA2 domain appears redundant. 
This exciting result is consistent with the observations made in the binding assays, but 
appears to differ with results in budding yeast. A similar experiment concluded that 
Flag-RAD23 with just a functional UBA1 domain was not enough to rescue the 
rad23Δrpn10Δ phenotype (Chen & Madura 2002). It could be the case that RAD23 is 
acting different in S. cerevisiae compared to Rhp23 in pombe. However, S. pombe 
maybe a better in vivo assay system for testing ubiquitin binding associated with the 
UPS since rad23Δrpn10Δ does not display any phenotype at permissive temperature and 
is cold sensitive (cs), where even at the lowest temperature tested (13
o
C) the double 
mutant showed some growth. This phenotype is not as severe as the rhp23Δpus1Δdph1Δ 
mutant or even the rhp23Δpus1Δ mutant in S. pombe. Chen & Madura (2002) also tested 
rescue of rad23Δrpn10Δ sensitivity to the arginine analog canavanine. Growth assays 
showed that neither WT or the mutant Flag-RAD23 could restore the phenotype to WT 
growth.  
From this study it is still unclear what the function of the UBA2 domain is. It has been 
well established that the UBA domains are not required for Rhp23 role in Nucleotide 
Excision Repair (NER) after DNA damage (Bertolaet et al. 2001). One observed 
function of the UBA2 domain is that it protects Rhp23 from being degraded (Heessen et 
al. 2005). This would fit in with this study as a protection role may not require ubiquitin 
binding ability of the domain. Rhp23 and its homologs have also been shown to have a 
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role in preventing degradation of substrates which requires ubiquitin recognition 
(Ortolan et al. 2000; Clarke et al. 2001; Chen & Madura 2002; Raasi & Pickart 2003).  
An attractive hypothesis is that the UBAs compete with proteasomal based receptors and 
bind chains of the tagged targets, thereby preventing delivery of substrates to the 
proteasome, and that this action is concentration dependent. Two other observed 
functions of the ubiquitin binding domains include blocking ubiquitin chain elongation 
when Rad23 is overexpressed as well as inhibiting deubiquitination of substrates which 
requires only the minimal ubiquitin binding domains (Ortolan et al. 2000; Hartmann-
Petersen, K. B. Hendil & Gordon 2003a). These finding suggest that the binding of the 
domains may physically block additional or removal of ubiquitin moieties to the chain. 
Taken together these observations predict that there is an additional layer of regulation 
provided by the shuttle factors, particularly Rhp23, to control which substrates are 
degraded and when. However the precise mechanism of how these events occur has yet 
to be described and it is possible that although the UBA2 domain does not appear to 














7.1 Role of Kinases Associated Domain 
Since its discovery, ubiquitin has been linked to numerous different pathways and its 
importance as a post translational modification may rival that of phosphorylation. 
Understanding how ubiquitination is regulated in normal conditions, and the 
consequences of its mis-regulation, has been of great interest to scientists as it has the 
potential to lead to new therapies for a multitude of different diseases.  
The KA1 domains were originally found in the MARK/Par1/Kin1 family of protein 
kinases. They are found at the C-terminal of serine/threonine kinases and were originally 
described as having a conserved aspartic acid residue and ended in a highly conserved 
ELKL motif. This definition has been widened to include domains which do not end in 
the ELKL motif and domains which have a conserved glutamic acid residue. 
Bioinformatics analysis performed by Kay Hofmann (Miltenyi Biotec GmbH, 
Stoeckhimer) found that three of the known kinases encoded by S. pombe contain KA1 
domains, Ssp2, Ppk9 and Kin1 whilst another associated domain, which he named the 
KA2 is found in Chk1. 
Previous work has shown that two of these kinases, Ssp2 and Ppk9 can bind to APC/C. 
This project first set out to determine if the KA1 domain of these proteins was 
responsible for this interaction, and if so, if this is a function common to all KA 
domains. The results presented in this work show that all three KA1 and the KA2 
domains can bind APC/C. Interestingly, the Cut9-HA strain used to performed in vitro 
binding assays demonstrated that the KA domains exclusively bind APC/C containing 
unphosphorylated Cut9. This would suggest that there is something specific about this 
form of APC/C that the KA domains recognise. Yeast two hybrid analysis showed that 
the KA domains did not interact with any of the core APC/C subunits, but a library 
screen revealed that the Chk1 KA2 domain could interact with the co-activator Slp1. 
This interaction was confirmed by binding assays using GST-Slp1, which can interact 
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with Chk1-HA, and also by native far Westerns for all four KA domains against whole 
cell extract from a Slp1-GFP strain.  
This mode of interaction may explain why the domains appear to select for a certain 
form of APC/C. Since APC/C is active throughout the cell cycle it utilises two co-
activators to recognise specific substrates at different points of the cell cycle. APC/Cs 
activity is also regulated by phosphorylation which can render it active or inactive 
depending on the subunits modified and the kinase responsible. A possible explaination 
could be that Slp1 only binds to APC/C when it contains unphosphorylated Cut9. As a 
result when the KA domains bind Slp1, they interact with APC/C containing 
unphosphorylated Cut9. It remains undetermined from these results whether the KA 
domains can bind free Slp1 or only when it is part of the APC/C complex. However, in 
the in vitro binding assay GST-Slp1 could only bind Chk1-HA and not Ssp2-HA or 
Ppk9-HA, yet in the native far Westerns the GST-KA domains could bind Slp1-GFP. 
This may suggest that the domains only interact with Slp1 when it is part of APC/C
Slp1
.  
The second aim of this project was to determine if these kinases have any role in 
regulating APC/C. Phosphorylation assays using GST tagged full length Ssp2, Ppk9 and 
Kin1 and TAP tagged purified APC/C showed that these kinases phosphorylated a 
specific ~30kDa protein. None of the core APC/C subunits or its co-activators correlate 
to this molecular weight. However Sczaniecka et al. (2008) performed similar 
purifications of APC/C and showed that the MCC subunit Mad2 co-purified with APC/C 
and appear in Western analysis at ~ 30kDa, making it a candidate. Repeat 
phosphorylation assay with GST-Mad2 showed that Ssp2 and Ppk9 can phosphorylate 
Mad2. Studies have shown that the phosphorylation state of Mad2 regulates its ability to 
bind Slp1 and form the MCC which inhibits APC/C
Slp1
 activity. However the kinases 
responsible for phosphorylating Slp1 have yet to be identified. Therefore these are the 
first kinases reported that can act on Mad2. 
Another interesting result seen from the phosphorylation assays was that full length 
proteins could not autophosphorylate, but ∆KAs could. This would support the 
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hypothesis that the KA domain may act as an auto-inhibitor domain for the N-terminal 
kinase domain. This is also supported by the tertiary structure of Ssp2 and Ppk9.  
Together this has lead to the proposed model in Figure 19, in which the KA domains 
bind to and inhibit the kinase domains. After a cellular event the KA domains then bind 
to Slp1 in the APC/C complex. The kinase domain is then free to act on Mad2 which 
also binds Slp1 as part of the MCC. This phosphorylation causes the MCC to dissociate 
and leaves APC/C
Slp1
 free to act.  
These findings have given rise to other questions not addressed in this work. It would be 
important to study how the addition of the KA containing kinases affects APC/C
Slp1
 
activity in a cell free system. The exact binding site of the domains on Slp1 is not 
known, or if KA1 and KA2 recognise the same site which could be determined by 
competition studies. Also, the phosphorylation sites on Mad2 need to be identified to see 
if all four kinases can phosphorylate the same residues.  
All four null mutants of the KA containing kinases are viable, as are every double, triple 
and even the quadruple mutant. Genetic analysis performed in this study could not find a 
phenotype that was common to all four mutants. However kin1∆ was linked to the UPS 
since a double mutant with the proteasome mutant mts3.1 was synthetically lethal. It was 
also the only mutant which showed an increase in mis-segregation of chromosomes, 
both of which is consistent with Kin1 regulating APC/C activity.  
 
7.2 Role of Ubiquitin Binding Domains in Rhp23 
The second project presented here was concerned with dissecting the role of the two 
UBA domains of Rhp23 in S. pombe. Unlike the shuttle factors Pus1 and Dph1, Rhp23 
has two UBD; an internal UBA1 and a C-terminal UBA2. These minimal domains were 
expressed as GST fusion proteins and assayed for K48 and K63 ubiquitin chain binding 
ability. Both of these domains can bind both chain types but two point mutants in either 
domain, which were predicted not to alter the structure, abolished ubiquitin binding.  
However, when these point mutations were tested in full length Rhp23, the binding 
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assay revealed that the UBA1 domain of Rhp23 seemed to be responsible for the 
majority of Rhp23 ability to bind K48 and K63 chains. Mutating the UBA2 domain has 
little effect on ubiquitin binding.  
To further test the two domains ubiquitin binding activity chimeric proteins were 
constructed. The shuttle protein Pus1 with its UIM domain removed was used since it 
could not bind ubiquitin. The minimal UBA domains were then grafted onto this protein. 
Binding assays showed that Pus1∆UIMUBA1 could bind both types of ubiquitin chains, 
but Pus1∆UIMUBA2 could not. A further chimeric protein was made in which Rhp23 
had its UBA1 domain mutated and its UBA2 domain replaced with a WT UBA1 
domain. This Rhp23M157AL183A∆UBA2+UBA1 protein could bind K48 and K63 
chains at a similar level to WT Rhp23. These experiments would suggest that the UBA1 
domain can bind ubiquitin regardless of whether it is an isolated domain or as part of a 
protein, either as an internal or C-terminal domain. However, the UBA2 domain only 
appears to bind ubiquitin when it is an isolated minimal domain. The mutation 
experiments and chimeric proteins show that the domain has little binding activity when 
part of a protein.  
These results are supported by quantitative binding assays performed in collaboration 
with Jane Endicott’s group (Department of Biochemistry, University of Oxford). The 
same WT and mutated Rhp23 proteins were expressed and the GST tag cleaved off. 
These proteins were subjected to fluorescence anisotropy experiments to measure 
binding constants which mirrored what was seen by Western blot analysis.  
in vivo analysis of the Rhp23 UBA domains has never been performed in S. pombe. 
rhp23∆pus1∆dph1∆ strains were created that expressed pREP containing WT or 
mutated Rhp23 to look for rescue. These results showed that WT and UBA2 mutated 
Rhp23 could rescue the triple mutant, were as the UBA1 mutated Rhp23and UBA1 and 
2 mutated Rhp23 could not. Taken together, these results show that UBA1 domain is 
more important than the UBA2 domain in the UPS. The Western blot analysis show that 
UBA domains can behave differently in isolation compared to in a full length protein, 
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suggesting that the protein environment can alter the domains function, and the only 
accurate way to determine a role of the domain is to study it as part of a protein. 
Although this work does not determine a role for the UBA2 domain, Heessen et al. 
(2005) demonstrate that the UBA2 domain is needed to protect Rhp23 from being 
degraded by the proteasome. Together this data suggests that the UBA1 domain is 
responsible for binding ubiquitin, regardless of its position in the protein, whilst the 
UBA2 domain may be responsible for protecting the protein from becoming a 
proteasome substrate itself. Although Heessen et al. (2005) presented some evidence to 
suggest that this function is specific to UBA2 domain; it would be interesting to repeat 
their assay using the Rhp23M157AL183A∆UBA2+UBA1 construct to determine 









Appendix A: Example of Yeast Two Hydrid Assay.  
The J69-4A budding yeast strain was transformed with bait and prey constructs indicated in the table and 
spotted directly onto plates.  SC-LW media was used to test for successful transformation, SC-LWH to 
look for weak interactions and SC-LWHA to test for strong interactions. Each construct was tested with 
the opposite empty vector to rule out self activation. Snf1 and Snf4 were used as a positive control whilst 




Appendix B: TAP Tag Purification of APC/C.                                                                                           
TAP tag purification of APC/C from Cut20/Lid1 strain which was separated on SDS PAGE gel then silver 
stained. Banding pattern was comparable to similar staining performed by Yoon et al. (2002) on purified 





Appendix C: Binding Affinities for Full Length Rhp23 and UBA Domains.                                              
a) Full length Rhp23 binding to K48-Ub2 (green) K63-Ub2 (black) mono-Ub (brown). b) UBA1 domain 
binding to K48-Ub2 K63-Ub2 mono-Ub. c) UBA2 domain binding to K48-Ub2 K63-Ub2 mono-Ub. d) 
Binding of K48-Ub2 to WT Rhp23 (black), Rhp23 M157AL183A (orange) Rhp23 L332AF358A (blue) 
Rhp23 M157AL183AL332AF358A (red). e) Binding UBA1 (black) UBA2 (blue) UBA1 M157AL183A 





Appendix D: in vivo Assay of Pus1ΔUIM Rescue of pus1Δ::urarhp23Δ::G418.                                                                                            
pus1Δ::ura transformed with pREP1 constructs and crossed to rhp23Δ::G418. Free spore analysis was 
performed and spores plated onto PMG-Leu to show the presence of spore carrying the plasmid, or PMG-
Leu-Ura+G418 to select for pus1Δ::ura rhp23Δ::G418 double mutants carrying the plasmid. Empty 
pREP1 could not rescue the double mutants, unlike the Pus1 control. However, Pus1ΔUIM could rescue 











Appendix F: Time Course of O.D from WT and KA Kinase Strains.                                                  
YES was inoculated with WT ssp2Δ, ppk9Δ, kin1Δ or chk1Δ and grown over night at 25oC. The O.D.600 


















Appendix G: Binding Constants for Full Length Rhp23 and Isolated UBA Domains.                           
Kd values were calculated full length and isolated domain proteins without the GST tagged by 
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